
<html lang="en"     class="pb-page"  data-request-id="dc1098df-2914-4157-97c0-e0c23787c3e7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm9014263;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-2"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase" /></meta><meta name="dc.Creator" content="Tina  Morwick" /></meta><meta name="dc.Creator" content="Frank H.  Büttner" /></meta><meta name="dc.Creator" content="Charles L.  Cywin" /></meta><meta name="dc.Creator" content="Georg  Dahmann" /></meta><meta name="dc.Creator" content="Eugene  Hickey" /></meta><meta name="dc.Creator" content="Scott  Jakes" /></meta><meta name="dc.Creator" content="Paul  Kaplita" /></meta><meta name="dc.Creator" content="Mohammed A.  Kashem" /></meta><meta name="dc.Creator" content="Steven  Kerr" /></meta><meta name="dc.Creator" content="Stanley  Kugler" /></meta><meta name="dc.Creator" content="Wang  Mao" /></meta><meta name="dc.Creator" content="Daniel  Marshall" /></meta><meta name="dc.Creator" content="Zofia  Paw" /></meta><meta name="dc.Creator" content="Cheng-Kon  Shih" /></meta><meta name="dc.Creator" content="Frank  Wu" /></meta><meta name="dc.Creator" content="Erick  Young" /></meta><meta name="dc.Description" content="A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both identified by high throughput screening (..." /></meta><meta name="Description" content="A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both identified by high throughput screening (..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9014263" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9014263" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9014263" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9014263" /></link>
        
    
    

<title>Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9014263" /></meta><meta property="og:title" content="Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0019.jpeg" /></meta><meta property="og:description" content="A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both identified by high throughput screening (HTS), are described. Details of the hit validation and lead generation process, including structure−activity relationship (SAR) studies, a selectivity assessment, target-independent profiling (TIP) results, and an analysis of functional activity using a rat aortic ring assay are discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9014263"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9014263">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9014263&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9014263&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9014263&amp;href=/doi/10.1021/jm9014263" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 759-777</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9014229" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901440f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tina++Morwick">Tina Morwick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank+H.++B%C3%BCttner">Frank H. Büttner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+L.++Cywin">Charles L. Cywin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georg++Dahmann">Georg Dahmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene++Hickey">Eugene Hickey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Jakes">Scott Jakes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Kaplita">Paul Kaplita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohammed+A.++Kashem">Mohammed A. Kashem</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Kerr">Steven Kerr</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley++Kugler">Stanley Kugler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wang++Mao">Wang Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Marshall">Daniel Marshall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zofia++Paw">Zofia Paw</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Kon++Shih">Cheng-Kon Shih</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Wu">Frank Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erick++Young">Erick Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Boehringer Ingelheim Pharma GmbH and Co. KG, Birkendorfer Strasse 65, D-88397 Biberach an der Riss, Germany</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (203) 798-5751; Fax: 203-798-5297. E-mail: <a href="/cdn-cgi/l/email-protection#5521383a27223c363e152731327b373a303d273c3b323027783c3b3230393d303c387b363a38"><span class="__cf_email__" data-cfemail="67130a0815100e040c27150300490508020f150e090002154a0e0900020b0f020e0a4904080a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9014263&amp;href=/doi/10.1021%2Fjm9014263" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 759–777</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 September 2009</li><li><span class="item_label"><b>Published</b> online</span>10 December 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 January 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9014263" title="DOI URL">https://doi.org/10.1021/jm9014263</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D759%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTina%2BMorwick%252C%2BFrank%2BH.%2BB%25C3%25BCttner%252C%2BCharles%2BL.%2BCywin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D2%26contentID%3Djm9014263%26title%3DHit%2Bto%2BLead%2BAccount%2Bof%2Bthe%2BDiscovery%2Bof%2BBisbenzamide%2Band%2BRelated%2BUreidobenzamide%2BInhibitors%2Bof%2BRho%2BKinase%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D777%26publicationDate%3DJanuary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9014263"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2688</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9014263" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tina&quot;,&quot;last_name&quot;:&quot;Morwick&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;H. Büttner&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;L. Cywin&quot;},{&quot;first_name&quot;:&quot;Georg&quot;,&quot;last_name&quot;:&quot;Dahmann&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;Hickey&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Jakes&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Kaplita&quot;},{&quot;first_name&quot;:&quot;Mohammed&quot;,&quot;last_name&quot;:&quot;A. Kashem&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Kerr&quot;},{&quot;first_name&quot;:&quot;Stanley&quot;,&quot;last_name&quot;:&quot;Kugler&quot;},{&quot;first_name&quot;:&quot;Wang&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Marshall&quot;},{&quot;first_name&quot;:&quot;Zofia&quot;,&quot;last_name&quot;:&quot;Paw&quot;},{&quot;first_name&quot;:&quot;Cheng-Kon&quot;,&quot;last_name&quot;:&quot;Shih&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Erick&quot;,&quot;last_name&quot;:&quot;Young&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;759-777&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9014263&quot;},&quot;abstract&quot;:&quot;A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both identified by high throughput screening (HTS), are described. Details of the hit validation and lead generation process, including structure−activity relationship (SAR) studies, a selectivity assessment, target-independent profiling (TIP) results, and an analysis of functional activity using a rat aortic ring assay are discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9014263&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9014263" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9014263&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9014263" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9014263&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9014263" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9014263&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9014263&amp;href=/doi/10.1021/jm9014263" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9014263" /></input><a href="/doi/pdf/10.1021/jm9014263" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9014263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9014263%26sid%3Dliteratum%253Aachs%26pmid%3D20000469%26genre%3Darticle%26aulast%3DMorwick%26date%3D2010%26atitle%3DHit%2Bto%2BLead%2BAccount%2Bof%2Bthe%2BDiscovery%2Bof%2BBisbenzamide%2Band%2BRelated%2BUreidobenzamide%2BInhibitors%2Bof%2BRho%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D2%26spage%3D759%26epage%3D777%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both identified by high throughput screening (HTS), are described. Details of the hit validation and lead generation process, including structure−activity relationship (SAR) studies, a selectivity assessment, target-independent profiling (TIP) results, and an analysis of functional activity using a rat aortic ring assay are discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The evolution from a pharmacology-based to a target-based approach in drug discovery has presented both opportunities and challenges to the pharmaceutical industry.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Utilization of high-throughput biochemical assays for the identification of small molecule chemical ligands which interact with distinct protein targets greatly enhances the ability to identify potential drug candidates, and knowledge of the specific molecular target provides information to support mechanism of action. Significant challenges exist, however, in the identification of druggable, disease-relevant targets, and the selection of biochemically active lead structures which can be developed into pharmacologically active agents useful in the treatment of disease. When high-throughput screening (HTS)<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: AGC, cAMP-dependent, cGMP-dependent and protein kinase C; CDC42BPB, CDC42-binding protein kinase β; DMPK, dystrophia myotonica protein kinase; GDP, guanosine-5′-diphosphate; GTP, guanosine-5′-triphosphate; HTS, high-throughput screening; HtL, hit-to-lead; IMAP, immobilized metal ion affinity-based fluorescence polarization; ITC, isothermal titration calorimetry; LHS, left-hand side; LI, lead identification; MBS, myosin binding subunit; MLC, myosin light chain; MLCK, myosin light chain kinase; MLCP, myosin light chain phosphatase; PI3K, phosphatidylinositol 3-kinase; PKA, protein kinase A; PKN2, PKC-related kinase, protein kinase N2; PKCε, protein kinase C epsilon; POC, percent of control; RBD, Rho binding domain; RHS, right-hand side; SCX, strong cation exchanger, silica-bound <i>p</i>-toluenesulfonic acid; <i>Si</i>-DMA, silica-bound dimethylamine; TF, tissue factor.</p></div> enables the target-based lead identification (LI) process, hit-to-lead (HtL) groups have been utilized.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This core LI group facilitates the validation of screening hits and selection of promising lead candidates. In this paper, we describe our HtL efforts to identify inhibitors of Rho kinase and our discovery of a series of bisbenzamides and related ureidobenzamides as novel chemotypes demonstrating potent Rho kinase inhibition.</div><div class="NLM_p">Rho kinase, also referred to as Rho-associated coiled-coil containing serine/threonine protein kinase (ROCK) is a downstream effector of RhoA G proteins following GTP-binding and activation. In humans, the Rho family consists of at least 20 members and belongs to the Ras superfamily of monomeric GTP/GDP-binding (GTP)ases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Rho A, one of the most well-characterized members, was originally identified as a homologue to oncogene Ras.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> RhoA influences multiple cellular processes including cytoskeletal rearrangement, gene expression, and membrane trafficking, as well as cell adhesion, migration, differentiation, proliferation, and apoptosis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The name Rho sometimes refers collectively to RhoA, RhoB, and RhoC, which share identical effector domains, and Rho kinases bind to all three.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A member of the AGC family of protein kinases, ROCK plays a key role in regulation of smooth muscle contraction and formation of stress fibers and focal adhesions in nonmuscle cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Two Rho kinase isoforms have been identified, ROCK1 and ROCK2, which share 65% overall homology with 92% identity in their kinase domains and absolute identity in the ATP-binding pocket.<a onclick="showRef(event, 'cit4b'); return false;" href="javascript:void(0);" class="ref cit4b">(4b)</a> These proteins are ubiquitously expressed, but ROCK1 is reportedly more prominent in lung, liver, and testes, while ROCK2 expression is enriched in brain and muscle.<a onclick="showRef(event, 'cit4b ref8'); return false;" href="javascript:void(0);" class="ref cit4b ref8">(4b, 8)</a> ROCK1 and ROCK2 have generally been considered to be functionally redundant. However, sporadic reports have highlighted some differences.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> For example, studies with primary rat embryo fibroblasts have suggested that stress fiber and focal adhesion formation may be dependent on ROCK1 but not ROCK2. Also, it has been noted that ROCK1, but not ROCK2, binds and phosphorylates RhoE.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A unique function for ROCK2 in mediating glucocorticoid-induced formation of tight junction sealing in rat mammary epithelial cells has also been reported. This apparently occurs as a consequence of differential expression and activity of Rho kinase isoforms following treatment with dexamethasone.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">A key mechanism for regulation of muscle cell contractility and nonmuscle cytoskeletal organization through the Rho/ROCK pathway involves the phosphorylation state of the molecular motor myosin II on Ser19 of its regulatory light chain (MLC). Phosphorylation of this residue leads to increased contractility and formation of stress fibers and focal adhesions. Maintaining Ser19 of MLC in a phosphorylated state is accomplished by protein kinases such as myosin light chain kinase (MLCK) through a Ca<sup>2+</sup>-dependent mechanism and inhibition of myosin light chain phosphatase (MLCP) via a Ca<sup>2+</sup>-independent process. Activated ROCK inhibits MLCP by phosphorylation of its regulatory myosin binding subunit (MBS), thereby prolonging the phosphorylated state of MLC at serine 19. Additionally, ROCK can reportedly directly phosphorylate MLC.<a onclick="showRef(event, 'cit4a cit4b ref12'); return false;" href="javascript:void(0);" class="ref cit4a cit4b ref12">(4a, 4b, 12)</a></div><div class="NLM_p">The Rho/ROCK pathway is activated by multiple stimuli including various GPCR agonists and inflammatory cytokines. ROCK activity is self-regulated by an autoinhibitory carboxy terminus. The C-terminal region incorporates a Rho-binding domain and the interaction between RBD and Rho-GTP reverses autoinhibition and activates the kinase. This autoinhibitory region also contains a pleckstrin homology domain, which may have a regulatory role by interaction with lipid mediators, and lipids such as arachidonic acid have been found to activate Rho kinase.<a onclick="showRef(event, 'cit4b ref13'); return false;" href="javascript:void(0);" class="ref cit4b ref13">(4b, 13)</a></div><div class="NLM_p">Multiple potential therapeutic opportunities have been suggested for Rho kinase inhibitors including cardiovascular and cerebrovascular conditions such as hypertension, heart failure, angina, myocardial infarction, atherosclerosis, coronary and cerebral vasospasm and stroke,<a onclick="showRef(event, 'cit4a cit4b cit6a cit6b ref14'); return false;" href="javascript:void(0);" class="ref cit4a cit4b cit6a cit6b ref14">(4a, 4b, 6a, 6b, 14)</a> neurological disorders including Alzheimer’s disease, multiple sclerosis, spinal cord injury, and neuropathic pain,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> osteoporosis,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> cancer,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> bronchial asthma,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and glaucoma.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Our interest in Rho kinase was associated with its role in cardiovascular function. Both Rho and ROCK are ubiquitously expressed in vascular cells including smooth muscle, endothelial, cardiac myocytes, platelets, leukocytes and monocytes/macrophages,<a onclick="showRef(event, 'cit4b'); return false;" href="javascript:void(0);" class="ref cit4b">(4b)</a> and inhibition of Rho kinase in animal models of cardiovascular disease has demonstrated positive results in a variety of the pathological conditions cited above.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, certain endogenous agents or xenobiotics associated with positive cardiovascular outcomes may derive some of their benefit through moderation of Rho/ROCK signaling. For example, down-regulation of Rho kinase expression has been associated with physiological concentrations of estrogen, and Rho/ROCK activity has also been found to inversely correlate with eNOS expression and NO availability.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> The cardiovascular benefits of HDL also may result in part from inhibition of thrombin-induced tissue factor (TF) upregulation via inhibition of RhoA and stimulation of PI3K.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Statins have demonstrated clinical benefits in cardiovascular disease beyond their cholesterol-lowering effect. These so-called pleiotropic or cholesterol-independent effects may be mediated by reduction of isoprenoid metabolites required for post-translational protein prenylation and membrane targeting, an essential mechanism for activation of RhoA.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Several ROCK inhibitors have been reported in the literature, and many are summarized in a recent review.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Benchmark compounds used extensively to investigate the functional outcome of Rho kinase inhibition include fasudil (HA-1077, <b>1</b>) and Y-27632 (<b>2</b>). Fasudil is the only marketed Rho kinase inhibitor approved in Japan for treatment of cerebral vasospasm after subarachnoid hemorrhage.<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> Fasudil undergoes oxidation in vivo to isoquinolinone <b>3</b> (hydroxyfasudil), which is equipotent,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and a dimethyl analogue (H-1152P, <b>4</b>) shows improved potency. X-ray crystal structures of <b>1</b>−<b>4</b> in complex with ROCK1 dimer have been published (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature benchmark Rho kinase inhibitors with X-ray structures. ROCK1 data reported in refs <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and <a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">26a</a>. ROCK2 data reported in refs <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and <a onclick="showRef(event, 'cit34a'); return false;" href="javascript:void(0);" class="ref cit34a">34a</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> HTS Assay and Hit Validation Results for Inhibitor <b>5</b></h3><div class="NLM_p">The corporate compound collection was screened in a homogeneous luciferase assay using ROCK2 (1−543), substrate AKRRRLSSLRA, and a luciferin-luciferase detection reagent to quantify residual ATP. Dose−response data on compounds showing reproducible activity from the screen was generated for ROCK2 using the same assay format. Selectivity data was acquired simultaneously on the ROCK2 actives utilizing four proteins which were selected for counterscreening (rule-out) based on sequence homology (DMPK, CDC42BPB), chemotype sensitivity (PKN2), and functional significance (DMPK, PKCε, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Hits of interest were also evaluated for ROCK1 potency, and our objective at the time was the identification a dual inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Counterscreens Used for Triaging ROCK2 Actives</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">kinase</th><th align="center" char=".">% ID<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left">PKCε</td><td align="char" char=".">39</td></tr><tr valign="top"><td align="left">DMPK</td><td align="char" char=".">50</td></tr><tr valign="top"><td align="left">CDC42BPB</td><td align="char" char=".">53</td></tr><tr valign="top"><td align="left">PKN2</td><td align="char" char=".">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Sequence ID to ROCK2 (kinase domain).</p></div></div></div><div class="NLM_p">Generic criteria for hit validation has been recently published.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> One series which passed the initial filtering exercise is exemplified by the bisbenzamide structure <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This hit demonstrated low micromolar potency for both ROCK1 and ROCK2 in the luciferase assay and comparable functional activity in our aortic ring assay, which was somewhat surprising assuming an ATP competitive mechanism of inhibition. One attraction of <b>5</b> was the bisbenzamide motif, which is unusual in comparison to known kinase inhibitors, and we speculated that the scaffold might offer some advantage toward achieving selectivity. Compound <b>5</b> was not active in the counterscreen assays (all >5 μM), but its relatively weak potency for Rho kinase provided a small window for selectivity assessment. Evaluation of physicochemical properties and in vitro pharmacokinetic and safety parameters for <b>5</b> is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The inhibitor had good aqueous solubility but poor metabolic stability, and our Caco-2 results suggested that permeability may be compromised by transporter-mediated efflux. The compound also showed moderate inhibition of CYPs 2C9 and 3A4. This assessment identified areas which would need to be addressed during the lead generation stage.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Results for resynthesized compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Target-Independent Profiling Results for <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center" char=".">MW</th><th align="center" char=".">sol<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="center" char=".">Caco-2<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center" char=".">Caco-2<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th align="center" char=".">HLM <i>t</i><sub>1/2</sub>(min)</th><th align="center" char=".">CYP 1A2<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 2C9<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 2C19<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 2D6<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 3A4<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top"><td align="char" char=".">419</td><td align="char" char=".">>100/63</td><td align="char" char=".">0.5</td><td align="char" char=".">29.1</td><td align="char" char=".">10</td><td align="char" char=".">>30</td><td align="char" char=".">16</td><td align="char" char=".">>30</td><td align="char" char=".">>30</td><td align="char" char=".">4/21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Solubility (μg/mL) @ pH 4.5/7.4.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last"><i>A</i> to <i>B</i> × 10<sup>−6</sup> cm/s.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>B</i> to <i>A</i> × 10<sup>−6</sup> cm/s.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">μM.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Substrates 7-benzyloxy-4-trifluoromethylcoumarine/7-benzyloxyquinoline (BFC/BQ). (See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for method details.)</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Lead Generation: SAR Studies</h3><div class="NLM_p">Compound <b>5</b> and additional related actives having similar potency were identified from the screen. An analogous series of ureidoarylamides was also found, and some examples from both series are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Because no crystal structure for Rho kinase was available at the time of our studies, a computational model was developed based on a crystal structure of PKA, another member of the AGC subfamily (37% homology with ROCK2, kinase domain), in complex with the Rho kinase inhibitor <b>1</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q8W">1Q8W</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Docking studies of <b>5</b> and related bisbenzamides were not conclusive, and several ligands including <b>5</b> did not dock using a hinge-binding interaction as a required constraint. Studies with ligands for which a binding hypothesis could be identified suggested the ligand may form a hydrogen bond interaction with hinge region residue Met172 (NH) via the pyridine nitrogen. Known Rho kinase inhibitors utilize a variety of residues for hydrogen bonding to the hinge including pyridines, quinolines, azaindoles, indazoles, amides, and ureas.<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> However, for the bisbenzamides, a search of the screening results (actives and inactives) suggested that the dimethoxyphenyl rather than the pyridine was important for potency. For the urea series, screening data attributed significance to the cyanophenyl seen in <b>8</b> and <b>9</b>, and while the pyridine fragment was also incorporated into this hit series, the data again indicated its presence was trivial. Our initial SAR studies targeted the bisbenzamide series probing the relevance of these two terminal sites. For the dimethoxyphenyl, removal of either methoxy group, conversion to the methylenedioxy, or replacement with a dimethyl (<b>10</b>−<b>13</b>) was generally detrimental, indicating the intact LHS fragment was important for binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Modifications to the ethylpyridine substituent are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Conversion to the constrained isoquinoline (<b>14</b>) provided a modest improvement. To assess whether the pyridine/isoquinoline nitrogen secured the hydrogen bond donor interaction from the hinge, the corresponding saturated derivatives with a basic amine replacement (<b>15</b>, <b>16</b>) were made. If the pyridine (or isoquinoline) nitrogen participated in this interaction, the corresponding basic amines should lose potency as these would be protonated and unable to accept a hydrogen bond. On the contrary, a moderate to significant improvement was observed, inconsistent with the docking hypothesis but compatible with the screening data analysis. Known Rho kinase inhibitors such as <b>1</b>−<b>4</b> also have a basic amine moiety. Having demonstrated a potentially optimizable binding interaction with a basic amine, further exploration of this area was carried out. Regioisomeric versions of <b>15</b> and <b>16</b> provided further improvement (<b>17</b>, <b>18</b>), and methylation of these analogues (<b>19</b>, <b>20</b>) was either mildly adverse (<b>19</b>) or had a negligible effect on potency (<b>20</b>). Having an aromatic ring instead of the acyclic ethyl group linking the amine fragment to the right-side amide apparently offered some advantage, albeit modest (<b>5</b> vs <b>14</b>, <b>15</b> vs <b>16</b>, <b>17</b> vs <b>18</b>). Consequently, we evaluated some substituted benzylic amines, and found the <i>p</i>-dimethylaminomethylphenyl to be optimal (<b>21</b>). These studies indicated a specific binding interaction for the basic amine. Further confirmation came from the benzyl alcohol <b>22</b>, which was expectedly less potent. ATP competition was evaluated for <b>15</b>, <b>16</b>, and <b>18</b> because these analogues provided a larger window than the hit structure <b>5</b> for observing the effects of increasing concentrations of ATP (above <i>K</i><sub>M,ATP</sub>). Using an IMAP assay format, these analogues were found to be ATP competitive, which documented a mechanism of inhibition and provided support for specific binding to the protein. (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). We also measured binding constants for <b>17</b> and <b>18</b> using isothermal titration calorimetry (ITC) (<i>K</i><sub>d</sub><b>17</b> = 18 nM; <i>K</i><sub>d</sub><b>18</b> = 7 nM). In this assay, the inhibitors demonstrated strong enthalpic binding with relative potencies consistent with the enzyme assay, which further precluded the likelihood of any nonspecific mechanism of inhibition.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Examples of bisbenzamide and ureiobenzamide actives from the screen. Compounds <b>7</b> and <b>9</b> are racemic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Dimethoxyphenyl Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0011.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. RHS Optimization</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0013.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Assay values reported as the mean ± SEM of <i>n</i> ≥ 2 independent replicates.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Racemic.</p></div></div></div><div class="NLM_p">Docking studies with optimized analogues featuring the basic amine moiety remained somewhat inconclusive, and again imposing the hinge-binding constraint, several structures did not dock. However, basic analogues which did provide a binding hypothesis suggested a potential hinge-binding interaction with the oxygen of the <i>p</i>-methoxy moiety in contrast to the pyridine identified earlier. This alternative binding mode is exemplified by the tetrahydroisoquinoline <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). As can be seen in the figure, the <i>p</i>-methoxy oxygen of <b>16</b> forms a hydrogen bond interaction with the NH of hinge region residue Met172. The tetrahydroisoquinoline nitrogen forms an interaction with the side chain acid of Asp385. The docking hypothesis generated for <b>16</b> seemed more reliable, but taken as a whole, the evidence from modeling studies to support this hinge-binding interaction was not compelling since many structures failed to dock and we therefore used our SAR studies to further probe the binding mode of our inhibitors.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A partial ribbon diagram shows the binding mode for bisbenzamide <b>16</b>. Key residues (backbone and/or side chain) are shown in space-filing mode and colored by element (blue = nitrogen, red = oxygen, yellow = sulfur). Compound <b>16</b> uses the aromatic <i>p</i>-methoxy oxygen for hinge binding to Met172 (3.0 Å), while the tetrahydroisoquinoline forms an interaction with the side chain acid of Asp385 (2.6 Å). Side chain fragments for a number of hydrophobic residues in the hinge-binding region (Met169, Ile98, Phe384, and Tyr171) are also depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The next series of structures were designed to evaluate the linker regions. For these studies, <b>17</b> is the direct comparison. We had previously looked at methylation of the linker amides on hit structure <b>5</b> and found this to have a modest effect on potency (∼2 fold reduction, data not shown). Beyond simple alkylation, most other modifications to the linker atoms resulted in a substantial to complete loss of potency as can be seen from the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The presence of a methylene component in the LHS linker adjacent to the central aromatic seemed important as various modifications to the 3-atom fragment which altered or eliminated this point of flexibility were not tolerated (<b>23</b>−<b>26</b>). This indicated that rotational freedom was important in this region possibly due to a bent bioactive conformation. Replacing the LHS amide with a sulfonamide was also detrimental (<b>27</b>). What was completely tolerated, however, was inversion of the amides (<b>28</b>, <b>29</b>). These results highlight the importance of the linker components. The amides in the linker regions were potential hinge-binding candidates, and this capacity has been associated with amide functionality in known Rho kinase inhibitors.<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> However, the tolerance associated with reversing these fragments diminished the likelihood than these residues engaged the critical hinge-binding interaction.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Linker Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0014.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0015.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Assay values reported as the mean ± SEM of <i>n</i> ≥ 2 independent replicates.</p></div></div></div><div class="NLM_p">We then revisited the dimethoxyphenyl fragment, and for these studies we enlisted the dimethylaminomethylphenyl RHS moiety, making <b>21</b> the direct comparison as it had good potency and offered some synthetic advantages (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Previously we had found that removal of either methoxy group from <b>5</b> resulted in inactive compounds (<b>10</b>, <b>11</b>). However, using a more potent basic amine replacement for the pyridine, we could now differentiate between the two, and found the <i>p</i>-methoxy to be somewhat more significant (<b>30</b>, <b>31</b>) as might be expected from the modeling studies. However, a considerable reduction in potency was observed on removal of either of these functional groups, affirming the importance of both. Conversion to the dihydroxy (<b>32</b>) was not tolerated nor was a methylenedioxy substitution (data not shown) as seen previously for <b>12</b>, suggesting a potential hydrophobic interaction for one or both of the methyl groups. Other replacements such as dimethyl or dichloro, or regiochemical modifications to the methoxy substituents (data not shown), were also not tolerated. Interestingly, keeping the <i>p</i>-methoxy and substituting a methyl, chloro, or trifluoromethyl for the <i>m</i>-methoxy group recaptured some of the loss in potency (<b>33</b>−<b>35</b>), further indicating that hydrophobic interactions likely contributed to binding in this region. However the reverse tactic employing the <i>m</i>-methoxy fragment was not useful (data not shown). Because the alkoxy group at the para position consistently demonstrated its significance, we further probed its hinge-binding potential generating <b>36</b> with an electron-withdrawing trifluoromethyl bonded to the oxygen. A moderate reduction in potency was seen (7-fold) providing some support for a hinge-binding hypothesis. However, comparing <b>33</b> to <b>34</b> and <b>35</b>, it was noted that no loss in potency occurred as a result of an adjacent electron-withdrawing group as might be expected if oxygen was a hydrogen bond acceptor. We also tried to incorporate other groups at this position, which may be more capable of mediating a hydrogen bond interaction including a nitrile (<b>37</b>), amide, and urea (not shown), but nothing proved useful. While these SAR results did not clearly support the hinge-binding hypothesis suggested by docking studies, they definitively established the significance of LHS aromatic substituents for binding. Furthermore, our studies afforded some evidence to suggest that hydrophobic interactions may be important. In support of these findings, it was noted that the region occupied by these fragments in docked structure <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) contained several hydrophobic residues in close proximity including Met169 (gatekeeper), Ile98, Phe384, and Tyr171.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Modifications to the Dimethoxyphenyl Fragment</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0016.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">R</th><th align="center" char="±">hROCK2 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>21</b></td><td align="left">3,4-diOMe</td><td align="char" char="±">69 ± 8.9</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">3-OMe</td><td align="char" char="±">>7000</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">4-OMe</td><td align="char" char="±">1300 ± 58</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">3,4-diOH</td><td align="char" char="±">>6000</td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">3-Me-4-OMe</td><td align="char" char="±">266 ± 61</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">3-Cl-4-OMe</td><td align="char" char="±">92 ± 13</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">3-CF<sub>3</sub>-4-OMe</td><td align="char" char="±">160 ± 42</td></tr><tr valign="top"><td align="left"><b>36</b></td><td align="left">3-Cl-4-OCF<sub>3</sub></td><td align="char" char="±">670 ± 110</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="left">4-CN</td><td align="char" char="±">1700 ± 385</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Assay values reported as the mean ± SEM of <i>n</i> ≥ 2 independent replicates.</p></div></div></div><div class="NLM_p">In summary, our SAR studies for the bisbenzamide series demonstrated structure-based inhibition and identified optimizable regions. We could not determine with confidence what moiety, if any, was involved in hydrogen-bonding with the hinge. Because this is a critical feature for most kinase inhibitors, the potential absence of hinge-binding was seen as an opportunity to gain selectivity. Fragments which were deemed important included a right-hand side (RHS) aromatic linking to a saturated, basic amine moiety, the two central amide linkers, one of which incorporated an essential adjacent methylene, and the LHS aromatic attachments.</div><div class="NLM_p">We next turned our attention to the ureidobenzamide series guided by the information acquired from the bisbenzamide work. Our starting point here focused on structure <b>8</b>, which had similar potency to hit compound <b>5</b>. Results are shown in Table 7. Replacing the pyridine of <b>8</b> with the ethylpiperidine fragment having the preferred regiochemistry led to a significant improvement in potency as seen previously (<b>38</b>). However replacement of the nitrile of <b>38</b> with the 3,4-dimethoxy pattern found optimal for the bisbenzamides had the opposite effect (<b>39</b>). This was not too surprising, as utilization of the nitrile in the bisbenzamide series also was not profitable (<b>37</b>), indicating some differences in binding for the two series. However, similar to previous findings, para substitution of the LHS aromatic contributed more significantly than meta, in this case using the nitrile substituent (<b>38</b> vs <b>40</b>). We looked at inversion of the RHS amide of <b>40</b>, an inconsequential modification in the bisbenzamide series. In this case, a moderate reduction in potency was observed (<b>41</b>). We then explored the RHS amine of <b>40</b> incorporating some of the interesting groups identified from the previous SAR. Similar regiochemical preference for the piperidine was observed comparing <b>42</b> to the preferred <b>40</b>, but incorporating the aromatic into the RHS linker had a more negligible effect on binding (<b>43</b>). A comparable tolerance was also seen for the dimethyl-substituted <i>p</i>-aminomethylphenyl analogue <b>44</b>, which was equipotent to its unsubstituted counterpart, <b>45</b>. We used the <i>p</i>-dimethylaminomethylphenyl RHS motif to further evaluate the LHS aromatic substitution. This group not only provided a synthetic advantage as before, but also, having a more moderate level of potency, it allowed us more room to quantitate improvements. Again, it was found that the substitution on the LHS aromatic was somewhat uncompromising, and most replacements for the nitrile were not tolerated. These included monosubstitution at the 3 or 4 position by methoxy, trifluoromethyl, or halogen, or a para-substituted ester or primary urea, all of which showed no inhibition up to a concentration of 5 μM (data not shown). However, incorporation of chlorine adjacent to the nitrile provided a boost in potency (<b>46</b>) as seen previously for <b>34</b>, consistently indicating the importance of hydrophobic interactions in this region. However, unlike before, on replacement of the nitrile with an amide (<b>47</b>) in an attempt to identify any hinge-binding potential for the substituent at this position, we observed an 8-fold advantage, suggesting that this series may have better access to the hinge, assuming a proximal location. Interestingly, incorporation of a chlorine substituent adjacent to the purported hinge-binding amide erased its contribution (<b>48</b>) unlike what was observed with the nitrile, suggesting these two substituents align differently to the protein. It was also noted that shifting this amide to the adjacent meta position (<b>49</b>) evoked a reduction in potency to a greater extent than seen for the nitrile. Combining the optimal RHS tetrahydroisoquinoline fragment with the preferred LHS amide substituent provided the most potent analogue <b>50</b>.</div><div class="NLM_p last">Our selection of the dimethylaminomethylphenyl motif for evaluation of LHS SAR for both the bisbenzamide and urea series led to one additional finding of interest. Some analogues incorporating this fragment demonstrated unusual inhibition curves with decreasing potency at high concentrations (above the IC<sub>50</sub>), suggesting a possible solubility problem, which was not substantiated by our target-independent profiling. It was subsequently found that compounds employing this motif were in fact weak inhibiters of the luciferase enzyme used to quantify residual ATP in the assay. Increasing utilization of luminescence technology in HTS has led to an awareness of this aspect of assay interference, and an analysis of common HTS scaffolds which act as inhibitors of firefly luciferase has recently been reported.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We subsequently evaluated these analogues and some comparators with alternative RHS fragments using an IMAP assay and verified that the relative potencies determined from the luciferase assay were not impacted by this level of assay interference (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Lead Generation: Chemistry</h3><div class="NLM_p">Standard coupling techniques were employed for synthesis of the analogues described herein. The synthesis of common intermediates <b>51</b>−<b>54</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Preparation of these intermediates and many of the reported analogues was facilitated by use of solid-phase reagents and scavengers including deprotection strategies incorporating catch and release technologies.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The general sequence for synthesis of hit compound <b>5</b> and analogues <b>10</b>−<b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) is exemplified by method 1 (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) demonstrating the synthesis of <b>5</b>. This directional approach, installing the RHS amide first, provided an efficient method for variation of the LHS substituents. Alternatively, initial formation of the LHS dimethoxyaryl amide fragment <b>52</b> provided a common intermediate for synthesis of analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The process is exemplified by the synthesis of <b>17</b> (method 2; Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Methylated analogues <b>19</b> and <b>20</b> were prepared from the corresponding amines using the Eschweiler−Clarke procedure.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, or <i>N</i>-methylmorpholine, DMF; (ii) SCX, dichloromethane; (iii) ammonia in methanol; (iv) Amberlyst A26 (OH<sup>−</sup> form), methanol/DMF; (v) formic acid, methanol; (vi) <i>Si</i>-DMA, DMF; (vii) SCX; (viii) LiOH, THF, water.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, DMF; (ii) trifluoroacetic acid, dichloromethane; (iii) formic acid, formaldehyde.</p></p></figure><div class="NLM_p">Variation of the linker region did not lend itself to utilization of common synthetic intermediates, and therefore several independent approaches to the synthesis of these analogues are exemplified in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Analogous couplings and deprotection strategies engaging the appropriate amine and acid fragments were employed. Standard urea formation using an aniline and arylisocyanate initiated the synthesis of <b>23</b>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 4-Isocyanato-1,2-dimethoxy-benzene, DMF; (ii) Amberlyst A26 (OH<sup>−</sup> form), methanol, DMF, or methanol/DMF; (iii) formic acid, methanol; (iv) <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, <i>N</i>-methylmorpholine or <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (v) 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert-</i>butyl ester (vi) SCX, dichloromethane; (vii) ammonia, methanol; (viii) isophthalic acid monomethyl ester; (ix) 3-aminobenzoic acid methyl ester; (x) SCX; (xi) <i>Si</i>-DMA; (xii) HCl, dioxane; (xiii) 3,4-dimethoxy-benzenesulfonyl chloride, <i>Si</i>-DMA, DMF; (xiv) 3-(aminomethyl)-1-<i>N</i>-boc-aniline; (xv) 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester; (xvi) (3-nitrophenyl)-acetic acid; (xvii) ammonium formate, Pd/C, methanol.</p></p></figure><div class="NLM_p">Using common intermediate <b>53</b>, analogues <b>30</b>−<b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) were synthesized by direct coupling of an aromatic acid. Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> outlines the method exemplifying the synthesis of <b>30</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, DMF.</p></p></figure><div class="NLM_p">Methods used for synthesis of urea analogues reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> are outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Synthesis of <b>40</b> was prosecuted using intermediate <b>54</b>, which was coupled to the RHS amine fragment. Deprotection provided the desired analogue. This general approach was also used to generate <b>38</b>−<b>39</b> and <b>42</b>−<b>45</b> employing the appropriate fragments. Linker-modified <b>41</b> featuring a reversed RHS amide was generated similarly by initial formation of the urea followed by deprotection of the aniline, amide coupling, and final deprotection. Preparation of <b>46</b> employed an inverted sequence utilizing intermediate <b>53</b>, which was heated in the microwave with the preformed symmetrical urea to generate the desired analogue. SCX enabled a catch and release purification. Amides <b>47</b>−<b>50</b> were acquired by hydrolysis of the corresponding nitriles. Having evaluated several conditions to effect this transformation, we ultimately found sulfuric acid in TFA to be most effective and is exemplified for the synthesis of <b>47</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR Studies for the Ureidobenzamide Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0017.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0018.gif" alt="" id="fx9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Assay values reported as the mean ± SEM of <i>n</i> ≥ 2 independent replicates.</p></div></div></div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, <i>N</i>,<i>N</i>-diisopropylethylamine or <i>N</i>-methylmorpholine, DMF; (ii) HCl, dioxane; (iii) <i>Si</i>-DMA, DMF; (iv) <i>p</i>-cyanophenylisocyanate, SCX, DMF; (v) SCX; (vi) trifluoroacetic acid, dichloromethane; (vii) 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester; DMF; (viii) SCX, dichloromethane; (ix) ammonia, methanol; (x) carbonyldiimidazole, DMF; (xi) SCX, methanol/acetonitrile; (xii) H<sub>2</sub>SO<sub>4</sub>, trifluoroacetic acid.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Lead Generation: Selectivity Assessment</h3><div class="NLM_p">We monitored selectivity for the bisbenzamide and ureidobenzamide series during the course of our SAR studies evaluating the potency of selected examples against three of the counterscreening proteins which had shown significant cross-reactivity from the hit set, including PKCε, CDC42BPB, and PKN2. We also tracked ROCK1 activity to confirm that our inhibitors maintained dual potency for the two isoforms. Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> shows the selectivity data for representative analogues from both series. The compounds showed similar potency for ROCK isoforms, with most analogues exhibiting a slight preference for ROCK2 including benchmark <b>1</b>. Good selectivity for ROCK over the counterscreen panel was observed, with three analogues showing weak and one moderate inhibition of PKN2. However, the degree of cross reactivity for these analogues was not significant as nearly a 100-fold level of selectivity or greater was maintained, and all analogues had improved selectivity as compared to literature benchmarks at the time of our studies.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Selectivity Data for Selected Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center" char=".">IC <sub>50</sub> nM ROCK2</th><th align="center" char=".">IC<sub>50</sub> nM ROCK1</th><th align="center" char=".">IC<sub>50</sub> nM PKCε</th><th align="center" char=".">IC<sub>50</sub> nM CDC42BPB</th><th align="center" char=".">IC<sub>50</sub> nM PKN2</th></tr></thead><tbody><tr valign="top"><td align="left"><b>15</b></td><td align="char" char=".">176</td><td align="char" char=".">180</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="char" char=".">53</td><td align="char" char=".">97</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">4400</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">33</td><td align="char" char=".">68</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">46</td><td align="char" char=".">86</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">69</td><td align="char" char=".">205</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="char" char=".">73</td><td align="char" char=".">190</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">92</td><td align="char" char=".">220</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="char" char=".">89</td><td align="char" char=".">74</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="char" char=".">18</td><td align="char" char=".">31</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">1700</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">14</td><td align="char" char=".">40</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">1600</td></tr><tr valign="top"><td align="left"><b>44</b></td><td align="char" char=".">65</td><td align="char" char=".">91</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="char" char=".">4</td><td align="char" char=".">6</td><td align="char" char=".">>5000</td><td align="char" char=".">>5000</td><td align="char" char=".">770</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="char" char=".">430</td><td align="char" char=".">660</td><td align="char" char=".">3000</td><td align="char" char=".">>5,000</td><td align="char" char=".">780</td></tr></tbody></table></div></div><div class="NLM_p last">General kinase selectivity is important for compounds intended for chronic indications, as these proteins are key regulators of cell signaling and homeostasis. As mentioned earlier, the scaffold represented a unique chemotype considering known kinase inhibitors, and we were optimistic that it might provide an opportunity for the development of selective inhibitors. Broad kinase profiling for bisbenzamide <b>18</b> (33 nM ROCK2) and urea <b>50</b> (4 nM ROCK2) provided evidence to support our optimism. Compound <b>18</b> showed no inhibition of an additional 72 kinases tested (IC<sub>50</sub> >10 μM or >50 POC at 3−6 μM) and weak potency for PRKG1 (IC<sub>50</sub>, 5.6 μM). Urea <b>50</b>, inactive against an additional 44 kinases tested (>50 POC at 3 μM), also afforded modest inhibition of PRKG1 (IC<sub>50</sub>, 3 μM), and marginal results for PRK2 and PKCα (33 and 50 POC at 3 μM, respectively). Again, these values afford >100-fold selectivity for the additional kinases evaluated (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Lead Generation: Target Independent Profiling</h3><div class="NLM_p">As mentioned earlier, one of the key challenges associated with the HtL process is the development of ligands identified from biochemical screens into safe and effective pharmacologically active agents. As a response to this challenge, various in vitro profiling tools have been incorporated into the HtL process. For hit compound <b>5</b>, we had identified specific issues as a result of this profiling process, which included poor metabolic stability, moderate CYP inhibition (2C9, 3A4), and an apparent efflux problem. As can be seen from the profiling data in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, replacement of the pyridine moiety of <b>5</b> with piperidine not only improved the potency but also improved metabolic stability and eliminated CYP inhibition (<b>15</b>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, adding an aromatic into the RHS linker in some cases reestablished variable levels of 3A4 (<b>20</b>, <b>21</b>, <b>33</b>, <b>43</b>) and 2C9 (<b>33</b>, <b>43</b>) activity, but the SAR for CYP inhibition did not correlate to other modifications which improved Rho kinase activity and we therefore felt that this was a manageable problem. However, permeability/efflux remained an issue. We found that passive permeability (PAMPA analysis) could be improved by utilizing a 3° rather than a 2° amine or replacing the amine with an alcohol (<b>20</b>, <b>21</b>, <b>22</b>). But as can be seen in the table, these changes alone did not significantly alter the efflux ratio as determined by Caco-2. An in vivo rat PK study was done on <b>21</b> because this analogue showed high permeability in the PAMPA assay. The results revealed very low bioavailability (1.8%) for this compound, apparently resulting from low intestinal absorption possibly due to transport mediated efflux. A potential solution to the unbalanced efflux ratio as measured by Caco-2 was ultimately found when analogues with modifications to the dimethoxy phenyl fragment were evaluated. Replacing the <i>m</i>-methoxy moiety with methyl or halogen led to more permeable compounds with a more acceptable B→A/A→B ratio (<b>33</b>, <b>34</b>). These analogues suffered a modest to moderate loss in potency in the molecular assay, but the modifications provided at least one mechanism to address this lingering issue. The series was also evaluated for hERG activity (<b>18</b>), and no inhibition was observed up to 70 μM. These studies helped to define options to improve properties and enabled the series to meet target-independent profiling criteria.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Profiling Data for Rho Kinase Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center" char=".">ROCK2 IC<sub>50</sub> (nM)</th><th align="center" char=".">sol (μg/mL)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th align="center">PAMPA × 10<sup>−6</sup></th><th align="center">Caco-2<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></th><th align="center" char=".">Caco-2<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></th><th align="center">HLM <i>t</i><sub>1/2</sub> (m)</th><th align="center" char=".">CYP 1A2<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 2C9<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th align="center">CYP 2C19<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th align="center" char=".">CYP 2D6<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th align="center">CYP 3A4<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>15</b></td><td align="char" char=".">176</td><td align="char" char=".">67</td><td align="left">0.6</td><td align="left">0.1</td><td align="char" char=".">0.6</td><td align="left">87</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30/>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="char" char=".">53</td><td align="char" char=".">16</td><td align="left">BQL<a class="ref internalNav" href="#t10fn7" aria-label="g">g</a></td><td align="left">0.1</td><td align="char" char=".">0.8</td><td align="left">139</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30/>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">33</td><td align="char" char=".">49</td><td align="left">3.6</td><td align="left">BQL<a class="ref internalNav" href="#t10fn7" aria-label="g">g</a></td><td align="char" char=".">5.4</td><td align="left">146</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">46</td><td align="char" char=".">>85</td><td align="left">16</td><td align="left">0.3</td><td align="char" char=".">27.1</td><td align="left">55</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">1.7/>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">69</td><td align="char" char=".">>100</td><td align="left">10</td><td align="left">BQL<a class="ref internalNav" href="#t10fn7" aria-label="g">g</a></td><td align="char" char=".">14.6</td><td align="left">66</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">8.5/>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">870</td><td align="char" char=".">48</td><td align="left">10</td><td align="left">0.6</td><td align="char" char=".">16.1</td><td align="left">41</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">NT<a class="ref internalNav" href="#t10fn8" aria-label="h">h</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">14</td><td align="char" char=".">>100</td><td align="left">BQL<a class="ref internalNav" href="#t10fn7" aria-label="g">g</a></td><td align="left">BQL<a class="ref internalNav" href="#t10fn7" aria-label="g">g</a></td><td align="char" char=".">8.8</td><td align="left">189</td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">22<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td><td align="left">5.9/>30<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="char" char=".">266</td><td align="char" char=".">>88</td><td align="left">21</td><td align="left">7.9</td><td align="char" char=".">30.8</td><td align="left">NT<a class="ref internalNav" href="#t10fn8" aria-label="h">h</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">12.5<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">13.5<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">92</td><td align="char" char=".">>96</td><td align="left">24</td><td align="left">7.7</td><td align="char" char=".">45.3</td><td align="left">NT<a class="ref internalNav" href="#t10fn8" aria-label="h">h</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">NT<a class="ref internalNav" href="#t10fn8" aria-label="h">h</a></td><td align="char" char=".">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td><td align="left">>30<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">HT solubility @ pH 7.4.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last"><i>A</i> to <i>B</i> × 10<sup>−6</sup> cm/s.</p></div><div class="footnote" id="t10fn3"><sup>c</sup><p class="last"><i>B</i> to <i>A</i> × 10<sup>−6</sup> cm/s.</p></div><div class="footnote" id="t10fn4"><sup>d</sup><p class="last">μM.</p></div><div class="footnote" id="t10fn5"><sup>e</sup><p class="last">Fluorescence assay; 3A4 substrates BFC/BQ.</p></div><div class="footnote" id="t10fn6"><sup>f</sup><p class="last">LCMS/MS assay.</p></div><div class="footnote" id="t10fn7"><sup>g</sup><p class="last">Below quantifiable limit.</p></div><div class="footnote" id="t10fn8"><sup>h</sup><p class="last">Not tested. (See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for method details.)</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Lead Generation: Functional Analysis</h3><div class="NLM_p">Inhibition of Rho kinase moderates smooth muscle contraction leading to blood vessel relaxation. Our functional assay measured the extent to which our inhibitors could reverse phenylephrine-induced contraction of rat aortic rings.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Selected functional results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>. Hit compound <b>5</b> demonstrated functional activity equivalent to its molecular potency. Assuming ATP competitive inhibition of Rho kinase is the only enabling mechanism, the absence of a potency shift was unexpected considering the reported <i>K</i><sub>M,ATP</sub> for Rho kinase isoforms (1.9 μM ROCK1, 20 μM ROCK2).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> For the optimized bisbenzamides, we noted an overall average shift of ∼40-fold between the ROCK-II molecular and aortic ring functional results. However, the correlation was not always consistent, and we expected that permeability/efflux was at least partially responsible. As can be seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>, the level of passive permeability as measured by PAMPA in conjunction with the efflux ratios calculated from Caco-2 studies shows a rough correlation to the observed shift. One of our most permeable compounds <b>34</b> gave a 17/7-fold (ROCK2/ROCK1) shift similar to the literature benchmark <b>1</b>, a significant improvement over related analogue <b>21</b>, which had a greater efflux ratio. Likewise, an improvement in passive permeability (PAMPA) for <b>20</b> as compared to its demethylated analogue <b>18</b> also translated into a smaller shift. Generally, ureidobenzamides demonstrated a greater shift as seen for <b>43</b>, and while not as broadly profiled as the bisbenzamide series, permeability/efflux constraints for the ureidobenzamides again appeared to be partially responsible.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Cellular Potency of Selected Inhibitors and Literature Standard <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char=";" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center" char=".">aortic rings IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th align="center" char=".">hROCK2 IC<sub>50</sub> (nM)</th><th align="center" char=".">hROCK1 IC<sub>50</sub> (nM)</th><th align="center" char=";">shift<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></th><th align="center">PAMPA × 10<sup>−6</sup></th><th align="center" char=".">Caco-2 (<i>B</i>→<i>A</i>/<i>A</i>→<i>B</i>)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5</b></td><td align="char" char=".">1.9</td><td align="char" char=".">2300</td><td align="char" char=".">4300</td><td align="char" char=";">0.82;0.44</td><td align="left">NT<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td align="char" char=".">29.1/0.5 (58)</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">6.4 ± 3.9</td><td align="char" char=".">33</td><td align="char" char=".">68</td><td align="char" char=";">194;94</td><td align="left">3.6</td><td align="char" char=".">5.4/<0.1 (>54)</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">1.2 ± 0.2</td><td align="char" char=".">46</td><td align="char" char=".">70</td><td align="char" char=";">26;17</td><td align="left">16</td><td align="char" char=".">27.1/0.3 (90.3)</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">6.0 ± 2.8</td><td align="char" char=".">69</td><td align="char" char=".">205</td><td align="char" char=";">87;29</td><td align="left">10</td><td align="char" char=".">14.6/<0.1 (>146)</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">1.6</td><td align="char" char=".">92</td><td align="char" char=".">220</td><td align="char" char=";">17.4;7.3</td><td align="left">24</td><td align="char" char=".">45.3/7.7 (5.9)</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="char" char=".">8.5 ± 2.5</td><td align="char" char=".">14</td><td align="char" char=".">40</td><td align="char" char=";">607;212</td><td align="left">BQL<a class="ref internalNav" href="#t11fn4" aria-label="d">d</a></td><td align="char" char=".">8.8/<0.1 (>88)</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="char" char=".">6.1 ± 1.8</td><td align="char" char=".">430</td><td align="char" char=".">660</td><td align="char" char=";">14.0;9.1</td><td align="left">NT<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td><td align="center" char=".">NT<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">Each individual result is the mean from four different segments from four different rats. Multiple individual results (<i>n</i> ≥ 2) are reported as the mean ± SEM.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last">Values represent the shift between luciferase molecular data and the aortic ring functional results (ROCK2;ROCK1).</p></div><div class="footnote" id="t11fn3"><sup>c</sup><p class="last">Not tested.</p></div><div class="footnote" id="t11fn4"><sup>d</sup><p class="last">Below quantifiable limit.</p></div></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have identified a bisbenzamide and related ureidobenzamide series of inhibitors of Rho kinase from an HTS discovery approach. The involvement of Rho kinase in various pathological processes renders significance to the development of potent and selective inhibitors as potential drug candidates, as well as agents for evaluating discrete biochemical mechanisms. Our series features a unique kinase platform demonstrating structure-based activity and affording notable selectivity within the kinase gene family (near/>100-fold selectivity against all kinases evaluated: 76 results for <b>18</b> and 50 results for <b>50</b>). A level of selectivity may be accrued as a result of unorthodox binding features in the region we hypothesized to be associated with the hinge, as our SAR studies suggest hydrophobic interactions may predominate. Optimized analogues have shown significant inhibition of the protein, and several have demonstrated moderate potency in our functional assay. We have also identified features of the original hit compound which contributed to poor target-independent properties and have investigated options which improve these deficiencies providing a potential path forward. Overall, these studies supported advancement of the series to lead optimization (LO) whereby further development has led to highly selective, orally bioavailable inhibitors of Rho kinase with potent pharmacological effects. These studies will be reported in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker UltraShield-400 MHz spectrometer in solvents as noted. Mass spectra were obtained on a Waters ZQ single quadrupole mass spectrometer using electrospray positive/negative ionization. Analytical LC/MS data were recorded on an analytical system consisting of a Waters ZQ mass spectrometer, Agilent 1100 DAD, and Sedex 85 ELS detectors, and an Agilent 1100 HPLC system, equipped with an Eclipse XDB C18 2.5 mm × 100 mm, 3.5 μm particle diameter, column. A linear gradient from 95% water/acetonitrile (0.1% formic acid) to 95% acetonitrile/water (0.1% formic acid) was used at a flow rate of 2.5 mL/min for 7 min followed by a 2 min hold at 95% acetonitrile/water (0.1% formic acid). Purity for all final compounds (HPLC/MS) is >95%.</div><div class="NLM_p last">Purification by flash chromatography was accomplished using RediSep prepacked disposable columns run on the Isco Combiflash. Preparative TLC was done using Uniplate silica gel plates purchased from Analtech. Microwave reactions were run in a Smith Synthesizer microwave reactor. Purification by reverse-phase HPLC utilized a mass-directed preparative scale LC/MS FractionLynx system controlled by MassLynx version 3.5. The system consisted of a 2525 high performance liquid chromatography (HPLC) pump, a ZQ single quadrupole mass spectrometer, two 515 high performance liquid chromatography (HPLC) pumps for at column dilution and a makeup pump, a 2767 Sample Manager, and a 2996 photo diode array detector (Waters Corporation, Milford, MA). All samples were purified on an Atlantis prep dC18 (5 μm particle diameter) 19 mm × 50 mm column. The mobile phases consisted of (A) water with 0.1% formic acid and (B) acetonitrile with 0.1% formic acid. The at column dilution solvent used was methanol with 0.1% formic acid at a constant flow rate of 1 mL/min and an overall system flow rate of 21 mL/min. All solvents were purchased from EM Science. All reagents were purchased from the Aldrich Chemical Co. with the following exceptions: SCX from Varian (Bond Elut SCX) or Silicycle (Silia<i>Bond</i> SCX), <i>Si</i>-DMA (Silia<i>Bond</i> DMA) from Silicycle, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDC) from Fluka, 2-pyridin-4-yl-ethylamine from Lancaster, 3-methyl-4-methoxybenzoic acid from Matrix, 4-dimethylaminomethylaniline from J&W Pharma, 4-hydroxymethylaniline from Lancaster, 3-aminomethyl-benzoic acid methyl ester hydrochloride from Maybridge, 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester from Astatech, 3-amino-benzoic acid methyl ester from TCI, 3-chloro-4-trifluoromethoxybenzoic acid from Indofine, 3-(aminomethyl)-1-<i>N</i>-boc-aniline from Peakdale, 3-<i>t-</i>butoxycarbonylamino-benzyl-ammonium chloride from Peakdale, 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester from Astatech, 3-(<i>tert</i>-butoxycarbonylamino-methyl)-benzoic acid from Fluka, 3-(3-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester from Astatech, and 7-amino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid <i>tert</i>-butyl ester from J&W Pharma. The acronym TFA is used throughout to designate trifluoroacetic acid and DCM to designate dichloromethane. Reported methods are unoptimized.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Standard Coupling Procedure</h3><div class="NLM_p last">A carboxylic acid, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (1.1−1.4 equiv), and benzotriazole-1-ol (1.1−1.4 equiv) were combined in a reaction vial and DMF was added (0.1−0.6 mmol acid/mL). The mixture was agitated briefly, and then <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA) or <i>N</i>-methylmorpholine (NMM) (2−3 equiv) was added. The mixture was agitated for 15−30 min, then the amine coupling fragment was added (0.6−1.4 equiv), and the resulting mixture was agitated for 16−70 h. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined extracts were washed with 1N HCl, NaHCO<sub>3</sub> (satd aq) and brine (as appropriate to the specific reaction), dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The isolated amide was either purified or used directly. Alternatively, the reaction mixture was purified directly by preparative HPLC.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Procedures for Synthesis of Common Intermediates <b>51</b>−<b>54</b></h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Aminomethyl-<i>N</i>-(2-pyridin-4-yl-ethyl)-benzamide (<b>51</b>)</h4><div class="NLM_p last">3-(<i>tert</i>-Butoxycarbonylamino-methyl)-benzoic acid (150.7 mg, 0.6 mmol) and 2-pyridin-4-yl-ethylamine (0.06 mL, 0.5 mmol) were coupled using the standard procedure with DIEA. The isolate, [3-(2-pyridin-4-yl-ethylcarbamoyl)-benzyl]-carbamic acid <i>tert</i>-butyl ester, which was used without purification, was dissolved in DCM (5 mL) and treated with SCX (1.36 g, 1.2 mmol). The resulting mixture was agitated for 24 h and then filtered. The silica was washed with DCM and methanol. The product was eluted with NH<sub>3</sub> (7 N in methanol), and the eluent was concentrated to provide the title compound (125 mg, 94%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (t, <i>J</i> = 7.0 Hz, 1H), 8.49 (dt, <i>J</i> = 4.8, 0.8 Hz, 1H), 7.79 (s, 1H), 7.69 (dt, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.64 (d, <i>J</i> = 7.6 Hz, 1H), 7.47 (d, <i>J</i> = 7.7 Hz, 1H), 7.37 (t, <i>J</i> = 7.6 Hz, 1H), 7.26 (d, <i>J</i> = 7.8 Hz, 1H), 7.20 (ddd, J = 7.5, 3.8, 1.0 Hz, 1H), 3.78 (s, 2H), 3.59 (dt, <i>J</i> = 7.0, 7.0 Hz, 2H), 2.98 (t, <i>J</i> = 7.0 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 256 (M + H). HPLC: 100%.</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-[(3,4-Dimethoxy-benzoylamino)-methyl]-benzoic Acid (<b>52</b>)</h4><div class="NLM_p last">3,4-Dimethoxybenzoic acid (400.8 mg, 2.2 mmol) and 3-methoxycarbonyl-benzyl-ammonium chloride (403.3 mg, 2 mmol) were coupled using the standard procedure with DIEA to give 3-[(3,4-dimethoxy-benzoylamino)-methyl]-benzoic acid methyl ester, which was used without purification. The ester was dissolved in a mixture of methanol (6 mL) and DMF (1 mL) and treated with Amberlyst A26 (OH<sup>−</sup> form) (3730 mg, 5 mmol), and the resulting mixture was agitated for 36 h. The resin was then filtered and washed with methanol (2 × 4 mL), DMF (1 × 4 mL), and methanol (2 × 4 mL). The product acid was eluted with a solution of 20% formic acid in methanol. The eluent was concentrated, and the resulting solid was triturated in diethylether. The title compound was isolated by filtration (386 mg, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.30 (br, 1H) 9.18 (t, <i>J</i> = 5.8 Hz, 1H), 8.47 (s, 1H), 8.13−8.08 (m, 2H), 7.61 (t, <i>J</i> = 7.7 Hz, 1H), 6.96−6.84 (m, 3H), 4.42 (d, <i>J</i> = 5.8 Hz, 2H), 3.74 (s, 3H), 3.72 (s, 3H). ESMS: <i>m</i>/<i>z</i> 316 (M + H). HPLC: 100%.</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-Aminomethyl-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (<b>53</b>)</h4><div class="NLM_p last">3-(<i>tert</i>-Butoxycarbonylamino-methyl)-benzoic acid (377 mg, 1.5 mmol) and 4-dimethylaminomethylaniline (150 mg, 1 mmol) were coupled using the standard procedure with NMM to provide [3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-carbamic acid <i>tert</i>-butyl ester (265 mg, 69% yield). ESMS: <i>m</i>/<i>z</i> 227 (M + H), which was used without purification. This intermediate was dissolved in DCM (5 mL). and the resulting solution was treated with SCX (2.27 g, 0.88 mmol/g, 2.0 mmol). The mixture was agitated for 16 h. The resin was isolated by filtration and washed with DCM, acetonitrile, and then methanol. The product was eluted with NH<sub>3</sub> (7 N in methanol). The eluent was concentrated to provide the title compound (172 mg, 89.5% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.75 (s, 1H), 7.66 (d, <i>J</i> = 7.8 Hz, 1H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 7.41 (d, <i>J</i> = 7.8 Hz, 1H)), 7.32 (t, <i>J</i> = 7.7 Hz, 1H), 7.17 (d, <i>J</i> = 8.5 Hz, 2H), 3.74 (s, 2H), 3.32 (s, 2H), 2.12 (s, 6H). ESMS: <i>m</i>/<i>z</i> 284 (M + H). HPLC: 96%.</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-[3-(4-Cyano-phenyl)-ureidomethyl]-benzoic Acid (<b>54</b>)</h4><div class="NLM_p last">3-Methoxycarbonyl-benzyl-ammonium chloride (605 mg, 3.0 mmol) was dissolved in DMF (6 mL) in a reaction vial. <i>Si</i>-DMA (3.3 g, 5 mmol) was added, and the mixture was agitated for 1 h. Subsequently, <i>p</i>-cyanophenylisocyanate (403.5 mg, 2.8 mmol) was added and the mixture was agitated 16 h. SCX (568 mg, 0.5 mmol) was added, and the mixture was agitated for 30 min. The sorbents were filtered and the filtrate was concentrated to provide 3-[3-(4-cyano-phenyl)-ureidomethyl]-benzoic acid methyl ester (843 mg, 91% yield), which was used directly. The urea was dissolved in THF (7 mL). A solution of lithium hydroxide (410 mg, 10 mmol) in water (3 mL) was added. The resulting mixture was heated at 50 °C for 2 h and then cooled to room temperature. The organic phase was separated, and the remaining aqueous solution was neutralized. The title compound was isolated by filtration (710 mg, 93% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.98 (s, 1H), 9.21 (s, 1H), 7.90 (s, 1H), 7.83 (d, <i>J</i> = 7.7 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 2H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.55 (d, <i>J</i> = 7.7 Hz, 1H), 7.47 (t, <i>J</i> = 7.7 Hz, 1H), 6.97 (t, <i>J</i> = 6.0 Hz, 1H), 4.37 (d, <i>J</i> = 6.0 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 296 (M + H). HPLC: 92%.</div></div></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3,4-Dimethoxy-<i>N</i>-[3-(2-pyridin-4-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>5</b>)</h3><div class="NLM_p">3,4-Dimethoxybenzoic acid (100 mg, 0.55 mmol) and <b>51</b> (100 mg, 0.39 mmol) were coupled using the standard procedure with DIEA. The isolate was purified by flash chromatography using a gradient of ethyl acetate in hexane to provide the title compound (92 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (d, <i>J</i> = 6.2 Hz, 2H), 7.69 (s, 1H), 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.44−7.48 (m, 2H), 7.38−7.28 (m, 4H), 7.18 (t, <i>J</i> = 5.9 Hz, 1H), 7.11 (t, <i>J</i> = 5.9 Hz, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 1H), 4.58 (d, <i>J</i> = 5.9 Hz, 2H), 3.92 (s, <i>3</i>H), 3.89 (s, <i>3</i>H), 3.72 (q, <i>J</i> = 6.3 Hz, 2H), 3.03 (t, <i>J</i> = 6.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 420 (M + H).</div><div class="NLM_p">Using the method described for the synthesis of <b>5</b>, compounds <b>10</b>−<b>13</b> were prepared from the corresponding substituted benzoic acids.</div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-Methoxy-<i>N</i>-[3-(2-pyridin-4-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>10</b>)</h4><div class="NLM_p last">Purified by preparative HPLC using an acetonitrile/water/formic acid gradient: 62.9% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 6.2 Hz, 2H), 7.80−7.75 (m, 2H), 7.69 (s, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.40−7.26 (m, 3H), 7.05−6.94 (m, 2H), 6.93−6.88 (m, 2H), 4.58 (d, <i>J</i> = 5.9 Hz, 2H), 3.86 (s, 3H), 3.73 (q, <i>J</i> = 6.7 Hz, 2H), 3.04 (t, <i>J</i> = 6.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 390 (M + H).</div></div><div id="sec3_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-Methoxy-<i>N</i>-[3-(2-pyridin-4-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>11</b>)</h4><div class="NLM_p last">Purified by preparative HPLC using an acetonitrile/water/formic acid gradient: 58% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (d, <i>J</i> = 6.1 Hz, 2H), 7.69 (s, 1H), 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.41−7.31 (m, 6H), 7.21 (t, <i>J</i> = 5.9 Hz, 1H), 7.12 (t, <i>J</i> = 5.9 Hz, 1H), 7.08−7.12 (m, 1H), 4.58 (d, <i>J</i> = 5.9 Hz, 2H), 3.82 (s, 3H), 3.72 (q, <i>J</i> = 6.7 Hz, 2H), 3.02 (t, <i>J</i> = 6.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 390 (M + H).</div></div><div id="sec3_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1,3-Benzodioxole-5-carboxylic acid 3-(2-pyridin-4-yl-ethylcarbamoyl)-benzylamide (<b>12</b>)</h4><div class="NLM_p last">Purified by preparative HPLC using an acetonitrile/water/formic acid gradient: 21% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (d, <i>J</i> = 5.3 Hz, 2H), 7.72 (s, 1H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 7.51 (d, <i>J</i> = 7.7 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.36−7.23 (m, 4H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 6.50 (t, <i>J</i> = 5.9 Hz, 1H), 6.39 (t, <i>J</i> = 5.9 Hz, 1H), 6.06 (s, 2H), 4.66 (d, <i>J</i> = 5.9 Hz, 2H), 3.76 (q, <i>J</i> = 6.7 Hz, 2H), 3.01 (t, <i>J</i> = 6.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 404 (M + H).</div></div><div id="sec3_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3,4-Dimethyl-<i>N</i>-[3-(2-pyridin-4-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>13</b>)</h4><div class="NLM_p last">Purified by preparative HPLC using an acetonitrile/water/formic acid gradient: 59.3% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 6.0 Hz, 2H), 7.69 (s, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 7.58 (s, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (d, <i>J</i> = 7.7 Hz, 1H), 7.35 (t, <i>J</i> = 7.7 Hz, 1H), 7.32−7.26 (m, 2H), 7.17 (d, <i>J</i> = 7.9 Hz, 1H), 7.09 (t, <i>J</i> = 5.8 Hz, 1H), 7.03 (t, <i>J</i> = 5.8 Hz, 1H), 4.58 (d, <i>J</i> = 6.0 Hz, 2H), 3.71 (q, <i>J</i> = 6.8 Hz, 2H), 3.01 (t, <i>J</i> = 6.9 Hz, 2H), 2.30 (s, 3H) 2.28 (s, 3H). ESMS: <i>m</i>/<i>z</i> 388 (M + H).</div></div><div id="sec3_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-[3-(Isoquinolin-6-ylcarbamoyl)-benzyl]-3,4-dimethoxy-benzamide (<b>14</b>)</h4><div class="NLM_p last">5-Aminoisoquinoline, (50 mg, 0.35 mmol) and <b>52</b> (50 mg, 0.16 mmol) were coupled using the standard procedure with DIEA. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide the title compound (23 mg, 33% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, 1H), 8.56 (s, 1H), 8.51−8.47 (m, 2H), 7.99 (d, <i>J</i> = 8.9 Hz, 1H), 7.95 (s, 1H), 7.85 (d, <i>J</i> = 7.7 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.69 (d, <i>J</i> = 5.9 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.57−7.45 (m, 2H), 7.36 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 6.72 (t, <i>J</i> = 5.9 Hz, 1H), 4.74 (d, <i>J</i> = 6.0 Hz, 2H), 3.95 (s, 3H), 3.94 (s, 3H). ESMS: <i>m</i>/<i>z</i> 442 (M + H).</div></div></div><div id="sec3_3_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure for Synthesis of <b>15</b>−<b>18</b></h3><div class="NLM_p">Intermediate <b>52</b> and the appropriate amine were coupled using the standard procedure with DIEA. Deprotection was accomplished by dissolution of the amide in DCM (0.1 mmol/mL), followed by treatment with TFA (20% of solvent). The resulting mixture was agitated for 2 h, then concentrated. If needed, purification was done by preparative HPLC using an acetonitrile/water/formic acid gradient or flash chromatography using a methanol DCM gradient.</div><div id="sec3_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3,4-Dimethoxy-<i>N</i>-[3-(2-piperidin-4-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>15</b>)</h4><div class="NLM_p last">Purification by flash chromatography using a methanol/DCM gradient provided the title compound, TFA salt: 41% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.60 (s, br, 1H), 8.27 (s, br, 1H), 7.76 (s, 1H), 7.68 (d, <i>J</i> = 7.6 Hz, 1H), 7.50 (d, <i>J</i> = 7.9 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.40−7.32 (m, 2H), 7.12 (t, <i>J</i> = 5.5 Hz, 1H), 6.96 (t, <i>J</i> = 5.5 Hz, 1H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 4.67 (d, <i>J</i> = 5.9 Hz, 2H), 3.92 (s, 3H), 3.91 (s, 3H), 3.51−3.38 (m, 4H), 2.88−2.81 (m, 2H), 2.02−1.98 (m, 2H), 1.73−1.46 (m, 5H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3,4-Dimethoxy-<i>N</i>-[3-(1,2,3,4-tetrahydro-isoquinolin-6-ylcarbamoyl)-benzyl]-benzamide (<b>16</b>)</h4><div class="NLM_p last">Purification by preparative HPLC using an acetonitrile/water/formic acid gradient provided the title compound: 35% yield. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.81 (s, 1H), 7.70 (d, <i>J</i> = 8.7 Hz, 1H), 7.49−7.32 (m, 6H), 6.93−6.90 (m, 2H), 4.54 (s, 2H), 3.86 (s, 2H), 3.78 (s, 3H), 3.77 (s, 3H), 3.00 (t, <i>J</i> = 6.0 Hz, 2H), 2.75 (t, <i>J</i> = 6.0 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 446 (M + H).</div></div><div id="sec3_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3,4-Dimethoxy-<i>N</i>-[3-(2-piperidin-3-yl-ethylcarbamoyl)-benzyl]-benzamide (<b>17</b>)</h4><div class="NLM_p last">TFA salt: 74% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81 (s, br, 1H), 8.58 (s, br, 1H), 7.86 (t, <i>J</i> = 5.5 Hz, 1H), 7.68 (s, 1H), 7.63−7.55 (m, 2H), 7.48−7.36 (m, 3H), 7.34−7.28 (m, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 1H), 4.54 (d, <i>J</i> = 5.0 Hz, 2H), 3.89 (s, 3H), 3.84 (s, 3H), 3.51−3.21 (m, 4H), 2.86−2.68 (m, 1H), 2.55−2.37 (m, 1H), 1.96−1.63 (m, 4H), 1.63−1.37 (m, 2H), 1.22−1.01 (m, 1H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3,4-Dimethoxy-<i>N</i>-[3-(1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzyl]-benzamide (<b>18</b>)</h4><div class="NLM_p last">Purification by preparative HPLC using an acetonitrile/water/formic acid gradient provided the title compound: 25% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.22 (s, 1H), 9.01 (t, <i>J</i> = 6.0 Hz, 1H), 7.89 (s, 1H), 7.83 (d, <i>J</i> = 13.3 Hz, 1H), 7.61−7.41 (m, 6H), 7.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.04 (d, <i>J</i> = 8.5 Hz, 1H), 4.55 (d, <i>J</i> = 5.9 Hz, 2H), 4.20 (s, 2H), 3.82 (s, 3H), 3.81 (s, 3H), 3.13 (t, <i>J</i> = 5.9 Hz, 2H), 2.79 (t, <i>J</i> = 5.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 446 (M + H).</div></div><div id="sec3_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3,4-Dimethoxy-<i>N</i>-{3-[2-(1-methyl-piperidin-3-yl)-ethylcarbamoyl]-benzyl}-benzamide (<b>19</b>)</h4><div class="NLM_p last">Compound <b>17</b> (80 mg, 0.188 mmol) was dissolved in formic acid (0.5 mL) and formaldehyde (0.5 mL, 37% aqueous solution) was added. The resulting mixture was heated at 70 °C 16 h. The reaction mixture was concentrated, and the isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (41 mg, 50% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (t, <i>J</i> = 5.9 Hz, 1H), 8.46 (t, <i>J</i> = 5.5 Hz, 1H), 7.79 (s, 1H), 7.70 (d, <i>J</i> = 7.4 Hz, 1H), 7.54 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.49 (d, <i>J</i> = 1.9 Hz, 1H), 7.47−7.38 (m, 2H), 7.04 (d, <i>J</i> = 8.5 Hz, 1H), 4.51 (d, <i>J</i> = 5.8 Hz, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 3.28 (dd, <i>J</i> = 12.9, 6.9 Hz, 4H), 2.92−2.76 (m, 2H), 2.28 (s, 3H), 2.13−1.99 (m, 1H), 1.91−1.69 (m, 2H), 1.68−1.55 (m, 1H), 1.56−1.34 (m, 2H), 0.88 (dd, <i>J</i> = 22.8, 11.1 Hz, 1H). ESMS: <i>m</i>/<i>z</i> 440 (M + H).</div></div><div id="sec3_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3,4-Dimethoxy-<i>N</i>-[3-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzyl]-benzamide (<b>20</b>)</h4><div class="NLM_p last">Prepared from <b>18</b> according to the procedure described for the synthesis of <b>19</b>: 22% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 7.87 (s, 1H), 7.77 (d, <i>J</i> = 7.7 Hz, 1H), 7.65 (s, 1H), 7.52−7.33 (m, 6H), 7.03 (d, <i>J</i> = 8.3 Hz, 1H), 6.81 (d, <i>J</i> = 8.4 Hz, 1H), 4.59 (d, <i>J</i> = 5.5 Hz, 2H), 3.98 (s, br, 2H), 3.88 (s, 3H), 3.85 (s, 3H), 3.32 (s, br, 2H), 3.05 (s, br, 2H), 2.78 (s, 3H). ESMS: <i>m</i>/<i>z</i> 460 (M + H).</div></div><div id="sec3_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3,4-dimethoxy-benzamide (<b>21</b>)</h4><div class="NLM_p last">4-Dimethylaminomethylaniline (25.5 mg, 0.17 mmol) and <b>52</b> (40 mg, 0.13 mmol) were coupled using the standard procedure with NMM. Purification by preparative HPLC using an acetonitrile/water/formic acid gradient provided the title compound (37 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.24 (s, 1H), 9.00 (t, <i>J</i> = 5.9 Hz, 1H), 7.89 (s, 1H), 7.84 (d, <i>J</i> = 7.3 Hz, 1H), 7.71 (d, <i>J</i> = 8.4 Hz, 2H), 7.61−7.43 (m, 4H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 4.56 (d, <i>J</i> = 5.9 Hz, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 3.42 (s, 2H), 2.18 (s, 6H). ESMS: <i>m</i>/<i>z</i> 448 (M + H).</div></div><div id="sec3_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-[3-(4-Hydroxymethyl-phenylcarbamoyl)-benzyl]-3,4-dimethoxy-benzamide (<b>22</b>)</h4><div class="NLM_p last">4-Hydroxyomethylaniline (19.7 mg, 0.16 mmol) and <b>52</b> (45.0 mg, 0.14 mmol) were coupled using the standard procedure with NMM purification by preparative HPLC using an acetonitrile/water/formic acid gradient provided the title compound (41 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.27 (s, 1H), 9.00 (t, <i>J</i> = 5.9 Hz, 1H), 7.89 (s, 1H), 7.83 (d, <i>J</i> = 7.3 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.56−7.47 (m, 4H), 7.27 (d, <i>J</i> = 8.4 Hz, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 5.14 (t, <i>J</i> = 5.7 Hz, 1H), 4.56 (d, <i>J</i> = 5.9 Hz, 2H), 4.46 (d, <i>J</i> = 5.9 Hz, 2H), 3.85 (s, 3H), 3.84 (s, 3H). ESMS: <i>m</i>/<i>z</i> 419 (M − H).</div></div><div id="sec3_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-[3-(3,4-Dimethoxy-phenyl)-ureido]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>23</b>)</h4><div class="NLM_p last">3-Amino-benzoic acid methyl ester (75.6 mg, 0.5 mmol) was dissolved in DMF (2 mL) in a reaction vial, and 4-isocyanato-1,2-dimethoxy-benzene (98.5 mg, 0.55 mmol) was added. The reaction mixture was agitated 7 h, diluted with DMF (1 mL), and treated with Amberlyst A26 (OH<sup>−</sup> form) (1.12 g, 1.5 mmol). The resulting mixture was agitated at ambient temperature for 16 h. The sorbent was filtered and washed with several portions of methanol. The product was eluted with 20% formic acid in methanol, and the sorbent was then washed with several portions of DMF. The eluent was concentrated to a solid which was triturated in methanol. Filtration provided 3-[3-(3,4-dimethoxy-phenyl)-ureido]-benzoic acid (106 mg, 67% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.93 (s, 1H), 8.80 (s, 1H), 8.53 (s, 1H), 8.14 (s, 1H), 7.61 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (d, <i>J</i> = 7.8 Hz, 1H), 7.39 (t, <i>J</i> = 7.9 Hz, 1H), 7.23 (s, 1H), 6.88 (s, 2H), 3.75 (s, 3H), 3.71 (s, 3H). ESMS: <i>m</i>/<i>z</i> 317 (M + H). HPLC: 95%. This intermediate (47.4 mg, 0.15 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (34.3 mg, 0.16 mmol) were coupled using the standard procedure with NMM. The isolate was dissolved directly in DCM (1 mL) and treated with SCX (398 mg, 0.35 mmol), and the resulting mixture was agitated for 16 h. The mixture was filtered and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated providing the title compound (53 mg, 82.8% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81 (s, 1H), 8.62 (s, 1H), 8.39 (t, <i>J</i> = 5.5 Hz, 1H), 7.87 (s, 1H), 7.59 (d, <i>J</i> = 7.9 Hz, 1H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 7.23 (s, 1H), 6.87 (s, 2H), 3.74 (s, 3H), 3.71 (s, 3H), 3.31−3.20 (m, 2H), 2.96 (d, <i>J</i> = 11.2 Hz, 1H), 2.87 (d, <i>J</i> = 12.0 Hz, 1H), 2.45−2.38 (m, 1H), 2.24−2.08 (m, 1H), 1.80 (d, <i>J</i> = 14.8 Hz, 1H), 1.59−1.52 (m, 1H), 1.47−1.31 (m, 4H), 1.08−0.94 (m, 1H). ESMS: <i>m</i>/<i>z</i> 427 (M + H).</div></div><div id="sec3_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3,4-Dimethoxy-benzyl)-<i>N</i>-(2-piperidin-3-yl-ethyl)-isophthalamide (<b>24</b>)</h4><div class="NLM_p last">Isophthalic acid monomethyl ester (180.2 mg, 1.0 mmol) and 3,4-dimethoxybenzylamine (0.167 mL, 1.1 mmol) were coupled using the standard procedure with NMM to provide <i>N</i>-(3,4-dimethoxy-benzyl)-isophthalamic acid methyl ester (350 mg, 98% yield). ESMS: <i>m</i>/<i>z</i> 330 (M + H). HPLC: 95%, which was used directly. This intermediate was dissolved in methanol/DMF (4/1, 5 mL) and treated with Amberlyst A26 (OH<sup>−</sup> form) (1.9 g, 2.5 mmol). The resulting mixture was agitated at ambient temperature for 36 h. The sorbent was filtered and washed with several protions of methanol and DMF. The product was eluted with 20% formic acid in methanol, and the sorbent was then washed with methanol and DMF. The eluent was concentrated to <i>N</i>-(3,4-dimethoxy-benzyl)-isophthalamic acid (240 mg, 76% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (br, 1H), 9.00 (t, <i>J</i> = 5.9 Hz, 1H), 7.96 (s, 1H), 7.83 (d, <i>J</i> = 7.5 Hz, 1H), 7.58−7.44 (m, 4H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 4.53 (d, <i>J</i> = 5.9 Hz, 2H), 3.81 (s, 3H), 3.80 (s, 3H). ESMS: <i>m</i>/<i>z</i> 316 (M + H). HPLC: 100%. This intermediate (44.1 mg, 0.14 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (34.3 mg, 0.16 mmol) were coupled using the standard procedure with NMM. The isolate was dissolved directly in DCM (1 mL) and treated with SCX (398 mg, 0.35 mmol), and the resulting mixture was agitated for 16 h. The mixture was filtered and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated to the title compound (48 mg, 59.6% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.08 (t, <i>J</i> = 5.8 Hz, 1H), 8.56 (t, <i>J</i> = 5.5 Hz, 1H), 8.33 (s, 1H), 8.05−7.90 (m, 2H), 7.56 (t, <i>J</i> = 7.7 Hz, 1H), 6.97 (d, <i>J</i> = 1.5 Hz, 1H), 6.94−6.83 (m, 2H), 4.42 (d, <i>J</i> = 5.8 Hz, 2H), 3.74 (s, 3H), 3.72 (s, 3H), 3.33−3.23 (m, 2H), 2.95 (d, <i>J</i> = 11.9 Hz, 1H), 2.86 (d, <i>J</i> = 11.8 Hz, 1H), 2.49−2.36 (m, 1H), 2.24−2.12 (m, 1H), 1.80 (d, <i>J</i> = 13.9 Hz, 1H), 1.59−1.50 (m, 1H), 1.51−1.30 (m, 4H), 1.09−0.93 (m, 1H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-[2-(3,4-Dimethoxy-phenyl)-acetylamino]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>25</b>)</h4><div class="NLM_p last">(3,4-Dimethoxy-phenyl)-acetic acid (215.8 mg, 1.1 mmol) was dissolved in DMF (7 mL). <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (249 mg, 1.3 mmol) and benzotriazole-1-ol (175.7 mg, 1.3 mmol) were added, followed by DIEA (0.23 mL, 1.32 mmol). The resulting mixture was agitated for 1 h, and 3-aminobenzoic acid methyl ester (151.2 mg, 1.0 mmol) was added. The reaction mixture was agitated for 16 h, then treated with SCX (1.7 g, 1.5 mmol) and <i>Si</i>-DMA (1.33 g, 2.0 mmol) and the resulting mixture was agitated for 2 h and then filtered. The filtrate was concentrated to 3-[2-(3,4-dimethoxy-phenyl)-acetylamino]-benzoic acid methyl ester. ESMS: <i>m</i>/<i>z</i> 330 (M + H). HPLC: 100%, which was used directly. This intermediate was dissolved in methanol (5 mL) and treated with Amberlyst A26 (OH<sup>−</sup> form) (1.5 g, 2 mmol). The resulting mixture was agitated at ambient temperature for 72 h. The sorbent was filtered and washed with several portions of methanol and DMF. The product was eluted with 20% formic acid in methanol and the sorbent was then washed with methanol and DMF. The eluent was concentrated to 3-[2-(3,4-dimethoxy-phenyl)-acetylamino]-benzoic acid (137 mg, 43% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.00 (br, 1H), 10.30 (s, 1H), 8.23 (s, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.61 (d, <i>J</i> = 7.8 Hz, 1H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 6.96 (s, 1H), 6.91−6.84 (m, 2H), 3.75 (s, 3H), 3.72 (s, 3H), 3.57 (s, 2H). ESMS: <i>m</i>/<i>z</i> 316 (M + H). HPLC: 100%. This intermediate (37.8 mg, 0.12 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (32 mg, 0.14 mmol) were coupled using the standard procedure with DIEA. The reaction mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-(2-{3-[2-(3,4-dimethoxy-phenyl)-acetylamino]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (53 mg, 84% yield). ESMS: <i>m</i>/<i>z</i> 526 (M + H). HPLC: 100%. This intermediate (53 mg, 0.1 mmol) was taken up in 0.5 M HCl in dioxane (1 mL) and methanol (0.5 mL). The mixture was agitated for 1 h then concentrated. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide the title compound (19 mg, 45% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.47 (t, <i>J</i> = 5.5 Hz, 1H), 8.04 (s, 1H), 7.78 (d, <i>J</i> = 9.2 Hz, 1H), 7.48 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 6.97 (s, 1H), 6.95−6.78 (m, 2H), 3.75 (s, 3H), 3.72 (s, 3H), 3.56 (s, 2H), 3.27 (dd, <i>J</i> = 12.8, 6.7 Hz, 2H), 3.16 (d, <i>J</i> = 11.9 Hz, 1H), 3.09 (d, <i>J</i> = 12.4 Hz, 1H), 2.64 (t, <i>J</i> = 12.2 Hz, 1H), 2.47−2.34 (m, 1H), 1.83 (d, <i>J</i> = 10.9 Hz, 1H), 1.77−1.64 (m, 1H), 1.55−1.35 (m, 4H), 1.18−1.01 (m, 1H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3,4-Dimethoxy-<i>N</i>-[3-(2-piperidin-3-yl-ethylcarbamoyl)-phenyl]-benzamide (<b>26</b>)</h4><div class="NLM_p last">3,4-Dimethoxybenzoic acid (364.3 mg, 2.0 mmol) and 3-aminobenzoic acid methyl ester (302.3 mg, 2.0 mmol) were coupled using the standard procedure with NMM to provide 3-(3,4-dimethoxy-benzoylamino)-benzoic acid methyl ester: ESMS: <i>m</i>/<i>z</i> 316 (M + H). HPLC: 95%, which was used directly. This intermediate was dissolved in DMF (3 mL) and treated with Amberlyst A26 (OH<sup>−</sup> form) (3.0 g, 4.0 mmol). The resulting mixture was agitated at ambient temperature for 16 h. The sorbent was filtered and washed with several portions of methanol. The product was eluted with 20% formic acid in methanol, and the sorbent was then washed with methanol. The eluent was concentrated to 3-(3,4-dimethoxy-benzoylamino)-benzoic acid (130 mg, 22% yield). ESMS: <i>m</i>/<i>z</i> 302 (M + H). HPLC: 85%. This intermediate (44 mg, 0.15 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (36.5 mg, 0.16 mmol) were coupled using the standard procedure with NMM. The reaction mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-{2-[3-(3,4-dimethoxy-benzoylamino)-benzoylamino]-ethyl}-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (48 mg, 64.2% yield). ESMS: <i>m</i>/<i>z</i> 512 (M + H). HPLC: 100%. This intermediate (48 mg, 0.094 mmol) was dissolved in DCM (1 mL) and treated with SCX (200 mg, 0.175 mmol), and the resulting mixture was agitated for 16 h. The mixture was filtered, and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated then taken up in 1N HCl aq (1 mL) and methanol (1 mL). The mixture was agitated briefly and then concentrated to provide the title compound, HCl salt (29 mg, 72.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.21 (s, 1H), 9.03 (br, 1H), 8.72 (br, 1H), 8.53 (t, <i>J</i> = 5.9 Hz, 1H), 8.22 (s, 1H), 7.96 (d, <i>J</i> = 7.9 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.60−7.52 (m, 2H), 7.42 (t, <i>J</i> = 7.9 Hz, 1H), 7.10 (d, <i>J</i> = 8.5 Hz, 1H), 3.85 (s, 3H), 3.85 (s, 3H), 3.40−3.12 (m, 4H), 2.80−2.68 (m, 1H), 2.60−2.48 (m, 1H), 1.92−1.72 (m, 3H), 1.70−1.40 (m, 3H), 1.22−1.08 (m, 1H). ESMS: <i>m</i>/<i>z</i> 412 (M + H).</div></div><div id="sec3_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-[(3,4-Dimethoxy-benzenesulfonylamino)-methyl]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>27</b>)</h4><div class="NLM_p last">3-Aminomethyl-benzoic acid methyl ester, hydrochloride (201.6 mg, 1.0 mmol) was dissolved in DMF (3 mL) and <i>Si</i>-DMA (2.0 g, 3.0 mmol) was added, and the resulting mixture was agitated for 30 min, after which time, 3,4-dimethoxybenzenesulfonyl chloride (236.7 mg, 1.0 mmol) was added and the reaction mixture was agitated for 16 h. The sorbent was filtered and washed with DMF, and the filtrate was concentrated. The isolate was dissolved in DCM (10 mL) and the solution was washed with 1N HCl (5 mL) and brine (5 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to 3-[(3,4-dimethoxy-benzenesulfonylamino)-methyl]-benzoic acid methyl ester. ESMS: <i>m</i>/<i>z</i> 366 (M + H). HPLC: 100%, which was used directly. This intermediate was dissolved in methanol/DMF (1:1, 3 mL) and treated with Amberlyst A26 (OH<sup>−</sup> form) (1.5 g, 2.0 mmol). The resulting mixture was agitated at ambient temperature for 16 h. The sorbent was filtered and washed with several portions of methanol. The product was eluted with 20% formic acid in methanol. The eluent was concentrated to 3-[(3,4-dimethoxy-benzenesulfonylamino)-methyl]-benzoic acid (192 mg, 54.6% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (br, 1H), 8.09 (t, <i>J</i> = 6.4 Hz, 1H), 7.82 (s, 1H), 7.78 (d, <i>J</i> = 7.7 Hz, 1H), 7.47 (d, <i>J</i> = 7.7 Hz, 1H), 7.41−7.34 (m, 2H), 7.25 (d, <i>J</i> = 2.1 Hz, 1H), 7.07 (d, <i>J</i> = 8.5 Hz, 1H), 4.03 (d, <i>J</i> = 6.4 Hz, 2H), 3.82 (s, 3H), 3.78 (s, 3H). ESMS: <i>m</i>/<i>z</i> 352 (M + H). HPLC: 100%. This intermediate (49.2 mg, 0.14 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (34.3 mg, 0.15 mmol) were coupled using the standard procedure with NMM. The reaction mixture purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-(2-{3-[(3,4-dimethoxy-benzenesulfonylamino)-methyl]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (53 mg, 67.4% yield). ESMS: <i>m</i>/<i>z</i> 562 (M + H). HPLC: 100%. This intermediate (53 mg, 0.094 mmol) was dissolved in DCM (1 mL) and treated with SCX (200 mg, 0.175 mmol), and the resulting mixture was agitated for 16 h. The mixture was filtered and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated then taken up in 1 M HCl aq (1 mL) and methanol (1 mL). The mixture was agitated briefly and then concentrated to provide the title compound, HCl salt (30 mg, 68.9% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05 (br, 1H), 8.72 (br, 1H), 8.52 (t, <i>J</i> = 5.5 Hz, 1H), 8.09 (t, <i>J</i> = 5.8 Hz, 1H), 7.77 (s, 1H), 7.71 (d, <i>J</i> = 7.0 Hz, 1H), 7.44−7.28 (m, 4H), 7.10 (d, <i>J</i> = 8.5 Hz, 1H), 3.97 (d, <i>J</i> = 5.6 Hz, 2H), 3.83 (s, 3H), 3.78 (s, 3H), 3.42−3.12 (m, 4H), 2.80−2.62 (m, 1H), 2.58−2.43 (m, 1H), 1.92−1.70 (m, 3H), 1.70−1.38 (m, 3H), 1.21−1.08 (m, 1H). ESMS: <i>m</i>/<i>z</i> 462 (M + H).</div></div><div id="sec3_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3,4-Dimethoxy-<i>N</i>-[3-(3-piperidin-3-yl-propionylamino)-benzyl]-benzamide (<b>28</b>)</h4><div class="NLM_p last">3,4-Dimethoxybenzoic acid (100 mg, 0.55 mmol) and 3-(aminomethyl)-1-<i>N</i>-boc-aniline (111 mg, 0.5 mmol) were coupled using the standard procedure with NMM to provide {3-[(3,4-dimethoxy-benzoylamino)-methyl]-phenyl}-carbamic acid <i>tert</i>-butyl ester (190 mg, 89% yield). This intermediate was dissolved in DCM (2 mL). SCX (1.14 g, 1.0 mmol) was added to the solution, and the resulting mixture was agitated for 48 h. The reaction mixture was filtered and the sorbent was washed with DCM (2 × 2 mL) and methanol (2 × 2 mL). The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated to provide <i>N</i>-(3-amino-benzyl)-3,4-dimethoxy-benzamide (112 mg, 78% yield). ESMS: <i>m</i>/<i>z</i> 287 (M + H). HPLC: 100%. 3-(2-Carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (41.2 mg, 0.16 mmol) and the intermediate prepared above, <i>N</i>-(3-amino-benzyl)-3,4-dimethoxy-benzamide (45.8 mg, 0.16 mmol), were coupled using the standard procedure with NMM to provide 3-(2-{3-[(3,4-dimethoxy-benzoylamino)-methyl]-phenylcarbamoyl}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (84 mg, 100% yield). ESMS: <i>m</i>/<i>z</i> 526 (M + H). HPLC: 100%. This intermediate (84 mg 0.16 mmol) was dissolved directly in DCM (1 mL) and treated with SCX (400 mg, 0.35 mmol). The resulting mixture was agitated 16 h. The reaction mixture was filtered, and the solids were washed with DCM (2 × 2 mL) and methanol (2 × 2 mL). The product was eluted with NH<sub>3</sub> (7N in methanol), and the eluent was concentrated to provide the title compound (24 mg, 35% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.87 (s, 1H), 8.92 (t, <i>J</i> = 5.9 Hz, 1H), 7.57−7.48 (m, 4H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.5 Hz, 1H), 6.98 (d, <i>J</i> = 7.6 Hz, 1H), 4.43 (d, <i>J</i> = 5.9 Hz, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 2.92 (d, <i>J</i> = 11.3 Hz, 1H), 2.85 (d, <i>J</i> = 11.8 Hz, 1H), 2.39 (td, <i>J</i> = 11.8, 2.7 Hz, 1H), 2.28 (t, <i>J</i> = 7.6 Hz, 2H), 2.18−2.08 (m, 1H), 1.75 (d, <i>J</i> = 13.8 Hz, 1H), 1.60−1.21 (m, 5H), 1.04−0.93 (m, 1H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-{3-[(3,4-Dimethoxy-phenylcarbamoyl)-methyl]-phenyl}-3-piperidin-3-yl-propionamide (<b>29</b>)</h4><div class="NLM_p last">3-Nitrophenylacetic acid (136 mg, 0.75 mmol) and 3,4-dimethoxyaniline (115 mg, 0.75 mmol) were coupled using the standard procedure with NMM. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide <i>N</i>-(3,4-dimethoxy-phenyl)-2-(3-nitro-phenyl)-acetamide (36 mg, 15% yield). This intermediate (36 mg, 0.114 mmol) was dissolved in methanol (1 mL) and ammonium formate (69 mg, 1.1 mmol) then Pd/C (5 mg) were added. The reaction vial was sealed and agitated at 45 °C 16 h. The reaction mixture was filtered, and the filtrate was diluted with ethyl acetate (10 mL). This mixture was washed with water (2 × 5 mL) and brine (1 × 5 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide the intermediate 2-(3-amino-phenyl)-<i>N</i>-(3,4-dimethoxy-phenyl)-acetamide (10 mg, 31% yield). ESMS: <i>m</i>/<i>z</i> 287 (M + H). HPLC: 95%. 3-(2-Carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (12.9 mg, 0.05 mmol) and the intermediate prepared above (10 mg, 0.035 mmol) were coupled using the standard procedure with NMM to provide 3-(2-{3-[(3,4-dimethoxy-phenylcarbamoyl)-methyl]-phenylcarbamoyl}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (19 mg, 72% yield). This intermediate was dissolved directly in DCM (1 mL) and treated with SCX (136 mg, 0.12 mmol). The resulting mixture was agitated 16 h, filtered, and the sorbent was washed with DCM (2 × 2 mL) and methanol (2 × 2 mL). The product was eluted with NH<sub>3</sub> (7N in methanol), and the eluent was concentrated. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (6.5 mg, 38% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.57 (s, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 1H), 7.35−7.22 (m, 2H), 7.09 (d, <i>J</i> = 7.6 Hz, 1H), 7.02 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 6.87 (d, <i>J</i> = 8.7 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.63 (s, 2H), 3.39−3.26 (m, 2H), 2.87 (td, <i>J</i> = 12.8, 3.1 Hz, 1H), 2.65 (t, <i>J</i> = 12.0 Hz, 1H), 2.49−2.37 (m, 2H), 1.95 (t, <i>J</i> = 16.3 Hz, 2H), 1.85−1.53 (m, 4H), 1.32−1.15 (m, 1H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3-methoxy-benzamide (<b>30</b>)</h4><div class="NLM_p">3-Methoxybenzoic acid (40 mg, 0.26 mmol) and <b>53</b> (40 mg, 0.14 mmol) were coupled using the standard procedure with DIEA. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (16 mg, 27% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (s, 1H), 7.91 (s, 1H), 7.83 (d, <i>J</i> = 9.0 Hz, 1H), 7.74 (d, <i>J</i> = 8.6 Hz, 2H), 7.57 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.7 Hz, 1H), 7.46−7.42 (m, 1H), 7.41−7.30 (m, 4H), 7.06 (ddd, <i>J</i> = 7.6, 2.6, 1.6 Hz, 1H), 7.01 (t, <i>J</i> = 5.8 Hz, 1H), 4.70 (d, <i>J</i> = 5.9 Hz, 2H), 3.92 (s, 2H), 3.85 (s, 3H), 2.55 (s, 6H). ESMS: <i>m</i>/<i>z</i> 418 (M + H).</div><div class="NLM_p last">Compounds <b>31</b>−<b>37</b> were prepared from <b>53</b> and the corresponding substituted benzoic acid according to the procedure described for the synthesis of <b>30</b>.</div></div><div id="sec3_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-benzamide (<b>31</b>)</h4><div class="NLM_p last">Yield 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.82 (br, 1H), 7.90 (s, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 3H), 7.75 (d, <i>J</i> = 8.4 Hz, 2H), 7.56 (d, <i>J</i> = 7.2 Hz, 1H), 7.47 (d, <i>J</i> = 7.6 Hz, 1H), 7.38 (d, <i>J</i> = 8.0 Hz, 2H), 6.93 (d, <i>J</i> = 8.7 Hz, 3H), 4.69 (d, <i>J</i> = 5.8 Hz, 2H), 3.96 (s, 2H), 3.86 (s, 3H), 2.57 (s, 6H). ESMS: <i>m</i>/<i>z</i> 418 (M + H).</div></div><div id="sec3_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3,4-dihydroxy-benzamide (<b>32</b>)</h4><div class="NLM_p last">Yield 10%. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.93 (s, 1H), 7.90−7.82 (m, 3H), 7.61 (d, <i>J</i> = 7.7 Hz, 1H), 7.55−7.47 (m, 3H), 7.35 (d, <i>J</i> = 2.2 Hz, 1H), 7.29 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 6.83 (d, <i>J</i> = 8.3 Hz, 1H), 4.64 (s, 2H), 4.28 (s, 2H), 2.86 (s, 6H). ESMS: <i>m</i>/<i>z</i> 420 (M + H).</div></div><div id="sec3_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-3-methyl-benzamide (<b>33</b>)</h4><div class="NLM_p last">Yield 29%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.80 (s, 1H), 7.63 (s, 1H), 7.56 (d, <i>J</i> = 7.7 Hz, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.45 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.39 (s, 1H), 7.27 (d, <i>J</i> = 7.7 Hz, 1H), 7.16 (t, <i>J</i> = 7.7 Hz, 1H), 7.09 (d, <i>J</i> = 8.5 Hz, 2H), 6.79 (t, <i>J</i> = 5.9 Hz, 1H), 6.57 (d, <i>J</i> = 8.6 Hz, 1H), 4.39 (d, <i>J</i> = 5.9 Hz, 2H), 3.78 (s, 2H), 3.62 (s, 3H), 2.39 (s, 6H), 1.97 (s, 3H). ESMS: <i>m</i>/<i>z</i> 432 (M + H).</div></div><div id="sec3_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-Chloro-<i>N</i>-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-benzamide (<b>34</b>)</h4><div class="NLM_p last">Yield 35%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1H), 7.89 (d, <i>J</i> = 2.2 Hz, 1H), 7.85 (s, 1H), 7.81−7.74 (m, 2H), 7.72 (d, <i>J</i> = 8.5 Hz, 2H), 7.49 (d, <i>J</i> = 7.7 Hz, 1H), 7.45 (t, <i>J</i> = 5.8 Hz, 1H), 7.38 (t, <i>J</i> = 7.7 Hz, 1H), 7.31 (d, <i>J</i> = 8.5 Hz, 2H), 6.91 (d, <i>J</i> = 8.7 Hz, 1H), 4.60 (d, <i>J</i> = 5.8 Hz, 2H), 4.03 (s, 2H), 3.93 (s, 3H), 2.65 (s, 6H). ESMS: <i>m</i>/<i>z</i> 452 (M + H).</div></div><div id="sec3_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-3-trifluoromethyl-benzamide (<b>35</b>)</h4><div class="NLM_p last">Yield 26%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.13 (d, <i>J</i> = 1.9 Hz, 1H), 8.10 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.93 (s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.74 (d, <i>J</i> = 8.5 Hz, 2H), 7.62 (t, <i>J</i> = 5.8 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 7.40 (t, <i>J</i> = 7.7 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 7.01 (d, <i>J</i> = 8.7 Hz, 1H), 4.65 (d, <i>J</i> = 5.8 Hz, 2H), 3.97 (s, 2H), 3.94 (s, 3H), 2.58 (s, 6H). ESMS: <i>m</i>/<i>z</i> 486 (M + H).</div></div><div id="sec3_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-Chloro-<i>N</i>-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-trifluoromethoxy-benzamide (<b>36</b>)</h4><div class="NLM_p last">Yield 30%. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.32 (s, 1H), 9.36 (t, <i>J</i> = 5.8 Hz, 1H), 8.21 (d, <i>J</i> = 2.0 Hz, 1H), 8.14 (s, 1H), 8.00 (dd, <i>J</i> = 8.6 Hz, 2.0 Hz, 1H), 7.89 (s, 1H), 7.85 (d, <i>J</i> = 7.4 Hz, 1H), 7.78−7.70 (m, 3H), 7.57−7.48 (m, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 4.58 (d, <i>J</i> = 5.8 Hz, 2H), 2.32 (s, 6H), buried CH<sub>2</sub>. ESMS: <i>m</i>/<i>z</i> 506 (M + H).</div></div><div id="sec3_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-Cyano-<i>N</i>-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-benzamide (<b>37</b>)</h4><div class="NLM_p last">Yield 18%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.83 (s, 1H), 7.99 (d, <i>J</i> = 8.6 Hz, 2H), 7.92 (s, 1H), 7.82 (d, <i>J</i> = 7.8 Hz, 1H), 7.79−7.69 (m, 4H), 7.57 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (t, <i>J</i> = 7.7 Hz, 1H), 7.42 (t, <i>J</i> = 5.9 Hz, 1H), 7.38 (d, J = 8.6 Hz, 2H), 4.71 (d, <i>J</i> = 5.8 Hz, 2H), 3.98 (s, 2H), 2.60 (s, 6H). ESMS: <i>m</i>/<i>z</i> 413 (M + H).</div></div><div id="sec3_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-[3-(3-Cyano-phenyl)-ureidomethyl]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>38</b>)</h4><div class="NLM_p last">3-Methoxycarbonyl-benzyl-ammonium chloride (111 mg, 0.55 mmol) was dissolved in DMF (2 mL) in a reaction vial. <i>Si</i>-DMA (570 mg, 0.85 mmol) was added, and the mixture was agitated for 1 h. Subsequently, <i>m</i>-cyanophenylisocyanate (72 mg, 0.5 mmol) was added and the mixture was agitated 16 h. SCX (114 mg, 0.1 mmol) was added and the mixture was agitated for 30 min. The solids were filtered and the solvent was concentrated to provide 3-[3-(3-cyano-phenyl)-ureidomethyl]-benzoic acid methyl ester: ESMS: <i>m</i>/<i>z</i> 310 (M + H). HPLC: 100%, which was used directly. The urea was dissolved in methanol (2 mL) and DMF (2 mL), and Amberlyst A26 (OH<sup>−</sup> form) (746 mg, 1.0 mmol) was added. The resulting mixture was agitated for 16 h, and then the sorbent was filtered and washed with several portions of methanol. The product was eluted with formic acid (20% in methanol), and the eluent was concentrated to provide 3-[3-(3-cyano-phenyl)-ureidomethyl]-benzoic acid (85 mg, 58% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.90 (br, 1H), 9.13 (s, 1H), 7.96 (t, <i>J</i> = 1.7 Hz, 1H), 7.90 (s, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 7.62 (d, <i>J</i> = 7.4 Hz, 1H), 7.55 (d, <i>J</i> = 7.7 Hz, 1H), 7.46 (d, <i>J</i> = 7.7 Hz, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 1H), 7.35 (d, <i>J</i> = 7.6 Hz, 1H), 7.04 (t, <i>J</i> = 5.9 Hz, 1H), 4.37 (d, <i>J</i> = 5.8 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 296 (M + H). HPLC: 95%. This intermediate (29.5 mg, 0.1 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (27.4 mg, 0.12 mmol) were coupled using the standard procedure with DIEA. The reaction mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-(2-{3-[3-(3-cyano-phenyl)-ureidomethyl]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (36 mg, 71% yield). ESMS: <i>m</i>/<i>z</i> 506 (M + H). HPLC: 100%. This intermediate (36 mg, 0.07 mmol) was treated with 0.5 M HCl in dioxane (1 mL, 0.5 mmol). Methanol (0.5 mL) was added to solublize, and the resulting mixture was agitated for 1 h then concentrated. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (20 mg, 70% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.96 (s, 1H), 8.53 (t, <i>J</i> = 5.6 Hz, 1H), 8.07−7.94 (m, 1H), 7.90−7.76 (m, 2H), 7.70 (d, <i>J</i> = 7.5 Hz, 1H), 7.65 (dq, <i>J</i> = 8.4, 1 Hz, 1H), 7.48−7.37 (m, 3H), 7.33−7.30 (m, 1H), 4.34 (d, <i>J</i> = 5.8 Hz, 2H), 3.49−3.27 (m, 2H), 3.19 (d, <i>J</i> = 13.0 Hz, 1H), 3.11 (d, <i>J</i> = 11.9 Hz, 1H), 2.75−2.61 (m, 1H), 2.55−2.45 (m, 1H), 1.84 (d, <i>J</i> = 14.6 Hz, 1H), 1.78−1.60 (m, 2H), 1.59−1.40 (m, 3H), 1.17−1.04 (m, 1H). ESMS: <i>m</i>/<i>z</i> 406 (M + H).</div></div><div id="sec3_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-[3-(3,4-Dimethoxy-phenyl)-ureidomethyl]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>39</b>)</h4><div class="NLM_p last">3-Methoxycarbonyl-benzyl-ammonium chloride (101 mg, 0.5 mmol) was dissolved in DMF (2 mL) in a reaction vial. <i>Si</i>-DMA (500 mg, 0.75 mmol) was added, and the mixture was agitated for 1 h. Subsequently, 3,4-dimethoxyphenylisocyanate (0.067 mL, 0.45 mmol) was added, and the mixture was agitated 16 h. SCX (100 mg, 0.09 mmol) was added, and the mixture was agitated for 15 min. The sorbents were filtered and washed with methanol and DMF, and the filtrate was concentrated to provide 3-[3-(3,4-dimethoxy-phenyl)-ureidomethyl]-benzoic acid methyl ester (155 mg, 90% yield). ESMS: <i>m</i>/<i>z</i> 345 (M + H). HPLC: 100%. The urea (110 mg, 0.32 mmol) was dissolved in DMF (1 mL), and Amberlyst A26 (OH<sup>−</sup> form) (746 mg, 1.0 mmol) was added. The resulting mixture was agitated for 16 h. The sorbent was filtered and washed with several portions of DMF then methanol. The product was eluted with a solution of 20% formic acid in methanol, and the eluent was concentrated to provide 3-[3-(3,4-dimethoxyphenyl)-ureidomethyl]-benzoic acid (72 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 13.00 (br, 1H), 8.48 (s, 1H), 7.88 (s, 1H), 7.80 (d, <i>J</i> = 7.6 Hz, 1H), 7.52 (d, <i>J</i> = 7.7 Hz, 1H), 7.44 (t, <i>J</i> = 7.6 Hz, 1H), 7.16 (s, 1H), 6.81 (s, 2H), 6.65 (t, <i>J</i> = 5.9 Hz, 1H), 4.33 (d, <i>J</i> = 5.8 Hz, 2H), 3.69 (s, 3H), 3.66 (s, 3H). ESMS: <i>m</i>/<i>z</i> 331 (M + H). HPLC: 100%. This intermediate (48 mg, 0.145 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (34.3 mg, 0.15 mmol) were coupled using the standard procedure with NMM to provide 3-(2-{3-[3-(3,4-dimethoxy-phenyl)-ureidomethyl]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester. ESMS: <i>m</i>/<i>z</i> 541 (M + H). HPLC: 100%, which was used directly. The intermediate was dissolved in DCM (1 mL) and treated with SCX (454 mg, 0.4 mmol), and the resulting mixture was agitated for 16 h. The mixture was filtered, and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated to provide the title compound (56 mg, 88% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.53−8.39 (m, 2H), 7.77 (s, 1H), 7.70 (d, <i>J</i> = 5.3 Hz, 1H), 7.48−7.37 (m, 2H), 7.19 (s, 1H), 6.82 (s, 2H), 6.63 (t, <i>J</i> = 5.9 Hz, 1H), 4.33 (d, <i>J</i> = 5.7 Hz, 2H), 3.70 (s, 3H), 3.68 (s, 3H), 3.41−3.25 (m, 4H), 3.00 (d, <i>J</i> = 13.7 Hz, 2H), 1.68 (d, <i>J</i> = 13.7 Hz, 2H), 1.48−1.40 (m, 3H), 1.18−1.04 (m, 2H). ESMS: <i>m</i>/<i>z</i> 441 (M + H).</div></div><div id="sec3_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-[3-(4-Cyano-phenyl)-ureidomethyl]-<i>N</i>-(2-piperidin-3-yl-ethyl)-benzamide (<b>40</b>)</h4><div class="NLM_p last">Common intermediate <b>54</b> (38.4 mg, 0.13 mmol) and 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (34.3 mg, 0.15 mmol) were coupled using the standard procedure with DIEA. The reaction mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-(2-{3-[3-(4-cyano-phenyl)-ureidomethyl]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (26 mg, 40% yield). ESMS: <i>m</i>/<i>z</i> 506 (M + H). HPLC: 100%. The intermediate (26 mg, 0.051 mmol) was treated with 0.5 M HCl in dioxane. Methanol (0.5 mL) was added to solublize, and the resulting mixture was agitated for 1 h then concentrated to provide the title compound, HCl salt (20.5 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.63 (s, 1H), 8.82 (d, <i>J</i> = 10.4 Hz, 1H), 8.58−8.45 (m, 2H), 7.81 (s, 1H), 7.72 (d, <i>J</i> = 7.2 Hz, 1H), 7.65 (d, <i>J</i> = 8.7 Hz, 2H), 7.61 (d, <i>J</i> = 8.8 Hz, 2H), 7.49−7.39 (m, 2H), 7.18 (t, <i>J</i> = 5.8 Hz, 1H), 4.37 (d, <i>J</i> = 5.7 Hz, 2H), 3.40−3.09 (m, 5H), 2.74 (dd, <i>J</i> = 24.0, 11.2 Hz, 1H), 1.86 (d, <i>J</i> = 14.0 Hz, 1H), 1.80−1.70 (m, 2H), 1.65−1.37 (m, 3H), 1.14 (dd, <i>J</i> = 25.8, 11.0 Hz, 1H). ESMS: <i>m</i>/<i>z</i> 406 (M + H).</div></div><div id="sec3_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-{3-[3-(4-Cyano-phenyl)-ureidomethyl]-phenyl}-3-piperidin-3-yl-propionamide (<b>41</b>)</h4><div class="NLM_p last">3-<i>t-</i>Butoxycarbonylamino-benzyl-ammonium chloride (103.5 mg, 0.4 mmol) was dissolved in DMF (1 mL) in a reaction vial, and <i>Si</i>-DMA (350 mg, 0.525 mmol) was added. The resulting mixture was agitated for 1 h, after which time <i>p</i>-cyanophenylisocyanate (52 mg, 0.36 mmol) was added and the reaction mixture was agitated 16 h. SCX (113 mg, 0.1 mmol) was added, and the mixture was agitated an additional 30 min. The reaction mixture was filtered and the sorbent was washed with DMF. The filtrate was concentrated to provide {3-[3-(4-cyano-phenyl)-ureidomethyl]-phenyl}-carbamic acid <i>tert</i>-butyl ester (140 mg, 95% yield). ESMS: <i>m</i>/<i>z</i> 367 (M + H). HPLC: 100%. The isolate was dissolved in DCM (5 mL) and treated with TFA (1 mL), and the resulting mixture was stirred at room temperature for 1.5 h. The solution was concentrated to provide 1-(3-amino-benzyl)-3-(4-cyano-phenyl)-urea (96 mg, 94% yield): ESMS: <i>m</i>/<i>z</i> 267 (M + H). HPLC: 94%. 3-(2-Carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (38.6 mg, 0.15 mmol), and the urea prepared above (40 mg, 0.15 mmol) were coupled using the standard procedure with NMM to provide 3-(2-{3-[3-(4-cyano-phenyl)-ureidomethyl]-phenylcarbamoyl}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (63 mg, 83% yield). ESMS: <i>m</i>/<i>z</i> 506 (M + H). HPLC: 74%. This intermediate was dissolved in DCM (1 mL) and treated with SCX (341 mg, 0.3 mmol). The resulting mixture was agitated for 16 h. The mixture was filtered and the sorbent was washed with several portions of DCM and methanol. The product was eluted with NH<sub>3</sub> (7N in methanol). The eluent was concentrated and the isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (9 mg, 18% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.97 (s, 1H), 9.95 (s, 1H), 7.76−7.59 (m, 5H), 7.53 (d, <i>J</i> = 8.1 Hz, 1H), 7.47 (s, 1H), 7.24 (t, <i>J</i> = 7.8 Hz, 1H), 6.96 (d, <i>J</i> = 7.6 Hz, 1H), 4.26 (d, <i>J</i> = 5.8 Hz, 2H), 3.16 (t, <i>J</i> = 12.5 Hz, 2H), 2.77−2.63 (m, 1H), 2.50−2.42 (m, 1H), 2.33 (t, <i>J</i> = 7.4 Hz, 2H), 1.82−1.71 (m, 2H), 1.65−1.45 (m 4H), 1.11 (dd, <i>J</i> = 22.9, 10.4 Hz, 1H). ESMS: <i>m</i>/<i>z</i> 406 (M + H).</div></div><div id="sec3_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-[3-(4-Cyano-phenyl)-ureidomethyl]-<i>N</i>-(2-piperidin-4-yl-ethyl)-benzamide (<b>42</b>)</h4><div class="NLM_p last">Common intermediate <b>54</b> (30 mg, 0.10 mmol) and 4-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (27.4 mg, 0.12 mmol) were coupled using the standard procedure with NMM to provide 4-(2-{3-[3-(4-cyano-phenyl)-ureidomethyl]-benzoylamino}-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (50 mg, 97% yield). ESMS: <i>m</i>/<i>z</i> 506 (M + H); HPLC: 100%. This intermediate was dissolved in DCM (1 mL), and TFA (0.3 mL) was added. The resulting mixture was agitated for 2 h and then concentrated. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (37 mg, 91% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.63 (s, 1H), 8.48 (t, <i>J</i> = 5.5 Hz, 1H), 7.78 (s, 1H), 7.75−7.57 (m, 5H), 7.49−7.34 (m, 3H), 4.35 (d, <i>J</i> = 5.8 Hz, 2H), 3.34−3.20 (m, 4H), 2.81 (dd, <i>J</i> = 14.0, 11.3 Hz, 2H), 1.85 (d, <i>J</i> = 12.6 Hz, 2H), 1.68−1.41 (m, 3H), 1.27 (dd, <i>J</i> = 23.4, 10.7 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 406 (M + H).</div></div><div id="sec3_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-[3-(4-Cyano-phenyl)-ureidomethyl]-<i>N</i>-(1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide (<b>43</b>)</h4><div class="NLM_p last">Prepared according to the procedure used for the synthesis of <b>42</b>: 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.29 (s, 1H), 9.47 (s, 1H), 7.88 (s, 1H), 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 7.69−7.59 (m, 5H), 7.58−7.46 (m, 3H), 7.24 (t, <i>J</i> = 5.8 Hz, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 4.40 (d, <i>J</i> = 5.9 Hz, 2H), 4.17 (s, 2H), 3.31−3.21 (m, 2H), 2.88 (t, <i>J</i> = 5.5 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 426 (M + H).</div></div><div id="sec3_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 3-[3-(4-Cyano-phenyl)-ureidomethyl]-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (<b>44</b>)</h4><div class="NLM_p last">Common intermediate <b>54</b> (23 mg, 0.078 mmol) and 4-dimethylaminomethylaniline (14.3 mg, 0.095 mmol) were coupled using the standard procedure with DIEA. The isolate was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide the title compound (28 mg, 76% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.10 (s, 1H), 9.17 (s, 1H), 7.70 (s, 1H), 7.66 (d, <i>J</i> = 7.0 Hz, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 2H), 7.50 (d, <i>J</i> = 8.9 Hz, 2H), 7.43 (d, <i>J</i> = 8.9 Hz, 2H), 7.37−7.29 (m, 2H), 7.10 (d, <i>J</i> = 8.5 Hz, 2H), 6.93 (t, <i>J</i> = 5.9 Hz, 1H), 4.23 (d, <i>J</i> = 5.9 Hz, 2H), 3.26 (s, 2H), 2.02 (s, 6H). ESMS: <i>m</i>/<i>z</i> 428 (M + H).</div></div><div id="sec3_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(4-Aminomethyl-phenyl)-3-[3-(4-cyano-phenyl)-ureidomethyl]-benzamide (<b>45</b>)</h4><div class="NLM_p last">Prepared according to the procedure used for the synthesis of <b>42</b>: 85% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.38 (s, 1H), 9.86 (s, 1H), 7.89 (s, 1H), 7.84 (d, <i>J</i> = 7.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.5 Hz, 2H), 7.79−7.61 (m, 5H), 7.55−7.47 (m, 2H), 7.41 (d, <i>J</i> = 8.5 Hz, 2H), 4.40 (d, <i>J</i> = 5.8 Hz, 2H), 3.94 (s, 2H). ESMS: <i>m</i>/<i>z</i> 400 (M + H).</div></div><div id="sec3_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-[3-(3-Chloro-4-cyano-phenyl)-ureidomethyl]-<i>N</i>-(3-dimethylaminomethyl-benzyl)-benzamide (<b>46</b>)</h4><div class="NLM_p last">2-Chloro-4-aminobenzonitrile (305 mg, 2 mmol) and carbonyldiimidazole (324 mg, 2 mmol) were combined in a reaction vial, and DMF (5 mL) was added. The resulting mixture was heated at 60 °C for 16 h, and the product, 1,3-bis-(3-chloro-4-cyano-phenyl)-urea, was isolated by filtration and washed with several portions of 1N HCl (220 mg, 73% yield). ESMS: <i>m</i>/<i>z</i> 331 (M + H). HPLC: 100%. This intermediate (200 mg, 0.6 mmol) was dispersed in DMF (2 mL) in a microwave vial, and a solution of <b>53</b> (200 mg, 0.7 mmol), in DMF (1 mL), was added. The vial was sealed and heated in the microwave at 150 °C for 70 min. The reaction mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient, then further purified by catch and release with Varian SCX cartridges to provide the title compound (60 mg, 18.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.26 (s, 1H), 9.48 (s, 1H), 7.96−7.92 (m, 1H), 7.89−7.82 (m, 2H), 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.72 (d, <i>J</i> = 8.4 Hz, 2H), 7.55−7.46 (m, 2H), 7.41 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.16 (t, <i>J</i> = 5.9 Hz, 1H), 4.41 (d, <i>J</i> = 5.9 Hz, 2H), 3.39 (s, 2H), 2.51 (s, 6H). ESMS: <i>m</i>/<i>z</i> 462 (M + H).</div></div><div id="sec3_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-[3-(4-Amido-phenyl)-ureidomethyl]-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (<b>47</b>)</h4><div class="NLM_p last">Compound <b>44</b> (20 mg, 0.058 mmol) was dissolved in 0.5 mL of 20% H<sub>2</sub>SO<sub>4</sub> in TFA. The resulting mixture was agitated for 36 h. The reaction mixture was concentrated, and ice was added followed by 0.7 mL methanol and the mixture was purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound (13 mg, 50% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.29 (s, 1H), 8.95 (s, 1H), 8.16 (s, 1H), 7.88 (s, 1H), 7.84 (d, <i>J</i> = 7.0 Hz, 1H), 7.79−7.71 (m, 4H), 7.55−7.44 (m, 3H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 7.15 (s, 1H), 6.89 (t, <i>J</i> = 5.8 Hz, 1H), 4.40 (d, <i>J</i> = 5.8 Hz, 2H), 3.50 (s, 2H), 2.24 (s, 6H). ESMS: <i>m</i>/<i>z</i> 446 (M + H).</div></div><div id="sec3_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-[3-(3-Chloro-4-amido-phenyl)-ureidomethyl]-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (<b>48</b>)</h4><div class="NLM_p last">Prepared from <b>46</b> according to the procedure used for the synthesis of <b>47</b>: 60% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.30 (s, 1H), 8.99 (s, 1H), 7.88 (s, 1H), 7.84 (d, <i>J</i> = 7.0 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 2H), 7.72−7.66 (m, 2H), 7.57−7.47 (m, 2H), 7.41 (s, 1H), 7.37−7.31 (m, 3H), 7.26 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 6.91 (t, <i>J</i> = 5.3 Hz, 1H), 4.40 (d, <i>J</i> = 5.8 Hz, 2H), 3.63 (s, 2H), 2.33 (s, 6H). ESMS: <i>m</i>/<i>z</i> 480 (M + H).</div></div><div id="sec3_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-[3-(3-Amido-phenyl)-ureidomethyl]-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (<b>49</b>)</h4><div class="NLM_p last">Intermediate <b>53</b> (36.8 mg, 0.13 mmol) was dissolved in DMF (1 mL) and 3-cyanophenylisocyanate (21.6 mg, 0.15 mmol) was added. The reaction mixture was agitated for 72 h then purified directly by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 3-[3-(3-cyano-phenyl)-ureidomethyl]-<i>N</i>-(4-dimethylaminomethyl-phenyl)-benzamide (28 mg, 50.4% yield). This intermediate was then converted to the title compound according to the method described for the synthesis of <b>47</b>: 45% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.29 (s, 1H), 8.80 (s, 1H), 7.91−7.81 (m, 4H), 7.75 (d, <i>J</i> = 8.5 Hz, 2H), 7.62 (d, <i>J</i> = 7.0 Hz, 1H), 7.55−7.47 (m, 2H), 7.39 (d, <i>J</i> = 7.7 Hz, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 4H), 6.81 (t, <i>J</i> = 6.0 Hz, 1H), 4.40 (d, <i>J</i> = 5.8 Hz, 2H), 3.52 (s, 2H), 2.25 (s, 6H). ESMS: <i>m</i>/<i>z</i> 446 (M + H).</div></div><div id="sec3_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 3-[3-(4-Amido-phenyl)-ureidomethyl]-<i>N</i>-(1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide (<b>50</b>)</h4><div class="NLM_p last">Prepared from <b>43</b> according to the procedure used for the synthesis of <b>47</b>: 72% yield. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.26 (s, 1H), 9.08 (s, 1H), 7.90 (s, 1H), 7.83 (d, <i>J</i> = 7.1 Hz, 1H), 7.80−7.73 (m, 3H), 7.59 (s, 1H), 7.56−7.43 (m, 5H), 7.19−7.08 (m, 2H), 7.03 (t, <i>J</i> = 5.8 Hz, 1H), 4.39 (d, <i>J</i> = 5.8 Hz, 2H), 4.04 (s, 2H), 3.14 (t, <i>J</i> = 5.8 Hz, 2H), 2.79 (t, <i>J</i> = 5.7 Hz, 2H). ESMS: <i>m</i>/<i>z</i> 444 (M + H).</div></div><div id="sec3_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> ROCK1/ROCK 2 Dose−Response Assay</h4><div class="NLM_p last">The activity of ROCK1 (1−477) and ROCK2 (1−543) kinases was measured utilizing Cambrex PKLight ATP detection reagent (Cambrex catalogue no. LT27-200), a homogeneous assay technology using luciferin-luciferase to quantify residual ATP. The assay was performed in 96-well half area, white, nonbinding surface microtiter plates (Corning, catalogue no. 3642) in assay buffer consisting of 25 mM HEPES (pH 7.5), 10 mM MgCl<sub>2</sub>, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 μM Na<sub>3</sub>VO<sub>4</sub>, and 200 μM TCEP. Test compounds received as 5 mg/mL DMSO stocks were serially diluted 1:3 in DMSO for the 10-point concentration response. The DMSO dilutions were further diluted in the assay buffer, and 10 μL of this dilution was added to the assay plate, for a final starting assay concentration of 3 μg/mL in 1% DMSO. ROCK1 (12.6 μM stock) was diluted to 5 nM in assay buffer, and 30 μL was added to the assay, for a final concentration of 3 nM in a total volume of 30 μL. ROCK2 (29.0 μM stock) was diluted to 8.33 nM in assay buffer, and 30 μL was added to the assay for a final concentration of 5 nM in a total volume of 30 μL. After 15 min of preincubation of the test compounds with the kinase, a 10 μL volume of a mixture of 3.75 μM ATP, and 2.5 μM peptide substrate (AKRRRLSSLRA,<a onclick="showRef(event, 'cit34a cit34b'); return false;" href="javascript:void(0);" class="ref cit34a cit34b">(34a, 34b)</a> ANASPEC, catalogue no. 27192) diluted in assay buffer was added to each well for a final concentration of 750 nM ATP and 500 nM peptide. The kinase reaction mixture was incubated for 90 min at 28 °C. Following incubation, 30 μL of ATP detection reagent diluted in reconstitution buffer was added to the assay plates, and the resulting mixtures were incubated at room temperature for 15 min. The relative light unit (RLU) signal was measured on the Analyst plate reader (Molecular Devices) in luminescence mode. The RLU signals were converted to percent of control (POC) values using the formula POC = 100(BCTRL − Signal)/(BCTRL − PCTRL), where signal is the test well signal, BCTRL is the average of background (negative control) well signals on the plate, and PCTRL is the average of positive control well signals on the plate. For the concentration-responsive compounds, POC values as a function of test compound concentration were fitted to a four parameter logistic equation of the form: <i>y</i> = <i>A</i> + (<i>B</i> − <i>A</i>)/[1 + (<i>x</i>/<i>C</i>)<sup><i>D</i></sup>], where <i>A</i>, <i>B</i>, <i>C</i>, and <i>D</i> are fitted parameters (parameter <i>B</i> is fixed at zero POC) and <i>x</i> and <i>y</i> are the independent and dependent variables, respectively. The IC<sub>50</sub> (50% inhibitory concentration) was determined as the inflection point parameter, <i>C</i>.</div></div><div id="sec3_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Rat Aortic Ring Assay</h4><div class="NLM_p last">Segments of rat thoracic aorta were dissected from Sprague−Dawley rats cleaned of excess connective tissue and cut into 3−4 mm rings in a Petri dish filled with 4 °C PBS (phosphate buffer solution: NaCl (118 mM/L), KCl (4.7 mM/L), CaCl<sub>2</sub> (1.6 mM/L), KH<sub>2</sub>PO<sub>4</sub> (1.2 mM/L), MgCl<sub>2</sub> (1.2 mM/L), dextrose (10 mM/L), NaHCO<sub>3</sub> (25 mM/L), NaEDTA (0.02 mM/L) at pH 7.25 and kept on ice before dissection. The rings were then suspended between two stainless steel wires, both of which were fixed to a stainless steel support rod on one side and the other side connected to a force transducer and placed into 37 °C temperature-controlled tissue baths containing PBS that was constantly oxygenated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Isometric force was continually measured and the data collected by a digital acquisition system. The rings were placed under a preload of 2.5<i>g</i> of force, which was continuously adjusted during a 1 h equilibration period to serve as baseline force. This amount of force was chosen from a series of preliminary force−force experiments, which showed near maximum contraction with 125 mM KCl. Rings were contracted with 50 mM KCL to obtain the maximum contraction level for normalization. Following a washout period of 30 min, the rings were preconstricted with 10<sup>−6</sup> M phenylephrine and relaxed with a bolus dose of 10<sup>−7</sup> M acetylcholine to check the integrity of the endothelium. Following a second washout period of 30 min, rings were preconstricted a second time with 10<sup>−6</sup> M phenylephrine and the contraction allowed to stabilize. A cumulative dose response of a Rho-kinase inhibitor was tested in a DMSO vehicle at a 1:1000 dilution using half log intervals. After each dose of inhibitor, the response was allowed to stabilize before the addition of the next dose. Following the cumulative dose response with inhibitor, the tissues were washed 3× in PBS and allowed to equilibrate at resting tension. A second KCL contraction was performed as stated above to check the viability of the tissue. Following this, a second phenylephrine contraction and acetylcholine bolus dose were given as above to check for the integrity of the endothelium following inhibitor testing. The effect of the Rho-kinase inhibitors were expressed as a percentage relaxation from the phenylephrine-induced contraction at each dose. The IC<sub>50</sub> for each inhibitor was determined from the concentration that produced 50% relaxation from the phenylephrine-induced contraction. The data for each inhibitor represents the mean from four different segments from four different rats.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/jm9014263">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">ATP competition studies, data comparison for luciferase inhibitors using IMAP and luciferase assay formats, IMAP dose−response assay method, additional kinase selectivity data, and target independent profiling methods. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9014263/suppl_file/jm9014263_si_001.pdf">jm9014263_si_001.pdf (102.09 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9014263" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tina Morwick</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9eeaf3f1ece9f7fdf5deecfaf9b0fcf1fbf6ecf7f0f9fbecb3f7f0f9fbf2f6fbf7f3b0fdf1f3"><span class="__cf_email__" data-cfemail="8ffbe2e0fdf8e6ece4cffdebe8a1ede0eae7fde6e1e8eafda2e6e1e8eae3e7eae6e2a1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank H. Büttner</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharma GmbH and Co. KG, Birkendorfer Strasse 65, D-88397 Biberach an der Riss, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles L. Cywin</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georg Dahmann</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharma GmbH and Co. KG, Birkendorfer Strasse 65, D-88397 Biberach an der Riss, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene Hickey</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Jakes</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Kaplita</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammed A. Kashem</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Kerr</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley Kugler</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wang Mao</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Marshall</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zofia Paw</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Kon Shih</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Wu</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erick Young</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06801-0368</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Rachel Kroe-Barrett for the ITC experiments.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sams-Dodd, F.</span><span> </span><span class="NLM_article-title">Target-based drug discovery: is something wrong?</span> <span class="citation_source-journal">Drug Discovery Today: Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2FS1359-6446%2804%2903316-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15718163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=139-147&author=F.+Sams-Dodd&title=Target-based+drug+discovery%3A+is+something+wrong%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Target-based drug discovery: is something wrong?</span></div><div class="casAuthors">Sams-Dodd, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  For the past decade the pharmaceutical industry has experienced a steady decline in productivity and a striking observation is that the decline coincided with the introduction of target-based drug discovery.  The target-based approach can very effectively develop novel treatments for a validated target, but the process of target validation is complex and assocd. with a high degree of uncertainty.  The purpose of this paper is to analyze these aspects in detail to det. if weaknesses in this part of the drug discovery path might explain why this paradigm has not resulted in increased productivity over the traditional in vivo approach, considering its superiority in screening capacity and its ability to define rational drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCMCxkUpqTZbVg90H21EOLACvtfcHk0lirIca_cyTtZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbk%253D&md5=30240d6154c02518e5fabe9fb6ebd9c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903316-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903316-1%26sid%3Dliteratum%253Aachs%26aulast%3DSams-Dodd%26aufirst%3DF.%26atitle%3DTarget-based%2520drug%2520discovery%253A%2520is%2520something%2520wrong%253F%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Targets%26date%3D2005%26volume%3D10%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkinson, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinker, A. C.</span><span> </span><span class="NLM_article-title">Components of successful lead generation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.2174%2F1568026053828411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15892684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=421-439&author=A.+M.+Davisauthor=D.+J.+Keelingauthor=J.+Steeleauthor=N.+P.+Tomkinsonauthor=A.+C.+Tinker&title=Components+of+successful+lead+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Components of successful lead generation</span></div><div class="casAuthors">Davis, Andrew M.; Keeling, David J.; Steele, John; Tomkinson, Nicholas P.; Tinker, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-439</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review aims to give an overview of current good practice in the prosecution of Lead Generation.  It will assess experiences across the field as judged from the contents of the limited no. of peer-review disclosures to date.  It will also rely heavily on the experiences of the authors from many campaigns within this organization.  Its focus will be on the assembly of an appropriate compd. collection for application in High Throughput Screening (HTS), the prosecution of HTS, the profiling of HTS output and, lastly the Hit-to-Lead optimization of selected HTS output.  Excluded from the scope are detailed aspects of library design [1], parallel synthesis [2], virtual library applications [3], virtual screening [4] and fragment screening [5] approaches, all of which have been the subject of recent reviews.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5UYz5NF4m7Vg90H21EOLACvtfcHk0li9XVg17tVK6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D&md5=ef29c85464f4ecbc63787210fda1b778</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568026053828411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828411%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DKeeling%26aufirst%3DD.%2BJ.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTomkinson%26aufirst%3DN.%2BP.%26aulast%3DTinker%26aufirst%3DA.%2BC.%26atitle%3DComponents%2520of%2520successful%2520lead%2520generation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D421%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alanine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. W.</span><span> </span><span class="NLM_article-title">Lead generation—enhancing the success of drug discovery by investing in the hit to lead process</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=12570752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlCmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=51-66&author=A.+Alanineauthor=M.+Nettekovenauthor=E.+Robertsauthor=A.+W.+Thomas&title=Lead+generation%E2%80%94enhancing+the+success+of+drug+discovery+by+investing+in+the+hit+to+lead+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead generation - enhancing the success of drug discovery by investing in the hit to lead process</span></div><div class="casAuthors">Alanine, Alexander; Nettekoven, Matthias; Roberts, Edward; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Improving on the poor success rates in the drug discovery industry requires that knowledge-based decisions are made to advance or stop a lead candidate as early as possible in the discovery process.  Failure to make such timely decisions on the rigorous selection of lead candidates has costly time and resource implications in downstream drug development.  To meet this challenge dedicated "hit to lead" groups have recently been established in many major pharmaceutical companies, and a key to the success of such groups is establishing a clear consistent process and rigorous metrics for lead quality.  The importance of such a "Lead Generation" group within the drug discovery process will be highlighted with the aim of placing a greater level of emphasis in discovering and refining novel lead series with enhanced drug-like properties.  This activity is facilitated by the application of productivity enhancing, integrated technologies coupled with the early evaluation of drug-like properties in the lead refinement process to ensure that a balanced activity - properties profile can be attained before committing to a full lead optimization program.  This article will survey the processes and tools employed in the hit to lead process in such a "Lead Generation" group in order to achieve these objectives, emphasizing the possible gains in productivity through close, early interactions between chem. and other expert groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcmXqBYvtvsrVg90H21EOLACvtfcHk0li9XVg17tVK6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlCmtb4%253D&md5=0a6a05dba28e1fd884e251dd9517641a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DLead%2520generation%25E2%2580%2594enhancing%2520the%2520success%2520of%2520drug%2520discovery%2520by%2520investing%2520in%2520the%2520hit%2520to%2520lead%2520process%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2003%26volume%3D6%26spage%3D51%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bleicher, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyler, R.</span><span> </span><span class="NLM_article-title">Lead generation: sowing the seeds for future success</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=588-600&author=K.+H.+Bleicherauthor=M.+Nettekovenauthor=J.-U.+Petersauthor=R.+Wyler&title=Lead+generation%3A+sowing+the+seeds+for+future+success"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBleicher%26aufirst%3DK.%2BH.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWyler%26aufirst%3DR.%26atitle%3DLead%2520generation%253A%2520sowing%2520the%2520seeds%2520for%2520future%2520success%26jtitle%3DChimia%26date%3D2004%26volume%3D58%26spage%3D588%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Michne, W. F.</span><span> </span><span class="NLM_article-title">Hit-to-lead chemistry: A key element in new lead generation</span> <span class="citation_source-journal">Pharm. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADyaK28XmsFOqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=19-21&author=W.+F.+Michne&title=Hit-to-lead+chemistry%3A+A+key+element+in+new+lead+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-lead chemistry: A key element in new lead generation</span></div><div class="casAuthors">Michne, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical News</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">19-21</span>CODEN:
                <span class="NLM_cas:coden">PHNEEP</span>;
        ISSN:<span class="NLM_cas:issn">1071-894X</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">A review with refs.  Structure, purity validation, pharmacophore evaluation etc., in combinatorial chem. of pharmaceuticals are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBfdGfJ5xQRbVg90H21EOLACvtfcHk0li9XVg17tVK6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFOqtLs%253D&md5=c9e06c47ee3f878bc082b275c9e740b3</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichne%26aufirst%3DW.%2BF.%26atitle%3DHit-to-lead%2520chemistry%253A%2520A%2520key%2520element%2520in%2520new%2520lead%2520generation%26jtitle%3DPharm.%2520News%26date%3D1996%26volume%3D3%26spage%3D19%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Boureux, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignal, E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, P.</span><span> </span><span class="NLM_article-title">Evolution of the Rho family of ras-like GTPases in eukaryotes</span> <span class="citation_source-journal">Mol. Biol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=203-16&issue=1&author=A+Boureuxauthor=E+Vignalauthor=S+Faureauthor=P.+Fort&title=Evolution+of+the+Rho+family+of+ras-like+GTPases+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoureux%26aufirst%3DA%26aulast%3DVignal%26aufirst%3DE%26aulast%3DFaure%26aufirst%3DS%26aulast%3DFort%26aufirst%3DP.%26atitle%3DEvolution%2520of%2520the%2520Rho%2520family%2520of%2520ras-like%2520GTPases%2520in%2520eukaryotes%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2007%26volume%3D24%26issue%3D1%26spage%3D203%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span> </span><span class="NLM_article-title">Rho-kinase inhibition in the therapy of cardiovascular disease</span> <span class="citation_source-journal">Cardiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1097%2F01.crd.0000138079.91392.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16230885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A280%3ADC%252BD2MngslOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=285-292&author=A.+Laiauthor=W.+H.+Frishman&title=Rho-kinase+inhibition+in+the+therapy+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-kinase inhibition in the therapy of cardiovascular disease</span></div><div class="casAuthors">Lai Andrew; Frishman William H</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology in review</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">285-92</span>
        ISSN:<span class="NLM_cas:issn">1061-5377</span>.
    </div><div class="casAbstract">Rho is a GTPase known to be a major mediator in the formation of stress fibers and focal adhesions, cell morphology, and smooth muscle contraction.  Its role in smooth muscle contraction has led to exploration into the connection between Rho-mediated kinase activity and cardiovascular disease.  The role of Rho-kinase in calcium sensitization for vascular smooth muscle contraction has recently been characterized.  Inappropriate coronary artery vasoconstriction resulting from increased Rho-kinase in the vascular system is likely involved in the pathogenesis of exercise-induced myocardial ischemia, spontaneous coronary artery spasm, and hypertension.  In clinical trials, Rho-kinase inhibitors such as fasudil and Y-27632 have demonstrated antiischemic, antivasospastic, and antihypertensive effects.  These compounds have also exhibited the ability to blunt progression of cardiomyocyte hypertrophy and cardiac remodeling in heart failure.  As such, Rho-kinase inhibition represents a potential novel therapeutic approach in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbAYRfozPqNb5oR8RchjrrfW6udTcc2eZ4d5wT64uHNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MngslOlsg%253D%253D&md5=f1d201c92db49a0f7356b7094085a29d</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1097%2F01.crd.0000138079.91392.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.crd.0000138079.91392.37%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DRho-kinase%2520inhibition%2520in%2520the%2520therapy%2520of%2520cardiovascular%2520disease%26jtitle%3DCardiol.%2520Rev.%26date%3D2005%26volume%3D13%26spage%3D285%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1517%2F14728222.9.4.715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16083339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFels74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=715-736&author=E.+Huauthor=D.+Lee&title=Rho+kinase+as+potential+therapeutic+target+for+cardiovascular+diseases%3A+opportunities+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges</span></div><div class="casAuthors">Hu, Erding; Lee, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">715-736</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via interaction with the small GTP-binding protein RhoA.  Growing evidence suggests that RhoA and ROCK participate in a variety of important physiol. functions in vasculature including smooth muscle contraction, cell proliferation, cell adhesion and migration, and many aspects of inflammatory responses.  As these processes mediate the onset and progression of cardiovascular disease, modulation of the Rho/ROCK signalling pathway is a potential strategy for targeting an array of cardiovascular indications.  Two widely employed ROCK inhibitors, fasudil and Y-27632, have provided preliminary but compelling evidence supporting the potential cardiovascular benefits of ROCK inhibition in preclin. animal disease models and in the clinic.  This review summarizes the mol. biol. of ROCK and its biol. functions in smooth muscle, endothelium and other vascular tissues.  In addn., there will be a focus on recent progress demonstrating the benefits of ROCK inhibition in several animal models of cardiovascular diseases.  Finally, recent progress in the identification of novel ROCK inhibitors and challenges assocd. with their development for clin. use will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotn9K3fSIGYbVg90H21EOLACvtfcHk0ljGtNHzX5qW6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFels74%253D&md5=fba30810e84a880da792e93647b033e8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.715%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DRho%2520kinase%2520as%2520potential%2520therapeutic%2520target%2520for%2520cardiovascular%2520diseases%253A%2520opportunities%2520and%2520challenges%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D715%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Takai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span> </span><span class="NLM_article-title">Small GTP-binding proteins</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=153-208&author=Y.+Takaiauthor=T.+Sasakiauthor=T.+Matozaki&title=Small+GTP-binding+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMatozaki%26aufirst%3DT.%26atitle%3DSmall%2520GTP-binding%2520proteins%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D153%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span> </span><span class="NLM_article-title">Rho-family GTPases in cadherin-mediated cell−cell adhesion</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2F35103068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=11733768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptF2rtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=887-897&author=M.+Fukataauthor=K.+Kaibuchi&title=Rho-family+GTPases+in+cadherin-mediated+cell%E2%88%92cell+adhesion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-family GTPases in cadherin-mediated cell-cell adhesion</span></div><div class="casAuthors">Fukata, Masaki; Kaibuchi, Kozo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">887-897</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell-cell adhesions are rearranged dynamically during tissue development and tumor metastasis.  Recently, Rho-family GTPases, including RhoA, Rac1 and Cdc42, have emerged as key regulators of cadherin-mediated cell-cell adhesion.  Following the identification and characterization of regulators and effectors of Rho GTPases, signal transduction pathways from cadherin to Rho GTPases and, in turn, from Rho GTPases to cadherin, are beginning to be clarified,.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp42-yzwOsrBbVg90H21EOLACvtfcHk0ljGtNHzX5qW6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptF2rtL4%253D&md5=93e679dc81b98c1468bd9ed3f0a4ac74</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2F35103068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35103068%26sid%3Dliteratum%253Aachs%26aulast%3DFukata%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26atitle%3DRho-family%2520GTPases%2520in%2520cadherin-mediated%2520cell%25E2%2588%2592cell%2520adhesion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D887%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ridley, A. J.</span><span> </span><span class="NLM_article-title">Rho family proteins: coordinating cell responses</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2FS0962-8924%2801%2902153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=11719051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=471-477&author=A.+J.+Ridley&title=Rho+family+proteins%3A+coordinating+cell+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Rho family proteins: coordinating cell responses</span></div><div class="casAuthors">Ridley, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">471-477</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Rho GTPases hit the headlines several times in 1990-1992: the proteins regulating their GTP-GDP cycle were identified and they were found to be key signal transducers, mediating growth factor-induced changes to the actin cytoskeleton and activating the phagocyte NADPH oxidase.  Since then, they have been implicated in numerous cellular processes, from cell migration to cell survival, transcriptional regulation and vesicle trafficking.  An explanation for why they affect so many aspects of cell behavior might lie in their ability to interact with a no. of downstream targets, so that they can coordinately activate several mol. processes required for a particular cellular response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBIvFHK1j2B7Vg90H21EOLACvtfcHk0lhXUweb5m8ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFKls78%253D&md5=ce7f8f86d8b881783432b4bfe54e30e2</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2801%2902153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252801%252902153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DRho%2520family%2520proteins%253A%2520coordinating%2520cell%2520responses%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D471%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, M.</span><span> </span><span class="NLM_article-title">Development of Rho-kinase inhibitors for cardiovascular medicine</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=296-302&author=H.+Shimokawaauthor=M.+Rashid&title=Development+of+Rho-kinase+inhibitors+for+cardiovascular+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DRashid%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520Rho-kinase%2520inhibitors%2520for%2520cardiovascular%2520medicine%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D296%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Loirand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guérin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacaud, P.</span><span> </span><span class="NLM_article-title">Rho Kinases in cardiovascular physiology and pathophysiology</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=322-334&author=G.+Loirandauthor=P.+Gu%C3%A9rinauthor=P.+Pacaud&title=Rho+Kinases+in+cardiovascular+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoirand%26aufirst%3DG.%26aulast%3DGu%25C3%25A9rin%26aufirst%3DP.%26aulast%3DPacaud%26aufirst%3DP.%26atitle%3DRho%2520Kinases%2520in%2520cardiovascular%2520physiology%2520and%2520pathophysiology%26jtitle%3DCirc.%2520Res.%26date%3D2006%26volume%3D98%26spage%3D322%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Trauger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span> </span><span class="NLM_article-title">Kinetic mechanism for human Rho-Kinase II (ROCK-II)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">8948</span><span class="NLM_x">–</span> <span class="NLM_lpage">8953</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0258243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=8948-8953&author=J.+W.+Traugerauthor=F.-F.+Linauthor=M.+S.+Turnerauthor=J.+Stephensauthor=P.+V.+LoGrasso&title=Kinetic+mechanism+for+human+Rho-Kinase+II+%28ROCK-II%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi0258243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0258243%26sid%3Dliteratum%253Aachs%26aulast%3DTrauger%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DF.-F.%26aulast%3DTurner%26aufirst%3DM.%2BS.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26atitle%3DKinetic%2520mechanism%2520for%2520human%2520Rho-Kinase%2520II%2520%2528ROCK-II%2529%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D8948%26epage%3D8953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Leung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L.</span><span> </span><span class="NLM_article-title">The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=8816443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5313-5327&author=T.+Leungauthor=X.-Q.+Chenauthor=E.+Manserauthor=L.+Lim&title=The+p160+RhoA-binding+kinase+ROK%CE%B1+is+a+member+of+a+kinase+family+and+is+involved+in+the+reorganization+of+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton</span></div><div class="casAuthors">Leung, Thomas; Chen, Xiang-Qun; Manser, Edward; Lim, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5313-5327</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The GTPase RhoA has been implicated in various cellular activity, including the formation of stress fiber,s motility, and cytokinesis.  We recently reported on a p150 serine/threonine kinase (termed ROKα) binding RhoA only in its active GTP-bound state and on its cDNA; introduction of RhoA into HeLa cells resulted in translocation of the cytoplasmic kinase to plasma membranes, consistent with ROKα being a target for RhoA (T. Leung, E. Manser, L. Tan, and L. Lim, J. Biol. Chem. 256:29051-29054, 1995).  Reanal. of the cDNA revealed that ROKα contains an addnl. N-terminal region.  We also isolated another cDNA which encoded a protein (ROKβ) with 90% identity of ROKα in the kinase domain.  Both ROKα and ROKβ, which has a mol. mass of 160 kDa, contained a highly conserved cysteine/histidine-rich domain located within a putative pleckstrin homol. domain.  The kinases bound Rho, RhoB, and RhoC but not Rac1 and Cdc42.  The Rho-binding domain comprises about 30 amino acids.  Mutations within this domain caused partial or complete loss of Rho binding.  The morphol. effects of ROKα were investigated by microinjecting HeLa cells with DNA constructs encoding various forms of ROKα.  Full-length ROKα promoted formation of stress fibers and focal adhesion complexes, consistent with its being an effector of RhoA.  ROKα truncated at the C terminus promoted this formation and also extensive condensation of actin microfilaments and nuclear disruption.  The proteins exhibited protein kinase activity which was required for stress fiber formation; the kinase-dead ROKαK112A and N-terminally truncated mutants showed no such promotion.  The latter mutant instead induced disassembly of stress fibers and focal adhesion complexes, accompanied by cell spreading.  These effects were mediated by the C-terminal region contg. Rho-binding, cysteine/histidine-rich, and pleckstrin homol. domains.  Thus, the multidomained ROKα appears to be involved in reorganization of the cytoskeleton, with the N and C termini acting as pos. and neg. regulators, resp., of the kinase domain whose activity is crucial for formation of stress fibers and focal adhesion complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaok4XDTUh7Vg90H21EOLACvtfcHk0lhXUweb5m8ffg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamt7g%253D&md5=ff30cf0f5819581e9d74001197154a25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.-Q.%26aulast%3DManser%26aufirst%3DE.%26aulast%3DLim%26aufirst%3DL.%26atitle%3DThe%2520p160%2520RhoA-binding%2520kinase%2520ROK%25CE%25B1%2520is%2520a%2520member%2520of%2520a%2520kinase%2520family%2520and%2520is%2520involved%2520in%2520the%2520reorganization%2520of%2520the%2520cytoskeleton%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5313%26epage%3D5327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Yoneda, A.; Multhaupt, H. A. B.; Couchman, J. R.</span><span> </span><span class="NLM_article-title">The Rho kinases I and II regulate different aspects of myosin II activity</span>.  <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span>− <span class="NLM_lpage">453</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2005&pages=443-453&author=A.+Yoneda&author=H.+A.+B.+Multhaupt&author=J.+R.+Couchman&title=The+Rho+kinases+I+and+II+regulate+different+aspects+of+myosin+II+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoneda%26aufirst%3DA.%26atitle%3DThe%2520Rho%2520kinases%2520I%2520and%2520II%2520regulate%2520different%2520aspects%2520of%2520myosin%2520II%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D170%26spage%3D443%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Riento, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalonga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guasch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, A. J.</span><span> </span><span class="NLM_article-title">RhoE function is regulated by ROCK I-mediated phosphorylation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1170-1180&author=K.+Rientoauthor=N.+Tottyauthor=P.+Villalongaauthor=R.+Gargauthor=R.+Guaschauthor=A.+J.+Ridley&title=RhoE+function+is+regulated+by+ROCK+I-mediated+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiento%26aufirst%3DK.%26aulast%3DTotty%26aufirst%3DN.%26aulast%3DVillalonga%26aufirst%3DP.%26aulast%3DGarg%26aufirst%3DR.%26aulast%3DGuasch%26aufirst%3DR.%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DRhoE%2520function%2520is%2520regulated%2520by%2520ROCK%2520I-mediated%2520phosphorylation%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D1170%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rubenstein, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, G. L.</span><span> </span><span class="NLM_article-title">Selective glucocorticoid control of Rho kinase isoforms regulate cell−cell interactions</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2007&pages=603-607&author=N.+M.+Rubensteinauthor=J.+A.+Callahanauthor=D.+H.+Loauthor=G.+L.+Firestone&title=Selective+glucocorticoid+control+of+Rho+kinase+isoforms+regulate+cell%E2%88%92cell+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstein%26aufirst%3DN.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BA.%26aulast%3DLo%26aufirst%3DD.%2BH.%26aulast%3DFirestone%26aufirst%3DG.%2BL.%26atitle%3DSelective%2520glucocorticoid%2520control%2520of%2520Rho%2520kinase%2520isoforms%2520regulate%2520cell%25E2%2588%2592cell%2520interactions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D354%26spage%3D603%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wettschureck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, S.</span><span> </span><span class="NLM_article-title">Rho/Rho-kinase mediated signaling in physiology and pathophysiology</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1007%2Fs00109-002-0370-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=12395147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVClt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=629-638&author=N.+Wettschureckauthor=S.+Offermanns&title=Rho%2FRho-kinase+mediated+signaling+in+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho/Rho-kinase mediated signaling in physiology and pathophysiology</span></div><div class="casAuthors">Wettschureck, Nina; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The small GTPase Rho is implicated in many cellular functions such as cell adhesion, cell motility and migration, growth control, cell contraction, and cytokinesis.  One of its main effectors, Rho-kinase, appears to play a key role in the regulation of force and velocity of actomyosin crossbridging in smooth muscle and nonmuscle cells by inhibiting myosin phosphatase-mediated dephosphorylation of the regulatory chain of myosin II.  Abnormal activation of the Rho/Rho-kinase pathway has been shown to play a role in diseases such as hypertension and bronchial asthma.  This review summarizes the current knowledge on the physiol. and pathophysiol. function of the Rho/Rho-kinase mediated pathway in various tissues with a focus on its possible role as a target for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUHS23PFmT7Vg90H21EOLACvtfcHk0lg69iBj1clDhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVClt7s%253D&md5=ea2b9a7f758e34d6d61392e8bf6e00de</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1007%2Fs00109-002-0370-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-002-0370-2%26sid%3Dliteratum%253Aachs%26aulast%3DWettschureck%26aufirst%3DN.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DRho%252FRho-kinase%2520mediated%2520signaling%2520in%2520physiology%2520and%2520pathophysiology%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2002%26volume%3D80%26spage%3D629%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span> </span><span class="NLM_article-title">Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">20246</span><span class="NLM_x">–</span> <span class="NLM_lpage">20249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=20246-20249&author=M.+Amanoauthor=M.+Itoauthor=K.+Kimuraauthor=Y.+Fukataauthor=K.+Chiharaauthor=T.+Nakanoauthor=Y.+Matsuuraauthor=K.+Kaibuchi&title=Phosphorylation+and+activation+of+myosin+by+Rho-associated+kinase+%28Rho-kinase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DFukata%26aufirst%3DY.%26aulast%3DChihara%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DY.%26aulast%3DKaibuchi%26aufirst%3DK.%26atitle%3DPhosphorylation%2520and%2520activation%2520of%2520myosin%2520by%2520Rho-associated%2520kinase%2520%2528Rho-kinase%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D20246%26epage%3D20249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kureishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span> </span><span class="NLM_article-title">Rho-associated kinase of chicken gizzard smooth muscle</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">3744</span><span class="NLM_x">–</span> <span class="NLM_lpage">3752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=3744-3752&author=J.+Fengauthor=M.+Itoauthor=Y.+Kureishiauthor=K.+Ichikawaauthor=M.+Amanoauthor=N.+Isakaauthor=K.+Okawaauthor=A.+Iwamatsuauthor=K.+Kaibuchiauthor=D.+J.+Hartshorneauthor=T.+Nakano&title=Rho-associated+kinase+of+chicken+gizzard+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKureishi%26aufirst%3DY.%26aulast%3DIchikawa%26aufirst%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DIsaka%26aufirst%3DN.%26aulast%3DOkawa%26aufirst%3DK.%26aulast%3DIwamatsu%26aufirst%3DA.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHartshorne%26aufirst%3DD.%2BJ.%26aulast%3DNakano%26aufirst%3DT.%26atitle%3DRho-associated%2520kinase%2520of%2520chicken%2520gizzard%2520smooth%2520muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D3744%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlyo, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlyo, A. P.</span><span> </span><span class="NLM_article-title">The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPgammaS-, and phorbol ester-induced Ca<sup>2+</sup>-sensitization of smooth muscle</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=1998&pages=183-187&author=X.+Fuauthor=M.+C.+Gongauthor=T.+Jiaauthor=A.+V.+Somlyoauthor=A.+P.+Somlyo&title=The+effects+of+the+Rho-kinase+inhibitor+Y-27632+on+arachidonic+acid-%2C+GTPgammaS-%2C+and+phorbol+ester-induced+Ca2%2B-sensitization+of+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DM.%2BC.%26aulast%3DJia%26aufirst%3DT.%26aulast%3DSomlyo%26aufirst%3DA.%2BV.%26aulast%3DSomlyo%26aufirst%3DA.%2BP.%26atitle%3DThe%2520effects%2520of%2520the%2520Rho-kinase%2520inhibitor%2520Y-27632%2520on%2520arachidonic%2520acid-%252C%2520GTPgammaS-%252C%2520and%2520phorbol%2520ester-induced%2520Ca2%252B-sensitization%2520of%2520smooth%2520muscle%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D440%26spage%3D183%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Budzyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marley, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Targeting Rho and Rho-kinase in the treatment of cardiovascular disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=97-104&author=K.+Budzynauthor=P.+D.+Marleyauthor=C.+G.+Sobey&title=Targeting+Rho+and+Rho-kinase+in+the+treatment+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudzyn%26aufirst%3DK.%26aulast%3DMarley%26aufirst%3DP.%2BD.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DTargeting%2520Rho%2520and%2520Rho-kinase%2520in%2520the%2520treatment%2520of%2520cardiovascular%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D97%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mueller, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teusch, N.</span><span> </span><span class="NLM_article-title">Rho kinase, a promising drug target for neurological disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2Fnrd1719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15864268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=387-398&author=B.+K.+Muellerauthor=H.+Mackauthor=N.+Teusch&title=Rho+kinase%2C+a+promising+drug+target+for+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase, a promising drug target for neurological disorders</span></div><div class="casAuthors">Mueller, Bernhard K.; Mack, Helmut; Teusch, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rho kinases (ROCKs), the first Rho effectors to be described, are serine/threonine kinases that are important in fundamental processes of cell migration, cell proliferation and cell survival.  Abnormal activation of the Rho/ROCK pathway has been obsd. in various disorders of the central nervous system.  Injury to the adult vertebrate brain and spinal cord activates ROCKs, thereby inhibiting neurite growth and sprouting.  Inhibition of ROCKs results in accelerated regeneration and enhanced functional recovery after spinal-cord injury in mammals, and inhibition of the Rho/ROCK pathway has also proved to be efficacious in animal models of stroke, inflammatory and demyelinating diseases, Alzheimer's disease and neuropathic pain.  ROCK inhibitors therefore have potential for preventing neurodegeneration and stimulating neuroregeneration in various neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3XJk9e8s-qLVg90H21EOLACvtfcHk0lggcs6sI16s3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktLw%253D&md5=605b180f2f817091aadfc143df6d0205</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1719%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DB.%2BK.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DTeusch%26aufirst%3DN.%26atitle%3DRho%2520kinase%252C%2520a%2520promising%2520drug%2520target%2520for%2520neurological%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrissobolis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Recent evidence for an involvement of Rho-kinase in cerebral vascular disease</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2174</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=2174-2180&author=S.+Chrissobolisauthor=C.+G.+Sobey&title=Recent+evidence+for+an+involvement+of+Rho-kinase+in+cerebral+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrissobolis%26aufirst%3DS.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DRecent%2520evidence%2520for%2520an%2520involvement%2520of%2520Rho-kinase%2520in%2520cerebral%2520vascular%2520disease%26jtitle%3DStroke%26date%3D2006%26volume%3D37%26spage%3D2174%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ohnaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, R.</span><span> </span><span class="NLM_article-title">Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=337-342&author=K.+Ohnakaauthor=S.+Shimodaauthor=H.+Nawataauthor=H.+Shimokawaauthor=K.+Kaibuchiauthor=Y.+Iwamotoauthor=R.+Takayanagi&title=Pitavastatin+enhanced+BMP-2+and+osteocalcin+expression+by+inhibition+of+Rho-associated+kinase+in+human+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhnaka%26aufirst%3DK.%26aulast%3DShimoda%26aufirst%3DS.%26aulast%3DNawata%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DTakayanagi%26aufirst%3DR.%26atitle%3DPitavastatin%2520enhanced%2520BMP-2%2520and%2520osteocalcin%2520expression%2520by%2520inhibition%2520of%2520Rho-associated%2520kinase%2520in%2520human%2520osteoblasts%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, H.</span><span> </span><span class="NLM_article-title">Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1158%2F1535-7163.MCT-06-0689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17513600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1517-1525&author=L.+Yinauthor=K.+Morishigeauthor=T.+Takahashiauthor=K.+Hashimotoauthor=S.+Ogataauthor=S.+Tsutsumiauthor=K.+Takataauthor=T.+Ohtaauthor=J.+Kawagoeauthor=K.+Takahashiauthor=H.+Kurachi&title=Fasudil+inhibits+vascular+endothelial+growth+factor-induced+angiogenesis+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo</span></div><div class="casAuthors">Yin, Limei; Morishige, Ken-ichirou; Takahashi, Toshifumi; Hashimoto, Kae; Ogata, Seiji; Tsutsumi, Seiji; Takata, Keiko; Ohta, Tsuyoshi; Kawagoe, Jun; Takahashi, Kazuhiro; Kurachi, Hirohisa</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1517-1525</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF)-induced endothelial cell migration is an important components of tumor angiogenesis.  Rho and Rho-assocd. kinase (ROCK) are key regulators of focal adhesion, stress fiber formation, and thus cell motility.  Inhibitors of this pathway have been shown to inhibit endothelial cell motility and angiogenesis.  In this study, we investigated the antiangiogenic effect of fasudil, one of the ROCK inhibitors.  Fasudil inhibited VEGF-induced endothelial cell migration, viability, and tube formation in vitro in human umbilical vein endothelial cells.  VEGF-induced endothelial cell migration was reduced by fasudil assocd. with loss of stress fiber formation, focal adhesion assembly, and with the suppression of tyrosine phosphorylation of focal adhesion proteins.  Furthermore, fasudil inhibited VEGF-induced phosphorylation of myosin light chain, which is one of the main substrates of ROCK.  Therefore, the effect of fasudil was suggested to be ROCK dependent.  Fasudil not only inhibited VEGF-induced cell proliferation but also reversed the protective effect of VEGF on apoptosis, which resulted in the decrease of cell viability.  Moreover, fasudil inhibited VEGF-induced angiogenesis in a directed in vivo angiogenesis assay.  These data are the first demonstration that fasudil has antiangiogenic properties.  Therefore, fasudil might be useful for the treatment of angiogenesis-related diseases, esp. cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHdvoZLbqPLVg90H21EOLACvtfcHk0lggcs6sI16s3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFaltL8%253D&md5=167575e2b22b39aaee3e0da760b8b514</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0689%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DL.%26aulast%3DMorishige%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DKawagoe%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKurachi%26aufirst%3DH.%26atitle%3DFasudil%2520inhibits%2520vascular%2520endothelial%2520growth%2520factor-induced%2520angiogenesis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1517%26epage%3D1525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rattan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, I.</span><span> </span><span class="NLM_article-title">Rho/ROCK pathway as a target of tumor therapy</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1002%2Fjnr.20707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16385577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1altb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=243-255&author=R.+Rattanauthor=S.+Giriauthor=A.+K.+Singhauthor=I.+Singh&title=Rho%2FROCK+pathway+as+a+target+of+tumor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho/ROCK pathway as a target of tumor therapy</span></div><div class="casAuthors">Rattan, R.; Giri, S.; Singh, A. K.; Singh, I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-255</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This study emphasizes the importance of Rho/ROCK pathway in lovastatin-induced apoptosis as replenishment with exogenous isoprenoid, geranylgeranylpyrophosphate (GGPP), resulted in inhibition of apoptosis in cultured tumor cells.  Treatment of C6 glioma cells with Toxin B and exoenzyme C3 resulted in cell death suggesting the role of geranylgeranylated protein(s) in the survival of glioma cells.  Relative apoptotic death obsd. in cells transfected with dominant neg. constructs of RhoA, Rac, and cdc42 imply Rho A as playing the major role in cell survival.  Furthermore, the inhibition of Rho A kinase (ROCK), a direct downstream effector of Rho A, by Y-27632 or dominant neg. of ROCK, induced apoptosis in glioma cells.  These findings indicate that RhoA/ROCK pathway is involved neg. in the regulation of glioma cell death pathway.  Moreover, in vivo studies of lovastatin treatment in animals implanted with C6 glioma cell tumors also resulted in smaller tumor size and induced apoptosis in the tumor tissue.  The implantation of stably transfected C6 glioma cells with expression vector of C3 exoenzyme, dominant neg. of RhoA and ROCK, resulted in significant smaller tumor mass, further establishing the importance of geranylgeranylated proteins, specifically RhoA and its downstream effecter ROCK, in cell survival and tumor genesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6duHq3j294bVg90H21EOLACvtfcHk0lgDH5JbTYgsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1altb8%253D&md5=6db753cef0aae61efa584826e65309b0</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20707%26sid%3Dliteratum%253Aachs%26aulast%3DRattan%26aufirst%3DR.%26aulast%3DGiri%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DI.%26atitle%3DRho%252FROCK%2520pathway%2520as%2520a%2520target%2520of%2520tumor%2520therapy%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2006%26volume%3D83%26spage%3D243%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokata, K.</span><span> </span><span class="NLM_article-title">Mast cell tryptase causes homologous desensitization of β-adrenoceptors by Ca<sup>2+</sup> sensitization in tracheal smooth muscle</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=18028457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs12gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=135-144&author=M.+Kobayashiauthor=H.+Kumeauthor=T.+Ogumaauthor=Y.+Makinoauthor=Y.+Itoauthor=K.+Shimokata&title=Mast+cell+tryptase+causes+homologous+desensitization+of+%CE%B2-adrenoceptors+by+Ca2%2B+sensitization+in+tracheal+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell tryptase causes homologous desensitization of β-adrenoceptors by Ca2+ sensitization in tracheal smooth muscle</span></div><div class="casAuthors">Kobayashi, M.; Kume, H.; Oguma, T.; Makino, Y.; Ito, Y.; Shimokata, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Recent studies have revealed that in asthma, mast cells infiltrate to the smooth muscle layer and release tryptase, an enzymic activator of protease-activated receptor 2 (PAR2).  This phenomenon, mast cell myositis, is proposed as a new feature of asthma.  However, little is known about the involvement of mast cell myositis in the pathophysiiol. of asthma.  This study was designed to det. whether mast cell degranulation has any functional impact on β-adrenoceptors via PAR2 in airway smooth muscle.  Moreover, we focused on Ca2+ signalling as a mechanism underlying alteration of smooth muscle tone and responsiveness.  Isometric tension and F340/F380, an indicator of the concn. of intracellular Ca2+ ([Ca2+]i), were simultaneously measured using fura-2-loaded tissues isolated from guinea-pig tracheal smooth muscle.  Tryptase (1-100 nM) caused tension with elevated F340/F380, and after exposure to tryptase for 15 min the inhibitory effect of isoprenaline (ISO) against methacholine was attenuated without elevating F340/F380 in a concn.-dependent manner.  Tryptase (< 1 nM) had a modest effect on tension, but prolonged treatment (≤ 120 min) with 0.1 nM tryptase also reduced the effects of ISO in a time-dependent manner.  When tissues were incubated with tryptase in the presence of Y-27632, a Rho-kinase inhibitor, reduced responsiveness to ISO by tryptase was reversed without affecting F340/F380.  In contrast, pre-treatment with SKF96365, a non-selective inhibitor of Ca2+ channels, did not antagonize the effect of tryptase.  Moreover, pre-treatment with SLIGKV-NH2, a non-enzymic activator of PAR2, resulted in a loss of β-adrenergic efficacy, similar to tryptase.  The effect of cAMP-related agents bypassing β-adrenoceptors was not attenuated after exposure to tryptase.  In mast cell myositis, tryptase released from mast cells acts on airway smooth muscle, leading to homologous β-adrenergic desensitization mediated by [Ca2+]i-independent mechanisms via PAR2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRi8myjepzLrVg90H21EOLACvtfcHk0lgDH5JbTYgsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs12gurY%253D&md5=d7273c991e8db28e4c3e0318ae11d2aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DKume%26aufirst%3DH.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DMakino%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DShimokata%26aufirst%3DK.%26atitle%3DMast%2520cell%2520tryptase%2520causes%2520homologous%2520desensitization%2520of%2520%25CE%25B2-adrenoceptors%2520by%2520Ca2%252B%2520sensitization%2520in%2520tracheal%2520smooth%2520muscle%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2008%26volume%3D38%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Rao, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D. L.</span><span> </span><span class="NLM_article-title">Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=167-177&author=V.+P.+Raoauthor=D.+L.+Epstein&title=Rho+GTPase%2FRho+kinase+inhibition+as+a+novel+target+for+the+treatment+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DV.%2BP.%26aulast%3DEpstein%26aufirst%3DD.%2BL.%26atitle%3DRho%2520GTPase%252FRho%2520kinase%2520inhibition%2520as%2520a%2520novel%2520target%2520for%2520the%2520treatment%2520of%2520glaucoma%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_contrib-group">Tokushige, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanihara, H.</span><span> </span><span class="NLM_article-title">Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys</span> <span class="citation_source-journal">Invest. Ophthalmol. Visualization Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3216</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1167%2Fiovs.05-1617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17591891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A280%3ADC%252BD2sznsF2rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3216-2322&author=H.+Tokushigeauthor=M.+Inataniauthor=S.+Nemotoauthor=H.+Sakakiauthor=K.+Katayamaauthor=M.+Uehataauthor=H.+Tanihara&title=Effects+of+topical+administration+of+Y-39983%2C+a+selective+Rho-associated+protein+kinase+inhibitor%2C+on+ocular+tissues+in+rabbits+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys</span></div><div class="casAuthors">Tokushige Hideki; Inatani Masaru; Nemoto Shingo; Sakaki Hideyuki; Katayama Koushirou; Uehata Masayoshi; Tanihara Hidenobu</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3216-22</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  To elucidate the intraocular pressure (IOP)-lowering effects and associated characteristics of Y-39983, a selective Rho-associated coiled coil-forming protein kinase (ROCK) inhibitor derived from Y-27632, in animal eyes.  METHODS:  Y-39983 was compared with Y-27632 for selectivity of ROCK inhibition by biochemical assay.  The IOP was monitored by pneumatonometer in albino rabbits and cynomolgus monkeys that were given topically administered Y-39983.  The total outflow facility and uveoscleral outflow were measured by two-level constant-pressure perfusion and perfusion technique using fluorescein isothiocyanate-dextran, respectively, at 2 hours after topical administration of Y-39983 in albino rabbits.  The ocular toxicologic effects of topical administration of Y-39983 were observed in albino rabbits and cynomolgus monkeys.  RESULTS:  A biochemical assay showed that Y-39983 inhibited ROCK more potently than Y-27632.  In rabbits, topical administration of Y-39983 significantly increased conventional outflow by 65.5%, followed by significant, dose-dependent reduction in IOP.  Maximum IOP reduction was 13.2 +/- 0.6 mm Hg (mean +/- SE) at 0.1% Y-39983 in rabbits.  In monkeys, at 3 hours after topical administration of 0.05% Y-39983, maximum reduction of IOP was 2.5 +/- 0.8 mm Hg.  No serious side effects were observed in ocular tissues except sporadic punctate subconjunctival hemorrhage during long-term topical administration of Y-39983 four times a day (at 2-hour intervals) in rabbits or monkeys.  However, punctate subconjunctival hemorrhage was not observed with administration twice daily (at a 6-hour interval) or three times a day (at 5-hour intervals).  CONCLUSIONS:  Y-39983 causes increased outflow facility followed by IOP reduction.  Y-39983 ophthalmic solution may be a candidate drug for lowering of IOP, since it increases conventional outflow and produces relatively few side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhRiX7jL_YgZw7prLlxLOzfW6udTcc2eYoc7hCASth2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sznsF2rsQ%253D%253D&md5=1fb9210486fe9cfc0f17360552415638</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1167%2Fiovs.05-1617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.05-1617%26sid%3Dliteratum%253Aachs%26aulast%3DTokushige%26aufirst%3DH.%26aulast%3DInatani%26aufirst%3DM.%26aulast%3DNemoto%26aufirst%3DS.%26aulast%3DSakaki%26aufirst%3DH.%26aulast%3DKatayama%26aufirst%3DK.%26aulast%3DUehata%26aufirst%3DM.%26aulast%3DTanihara%26aufirst%3DH.%26atitle%3DEffects%2520of%2520topical%2520administration%2520of%2520Y-39983%252C%2520a%2520selective%2520Rho-associated%2520protein%2520kinase%2520inhibitor%252C%2520on%2520ocular%2520tissues%2520in%2520rabbits%2520and%2520monkeys%26jtitle%3DInvest.%2520Ophthalmol.%2520Visualization%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D3216%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, A.</span><span> </span><span class="NLM_article-title">Rho-kinase is an important therapeutic target in cardiovascular medicine</span> <span class="citation_source-journal">Arterioscler. Thromb. Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1161%2F01.ATV.0000176193.83629.c8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16002741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1ers74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1767-1775&author=H.+Shimokawaauthor=A.+Takeshita&title=Rho-kinase+is+an+important+therapeutic+target+in+cardiovascular+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine</span></div><div class="casAuthors">Shimokawa, Hiroaki; Takeshita, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1767-1775</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Rho-kinase was identified as one of the effectors of the small GTP-binding protein Rho.  Accumulating evidence has demonstrated that Rho/Rho-kinase pathway plays an important role in various cellular functions, not only in vascular smooth muscle cell (VSMC) contraction but also in actin cytoskeleton organization, cell adhesion and motility, cytokinesis, and gene expressions, all of which may be involved in the pathogenesis of cardiovascular disease.  At mol. level, Rho-kinase upregulates various mols. that accelerate inflammation/oxidative stress, thrombus formation, and fibrosis, whereas it downregulates endothelial nitric oxide synthase.  The expression of Rho-kinase itself is mediated by protein kinase C/NF-κB pathway with an inhibitory and stimulatory modulation by estrogen and nicotine, resp.  At cellular level, Rho-kinase mediates VSMC hypercontraction, stimulates VSMC proliferation and migration, and enhances inflammatory cell motility.  In animal studies, Rho-kinase was shown to be substantially involved in the pathogenesis of vasospasm, arteriosclerosis, ischemia/reperfusion injury, hypertension, pulmonary hypertension, stroke and heart failure, and to enhance central sympathetic nerve activity.  Finally, in clin. studies, fasudil, a Rho-kinase inhibitor, is effective for the treatment of a wide range of cardiovascular disease, including cerebral and coronary vasospasm, angina, hypertension, pulmonary hypertension, and heart failure, with a reasonable safety.  Thus, Rho-kinase is an important therapeutic target in cardiovascular medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj0SltEY8BZbVg90H21EOLACvtfcHk0lio_Rh0QTEG5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1ers74%253D&md5=e87eff04bc1d815a49af81d62ae2c186</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000176193.83629.c8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000176193.83629.c8%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DA.%26atitle%3DRho-kinase%2520is%2520an%2520important%2520therapeutic%2520target%2520in%2520cardiovascular%2520medicine%26jtitle%3DArterioscler.%2520Thromb.%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1767%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Budzyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Vascular rho kinases and their potential therapeutic applications</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=590-596&author=K.+Budzynauthor=C.+G.+Sobey&title=Vascular+rho+kinases+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudzyn%26aufirst%3DK.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DVascular%2520rho%2520kinases%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Viswambharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ming, X.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergères, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span> </span><span class="NLM_article-title">Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=918-925&author=H.+Viswambharanauthor=X.-F.+Mingauthor=S.+Zhuauthor=A.+Hubschauthor=P.+Lerchauthor=G.+Verg%C3%A8resauthor=S.+Rusconiauthor=Z.+Yang&title=Reconstituted+high-density+lipoprotein+inhibits+thrombin-induced+endothelial+tissue+factor+expression+through+inhibition+of+RhoA+and+stimulation+of+phosphatidylinositol+3-kinase+but+not+Akt%2Fendothelial+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViswambharan%26aufirst%3DH.%26aulast%3DMing%26aufirst%3DX.-F.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DHubsch%26aufirst%3DA.%26aulast%3DLerch%26aufirst%3DP.%26aulast%3DVerg%25C3%25A8res%26aufirst%3DG.%26aulast%3DRusconi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DZ.%26atitle%3DReconstituted%2520high-density%2520lipoprotein%2520inhibits%2520thrombin-induced%2520endothelial%2520tissue%2520factor%2520expression%2520through%2520inhibition%2520of%2520RhoA%2520and%2520stimulation%2520of%2520phosphatidylinositol%25203-kinase%2520but%2520not%2520Akt%252Fendothelial%2520nitric%2520oxide%2520synthase%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D94%26spage%3D918%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, D. A.</span><span> </span><span class="NLM_article-title">Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=617-635&author=T.+A.+McKinseyauthor=D.+A.+Kass&title=Small-molecule+therapies+for+cardiac+hypertrophy%3A+moving+beneath+the+cell+surface"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DSmall-molecule%2520therapies%2520for%2520cardiac%2520hypertrophy%253A%2520moving%2520beneath%2520the%2520cell%2520surface%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D617%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jain, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridker, P. M.</span><span> </span><span class="NLM_article-title">Anti-inflammatory effects of statins: clinical evidence and basic mechanisms</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2Fnrd1901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16341063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=977-987&author=M.+K.+Jainauthor=P.+M.+Ridker&title=Anti-inflammatory+effects+of+statins%3A+clinical+evidence+and+basic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms</span></div><div class="casAuthors">Jain, Mukesh K.; Ridker, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">977-987</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic inflammation is a key feature of vascular disease states such as atherosclerosis.  Multiple clin. studies have shown that a class of medications termed statins lower cardiovascular morbidity and mortality.  Originally developed to lower serum cholesterol, increasing evidence suggests that these medications have potent anti-inflammatory effects that contribute to their beneficial effects in patients.  Here, we discuss the clin. and exptl. evidence underlying the anti-inflammatory effects of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvbfgcemlOMbVg90H21EOLACvtfcHk0lio_Rh0QTEG5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjP&md5=164e13cfaee16c787e0b029471c356a2</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1901%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DM.%2BK.%26aulast%3DRidker%26aufirst%3DP.%2BM.%26atitle%3DAnti-inflammatory%2520effects%2520of%2520statins%253A%2520clinical%2520evidence%2520and%2520basic%2520mechanisms%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D977%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span> </span><span class="NLM_article-title">Rho-kinase inhibitors for cardiovascular disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=87-102&author=R.+A.+Stavenger&title=Rho-kinase+inhibitors+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26atitle%3DRho-kinase%2520inhibitors%2520for%2520cardiovascular%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D87%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iijima, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of Rho kinase inhibitors (I)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2115-2137&author=A.+Takamiauthor=M.+Iwakuboauthor=Y.+Okadaauthor=T.+Kawataauthor=H.+Odaiauthor=N.+Takahashiauthor=K.+Shindoauthor=K.+Kimuraauthor=Y.+Tagamiauthor=M.+Miyakeauthor=K.+Fukushimaauthor=M.+Inagakiauthor=M.+Amanoauthor=K.+Kaibuchiauthor=H.+Iijima&title=Design+and+synthesis+of+Rho+kinase+inhibitors+%28I%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DA.%26aulast%3DIwakubo%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DOdai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DTagami%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DIijima%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520Rho%2520kinase%2520inhibitors%2520%2528I%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2115%26epage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6-9&author=K.+B.+Goodmanauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=D.+E.+Gaitanopoulosauthor=R.+L.+Ivyauthor=C.+A.+Sehonauthor=R.+A.+Stavengerauthor=G.+Z.+Wangauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=S.+F.+Semusauthor=C.+Evansauthor=H.+E.+Friesauthor=L.+J.+Jolivetteauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=R.+Bentleyauthor=C.+P.+Doeauthor=E.+Huauthor=D.+Lee&title=Development+of+dihydropyridone+indazole+amides+as+selective+Rho-kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors</span></div><div class="casAuthors">Goodman, Krista B.; Cui, Haifeng; Dowdell, Sarah E.; Gaitanopoulos, Dimitri E.; Ivy, Robert L.; Sehon, Clark A.; Stavenger, Robert A.; Wang, Gren Z.; Viet, Andrew Q.; Xu, Weiwei; Ye, Guosen; Semus, Simon F.; Evans, Christopher; Fries, Harvey E.; Jolivette, Larry J.; Kirkpatrick, Robert B.; Dul, Edward; Khandekar, Sanjay S.; Yi, Tracey; Jung, David K.; Wright, Lois L.; Smith, Gary K.; Behm, David J.; Bentley, Ross; Doe, Christopher P.; Hu, Erding; Lee, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rho kinase (ROCK1) mediates vascular smooth muscle contraction and is a potential target for the treatment of hypertension and related disorders.  Indazole amide 3 was identified as a potent and selective ROCK1 inhibitor but possessed poor oral bioavailability.  Optimization of this lead resulted in the discovery of a series of dihydropyridones, exemplified by 13, with improved pharmacokinetic parameters relative to the initial lead.  Indazole substitution played a crit. role in decreasing clearance and improving oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOGlkSgS6prVg90H21EOLACvtfcHk0lgQB4RlF4GZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbnF&md5=4a2b2f5636a4631f95e521ec98068e0e</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm0609014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609014%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DG.%2BZ.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DFries%26aufirst%3DH.%2BE.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520dihydropyridone%2520indazole%2520amides%2520as%2520selective%2520Rho-kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060873p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2-5&author=R.+A.+Stavengerauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=R.+G.+Franzauthor=D.+E.+Gaitanopoulosauthor=K.+B.+Goodmanauthor=M.+A.+Hilfikerauthor=R.+L.+Ivyauthor=J.+D.+Leberauthor=J.+P.+Marinoauthor=H.-J.+Ohauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=D.+Zhangauthor=Y.+Zhaoauthor=L.+J.+Jolivetteauthor=M.+S.+Headauthor=S.+F.+Semusauthor=P.+A.+Elkinsauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=C.+P.+Doeauthor=R.+Bentleyauthor=Z.+X.+Chenauthor=E.+Huauthor=D.+Lee&title=Discovery+of+aminofurazan-azabenzimidazoles+as+inhibitors+of+Rho-kinase+with+high+kinase+selectivity+and+antihypertensive+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=10.1021%2Fjm060873p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060873p%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DFranz%26aufirst%3DR.%2BG.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DHilfiker%26aufirst%3DM.%2BA.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520aminofurazan-azabenzimidazoles%2520as%2520inhibitors%2520of%2520Rho-kinase%2520with%2520high%2520kinase%2520selectivity%2520and%2520antihypertensive%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sehon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6631</span><span class="NLM_x">–</span> <span class="NLM_lpage">6634</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6631-6634&author=C.+A.+Sehonauthor=G.+Z.+Wangauthor=A.+Q.+Vietauthor=K.+B.+Goodmanauthor=S.+E.+Dowdellauthor=P.+A.+Elkinsauthor=S.+F.+Semusauthor=C.+Evansauthor=L.+J.+Jolivetteauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=R.+Bentleyauthor=C.+P.+Doeauthor=E.+Huauthor=D.+Lee&title=Potent%2C+selective+and+orally+bioavailable+dihydropyrimidine+inhibitors+of+Rho+kinase+%28ROCK1%29+as+potential+therapeutic+agents+for+cardiovascular+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=10.1021%2Fjm8005096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005096%26sid%3Dliteratum%253Aachs%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DG.%2BZ.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520bioavailable%2520dihydropyrimidine%2520inhibitors%2520of%2520Rho%2520kinase%2520%2528ROCK1%2529%2520as%2520potential%2520therapeutic%2520agents%2520for%2520cardiovascular%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6631%26epage%3D6634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schürer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P.</span><span> </span><span class="NLM_article-title">Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800986w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24f&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6642-6645&author=Y.+Fengauthor=Y.+Yinauthor=A.+Weiserauthor=E.+Griffinauthor=M.+D.+Cameronauthor=L.+Linauthor=C.+Ruizauthor=S.+C.+Sch%C3%BCrerauthor=T.+Inoueauthor=P.+V.+Raoauthor=T.+Schr%C3%B6terauthor=P.+LoGrasso&title=Discovery+of+substituted+4-%28pyrazol-4-yl%29-phenylbenzodioxane-2-carboxamides+as+potent+and+highly+selective+Rho+kinase+%28ROCK-II%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24fR"><div class="casContent"><span class="casTitleNuber">24f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Substituted 4-(Pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors</span></div><div class="casAuthors">Feng, Yangbo; Yin, Yan; Weiser, Amiee; Griffin, Evelyn; Cameron, Michael D.; Lin, Li; Ruiz, Claudia; Schurer, Stephan C.; Inoue, Toshihiro; Rao, P. Vasanth; Schroter, Thomas; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6642-6645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a new class of potent and selective ROCK-II inhibitors is presented.  Compd. SR-3677 (I) had an IC50 of ∼3 nM in enzyme and cell based assays and had an off-target hit rate of 1.4% against 353 kinases, and inhibited only 3 out of 70 nonkinase enzymes and receptors.  Pharmacol. studies showed that I was efficacious in both, increasing ex vivo aq. humor outflow in porcine eyes and inhibiting myosin light chain phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolgwD1AJB2GbVg90H21EOLACvtfcHk0lgLuJSCQZbclQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtLvJ&md5=1c550d187ef3a061cf249cdd001b7d04</span></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=10.1021%2Fjm800986w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800986w%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DWeiser%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DSch%25C3%25BCrer%26aufirst%3DS.%2BC.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BV.%26aulast%3DSchr%25C3%25B6ter%26aufirst%3DT.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520substituted%25204-%2528pyrazol-4-yl%2529-phenylbenzodioxane-2-carboxamides%2520as%2520potent%2520and%2520highly%2520selective%2520Rho%2520kinase%2520%2528ROCK-II%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6642%26epage%3D6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liao, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noma, K.</span><span> </span><span class="NLM_article-title">J. Rho kinase (ROCK) inhibitors</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=17-24&author=J.+K.+Liaoauthor=M.+Setoauthor=K.+Noma&title=J.+Rho+kinase+%28ROCK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DNoma%26aufirst%3DK.%26atitle%3DJ.%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitors%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, J.</span><span> </span><span class="NLM_article-title">The structure of dimeric ROCK I reveals the mechanism for ligand selectivity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=260-268&author=M.+Jacobsauthor=K.+Hayakawaauthor=L.+Swensonauthor=S.+Bellonauthor=M.+Flemingauthor=P.+Taslimiauthor=J.+Doran&title=The+structure+of+dimeric+ROCK+I+reveals+the+mechanism+for+ligand+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DDoran%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520dimeric%2520ROCK%2520I%2520reveals%2520the%2520mechanism%2520for%2520ligand%2520selectivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D260%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span> </span><span class="NLM_article-title">Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1093%2Fjb%2Fmvj172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16891330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2006&pages=305-311&author=H.+Yamaguchiauthor=Y.+Miwaauthor=M.+Kasaauthor=K.+Kitanoauthor=M.+Amanoauthor=K.+Kaibuchiauthor=T.+Hakoshima&title=Structural+basis+for+induced-fit+binding+of+Rho-kinase+to+the+inhibitor+Y-27632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632</span></div><div class="casAuthors">Yamaguchi, Hiroto; Miwa, Yukiko; Kasa, Miyuki; Kitano, Ken; Amano, Mutsuki; Kaibuchi, Kozo; Hakoshima, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-311</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Rho-kinase is a main player in the regulation of cytoskeletal events and a promising drug target in the treatment of both vascular and neurol. disorders.  Here we report the crystal structure of the Rho-kinase catalytic domain in complex with the specific inhibitor Y-27632.  Comparison with the structure of PKA bound to this inhibitor revealed a potential induced-fit binding mode that can be accommodated by the phosphate binding loop (P-loop).  This binding mode resembles that obsd. in the Rho-kinase-fasudil complex.  A structural database search indicated that a pocket underneath the phosphate-binding loop is present that favors binding to a small arom. ring.  Introduction of such a ring group might spawn a new modification scheme of pre-existing protein kinase inhibitors for improved binding capability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrechzHfFmzYbVg90H21EOLACvtfcHk0lgLuJSCQZbclQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7%252FF&md5=edbb89b5fe6cb429e915b84f3488a08f</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj172%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DY.%26aulast%3DKasa%26aufirst%3DM.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520for%2520induced-fit%2520binding%2520of%2520Rho-kinase%2520to%2520the%2520inhibitor%2520Y-27632%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D140%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span> </span><span class="NLM_article-title">Molecular mechanism for the regulation of Rho-kinase by dimerization and its inhibition by fasudil</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=589-600&author=H.+Yamaguchiauthor=M.+Kasaauthor=+K.author=M.+Amanoauthor=K.+Kaibuchiauthor=T.+Hakoshima&title=Molecular+mechanism+for+the+regulation+of+Rho-kinase+by+dimerization+and+its+inhibition+by+fasudil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DKasa%26aufirst%3DM.%26aulast%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DMolecular%2520mechanism%2520for%2520the%2520regulation%2520of%2520Rho-kinase%2520by%2520dimerization%2520and%2520its%2520inhibition%2520by%2520fasudil%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D589%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brickwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeTuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksiazek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledziona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Evolution of the thienopyridine class of inhibitors of IκB kinase-β: Part I—hit-to-lead strategies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0510979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2898-2908&author=T.+M.+Morwickauthor=A.+Berryauthor=J.+Brickwoodauthor=M.+Cardozoauthor=K.+Catronauthor=M.+DeTuriauthor=J.+Emeighauthor=C.+Homonauthor=M.+Hrapchakauthor=S.+Jacoberauthor=S.+Jakesauthor=P.+Kaplitaauthor=T.+Kellyauthor=J.+Ksiazekauthor=M.+Liuzziauthor=R.+Magoldaauthor=C.+Maoauthor=D.+Marshallauthor=D.+McNeilauthor=A.+III+Prokopowiczauthor=C.+Sarkoauthor=E.+Scoutenauthor=C.+Sledzionaauthor=S.+Sunauthor=J.+Watrousauthor=J.-P.+Wuauthor=C.+L.+Cywin&title=Evolution+of+the+thienopyridine+class+of+inhibitors+of+I%CE%BAB+kinase-%CE%B2%3A+Part+I%E2%80%94hit-to-lead+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0510979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0510979%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBrickwood%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCatron%26aufirst%3DK.%26aulast%3DDeTuri%26aufirst%3DM.%26aulast%3DEmeigh%26aufirst%3DJ.%26aulast%3DHomon%26aufirst%3DC.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKaplita%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DKsiazek%26aufirst%3DJ.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMcNeil%26aufirst%3DD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BIII%26aulast%3DSarko%26aufirst%3DC.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DSledziona%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWatrous%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DEvolution%2520of%2520the%2520thienopyridine%2520class%2520of%2520inhibitors%2520of%2520I%25CE%25BAB%2520kinase-%25CE%25B2%253A%2520Part%2520I%25E2%2580%2594hit-to-lead%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2898%26epage%3D2908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Breitenlechner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gassel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossemeyer, D.</span><span> </span><span class="NLM_article-title">Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P: Structural Basis of Selectivity</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1595-1607&author=C.+Breitenlechnerauthor=M.+Gasselauthor=H.+Hidakaauthor=V.+Kinzelauthor=R.+Huberauthor=R.+A.+Enghauthor=D.+Bossemeyer&title=Protein+Kinase+A+in+Complex+with+Rho-Kinase+Inhibitors+Y-27632%2C+Fasudil%2C+and+H-1152P%3A+Structural+Basis+of+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenlechner%26aufirst%3DC.%26aulast%3DGassel%26aufirst%3DM.%26aulast%3DHidaka%26aufirst%3DH.%26aulast%3DKinzel%26aufirst%3DV.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DBossemeyer%26aufirst%3DD.%26atitle%3DProtein%2520Kinase%2520A%2520in%2520Complex%2520with%2520Rho-Kinase%2520Inhibitors%2520Y-27632%252C%2520Fasudil%252C%2520and%2520H-1152P%253A%2520Structural%2520Basis%2520of%2520Selectivity%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southall, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span> </span><span class="NLM_article-title">Characterization of chemical libraries for luciferase inhibitory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2372</span><span class="NLM_x">–</span> <span class="NLM_lpage">2386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701302v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2372-2386&author=D.+S.+Auldauthor=N.+T.+Southallauthor=A.+Jadhavauthor=R.+L.+Johnsonauthor=D.+J.+Dillerauthor=A.+Simeonovauthor=C.+P.+Austinauthor=J.+Inglese&title=Characterization+of+chemical+libraries+for+luciferase+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm701302v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701302v%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSouthall%26aufirst%3DN.%2BT.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520chemical%2520libraries%2520for%2520luciferase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2372%26epage%3D2386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><div class="note"><p class="first last">See also:</p></div><span class="NLM_contrib-group">Auld, D. S.; Zhang, Y.-Q.; Southall, N. T.; Rai, G.; Landsman, M.; MacLure, J.; Langevin, D.; Thomas, C. J.; Austin, C. P.; Inglese, J.</span><span> </span><span class="NLM_article-title">A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1450</span>− <span class="NLM_lpage">1458</span> for a comparison of assay reagents.</span><div class="citationLinks">[<a href="/doi/10.1021/jm8014525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1450-1458&author=D.+S.+Auld&author=Y.-Q.+Zhang&author=N.+T.+Southall&author=G.+Rai&author=M.+Landsman&author=J.+MacLure&author=D.+Langevin&author=C.+J.+Thomas&author=C.+P.+Austin&author=J.+Inglese&title=A+basis+for+reduced+chemical+library+inhibition+of+firefly+luciferase+obtained+from+directed+evolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fjm8014525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014525%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DA%2520basis%2520for%2520reduced%2520chemical%2520library%2520inhibition%2520of%2520firefly%2520luciferase%2520obtained%2520from%2520directed%2520evolution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1450%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morwick, T. M.</span><span> </span><span class="NLM_article-title">High-throughput ester hydrolysis with catch-and-release isolation of carboxylic acids</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc060064r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=649-651&author=T.+M.+Morwick&title=High-throughput+ester+hydrolysis+with+catch-and-release+isolation+of+carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput ester hydrolysis with catch-and-release isolation of carboxylic acids</span></div><div class="casAuthors">Morwick, Tina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-651</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of Amberlyst A26 for high-throughput esters hydrolysis with catch-ana-release isolation of the product carboxylic acids was studied.  It was found that electronic effects on reactivity were significant.  For electron-rich system, the modest conversions could be overcome using microwave irradn.  In addn., a strong acid eluent was required in some cases to achieve good recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxAQS7Xb7aNLVg90H21EOLACvtfcHk0lhec4NQAqHqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsrk%253D&md5=60807be7fdabda6e2437e9131ef1b650</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fcc060064r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc060064r%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26atitle%3DHigh-throughput%2520ester%2520hydrolysis%2520with%2520catch-and-release%2520isolation%2520of%2520carboxylic%2520acids%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2006%26volume%3D8%26spage%3D649%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergbreiter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romo, D.</span><span> </span><span class="NLM_article-title">Simultaneous deprotection and purification of BOC-amines based on ionic resin capture</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3471</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo972001o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3471&author=Y.-S.+Liuauthor=C.+Zhaoauthor=D.+E.+Bergbreiterauthor=D.+Romo&title=Simultaneous+deprotection+and+purification+of+BOC-amines+based+on+ionic+resin+capture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjo972001o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo972001o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-S.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DBergbreiter%26aufirst%3DD.%2BE.%26aulast%3DRomo%26aufirst%3DD.%26atitle%3DSimultaneous%2520deprotection%2520and%2520purification%2520of%2520BOC-amines%2520based%2520on%2520ionic%2520resin%2520capture%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">The Leukart Reaction</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1941&pages=301-330&author=M.+L.+Moore&title=The+Leukart+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DThe%2520Leukart%2520Reaction%26jtitle%3DOrg.%2520React.%26date%3D1941%26volume%3D5%26spage%3D301%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manners, C. N.</span><span> </span><span class="NLM_article-title">Development of a generalized, quantitative physiochemical model of CYP3A4 inhibition for use in early drug discovery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=652-655&author=R.+J.+Rileyauthor=A.+J.+Parkerauthor=S.+Triggauthor=C.+N.+Manners&title=Development+of+a+generalized%2C+quantitative+physiochemical+model+of+CYP3A4+inhibition+for+use+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BJ.%26aulast%3DTrigg%26aufirst%3DS.%26aulast%3DManners%26aufirst%3DC.%2BN.%26atitle%3DDevelopment%2520of%2520a%2520generalized%252C%2520quantitative%2520physiochemical%2520model%2520of%2520CYP3A4%2520inhibition%2520for%2520use%2520in%2520early%2520drug%2520discovery%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D652%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Doe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafferty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willette, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span> </span><span class="NLM_article-title">Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1124%2Fjpet.106.110635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17018693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=89-98&author=C.+Doeauthor=R.+Bentleyauthor=D.+J.+Behmauthor=R.+Laffertyauthor=R.+Stavengerauthor=D.+Jungauthor=M.+Bamfordauthor=T.+Panchalauthor=E.+Grygielkoauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=Z.+Chenauthor=C.+Webbauthor=S.+Khandekarauthor=T.+Yiauthor=R.+Kirkpatrickauthor=E.+Dulauthor=L.+Jolivetteauthor=J.+P.+Marinoauthor=R.+Willetteauthor=D.+Leeauthor=E.+Hu&title=Novel+Rho+kinase+inhibitors+with+anti-inflammatory+and+vasodilatory+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities</span></div><div class="casAuthors">Doe, Chris; Bentley, Ross; Behm, David J.; Lafferty, Robert; Stavenger, Robert; Jung, David; Bamford, Mark; Panchal, Terry; Grygielko, Eugene; Wright, Lois L.; Smith, Gary K.; Chen, Zunxuan; Webb, Christine; Khandekar, Sanjay; Yi, Tracey; Kirkpatrick, Robert; Dul, Edward; Jolivette, Larry; Marino, Joseph P., Jr.; Willette, Robert; Lee, Dennis; Hu, Erding</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Increased Rho kinase (ROCK) activity contributes to smooth muscle contraction and regulates blood pressure homeostasis.  We hypothesized that potent and selective ROCK inhibitors with novel structural motifs would help elucidate the functional role of ROCK and further explore the therapeutic potential of ROCK inhibition for hypertension.  In this article, we characterized two aminofurazan-based inhibitors, GSK269962A [N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]-oxy}benzamide] and SB-7720770-B [4-(7-{[(3S)-3-amino-1-pyrrolidinyl]carbonyl}-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine], as members of a novel class of compds. that potently inhibit ROCK enzymic activity.  GSK269962A and SB-772077-B have IC50 values of 1.6 and 5.6 nM toward recombinant human ROCK1, resp.  GSK269962A also exhibited more than 30-fold selectivity against a panel of serine/threonine kinases.  In lipopolysaccharide-stimulated monocytes, these inhibitors blocked the generation of inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-α.  Furthermore, both SB-772077-B and GSK269962A induced vasorelaxation in preconstricted rat aorta with an IC50 of 39 and 35 nM, resp.  Oral administration of either GSK269962A or SB-772077-B produced a profound dose-dependent redn. of systemic blood pressure in spontaneously hypertensive rats.  At doses of 1, 3, and 30 mg/kg, both compds. induced a redn. in blood pressure of approx. 10, 20, and 50 mm Hg.  In addn., administration of SB-772077-B also dramatically lowered blood pressure in DOCA salt-induced hypertensive rats.  SB-772077-B and GSK269962A represent a novel class of ROCK inhibitors that have profound effects in the vasculature and may enable us to further evaluate the potential beneficial effects of ROCK inhibition in animal models of cardiovascular as well as other chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOuPjuVLTrwrVg90H21EOLACvtfcHk0liL0qYimq9Btg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFeqsw%253D%253D&md5=ab8ba12bca20241815721e2cc9273774</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110635%26sid%3Dliteratum%253Aachs%26aulast%3DDoe%26aufirst%3DC.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DLafferty%26aufirst%3DR.%26aulast%3DStavenger%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DD.%26aulast%3DBamford%26aufirst%3DM.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DGrygielko%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWebb%26aufirst%3DC.%26aulast%3DKhandekar%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DKirkpatrick%26aufirst%3DR.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DJolivette%26aufirst%3DL.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DWillette%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DE.%26atitle%3DNovel%2520Rho%2520kinase%2520inhibitors%2520with%2520anti-inflammatory%2520and%2520vasodilatory%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Turner, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. L.</span><span> </span><span class="NLM_article-title">Characterization and purification of truncated human Rho-kinase II expressed in <i>Sf</i>-21 cells</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2002&pages=13-20&author=M.+S.+Turnerauthor=F.-F.+Linauthor=J.+W.+Traugerauthor=J.+Stephensauthor=P.+L.+LoGrasso&title=Characterization+and+purification+of+truncated+human+Rho-kinase+II+expressed+in+Sf-21+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DF.-F.%26aulast%3DTrauger%26aufirst%3DJ.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%2BL.%26atitle%3DCharacterization%2520and%2520purification%2520of%2520truncated%2520human%2520Rho-kinase%2520II%2520expressed%2520in%2520Sf-21%2520cells%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2002%26volume%3D405%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span> </span><span class="NLM_article-title">Expression, purification, and characterization of an enzymatically active truncated human Rho-kinase I (ROCK I) domain expressed in <i>Sf</i>-9 insect cells</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.2174%2F092986606775974357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16712513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Kru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=369-376&author=S.+S.+Khandekarauthor=T.+Yiauthor=E.+Dulauthor=L.+L.+Wrightauthor=S.+Chenauthor=G.+F.+Scottauthor=G.+K.+Smithauthor=D.+Leeauthor=E.+Huauthor=R.+B.+Kirkpatrick&title=Expression%2C+purification%2C+and+characterization+of+an+enzymatically+active+truncated+human+Rho-kinase+I+%28ROCK+I%29+domain+expressed+in+Sf-9+insect+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of an enzymatically active truncated human Rho-Kinase I (ROCK I) domain expressed in Sf-9 insect cells</span></div><div class="casAuthors">Khandekar, Sanjay S.; Yi, Tracey; Dul, Ed; Wright, Lois L.; Chen, Susan; Scott, Gilbert F.; Smith, Gary K.; Lee, Dennis; Hu, Erding; Kirkpatrick, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">369-376</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Rho Kinase I (ROCK I) is a serine/threonine kinase that is involved in diverse cellular signaling.  To further understand the physiol. role of ROCK I and to identify and develop potent and selective inhibitors of ROCK I, we have overexpressed and purified a constitutively active dimeric human ROCK I (3-543) kinase domain using the Sf9-baculovirus expression system.  In addn., using a limited proteolysis technique, we have identified a minimal functional subdomain of ROCK I that can be used in crystn. studies.  The availability of multimilligram amts. of purified and well characterized functional human ROCK I kinase domains will be useful in screening and structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHzawF_k5M77Vg90H21EOLACvtfcHk0liL0qYimq9Btg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Kru7Y%253D&md5=303f080a3e5bd3394aca7f2182f8ce88</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.2174%2F092986606775974357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986606775974357%26sid%3Dliteratum%253Aachs%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DG.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26atitle%3DExpression%252C%2520purification%252C%2520and%2520characterization%2520of%2520an%2520enzymatically%2520active%2520truncated%2520human%2520Rho-kinase%2520I%2520%2528ROCK%2520I%2529%2520domain%2520expressed%2520in%2520Sf-9%2520insect%2520cells%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2006%26volume%3D13%26spage%3D369%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0li2XdphUKW_FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b','cit24c','cit24d','cit24e','cit24f'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b','cit34c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Fiona  Pachl</span>, <span class="hlFld-ContribAuthor ">Benjamin  Ruprecht</span>, <span class="hlFld-ContribAuthor ">Susan  Klaeger</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Dominic  Helm</span>, <span class="hlFld-ContribAuthor ">Huichao  Qiao</span>, <span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Mathias  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Thomas  Kuehne</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Wu</span>, <span class="hlFld-ContribAuthor ">Antje  Dittmann</span>, <span class="hlFld-ContribAuthor ">Carsten  Hopf</span>, <span class="hlFld-ContribAuthor ">Karl  Kramer</span>, and <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2015,</strong> <em>14 </em>
                                    (3)
                                     , 1574-1586. <a href="https://doi.org/10.1021/pr5012608" title="DOI URL">https://doi.org/10.1021/pr5012608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/pr5012608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fpr5012608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DOptimized%252BChemical%252BProteomics%252BAssay%252Bfor%252BKinase%252BInhibitor%252BProfiling%26aulast%3DM%25C3%25A9dard%26aufirst%3DGuillaume%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D20022015%26date%3D06032015%26date%3D08022015%26volume%3D14%26issue%3D3%26spage%3D1574%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  St. Jean,Jr.</span> and <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>  . </span><span class="cited-content_cbyCitation_article-title">Mitigating Heterocycle Metabolism in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (13)
                                     , 6002-6020. <a href="https://doi.org/10.1021/jm300343m" title="DOI URL">https://doi.org/10.1021/jm300343m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300343m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMitigating%252BHeterocycle%252BMetabolism%252Bin%252BDrug%252BDiscovery%26aulast%3DSt.%2BJean%26aufirst%3DDavid%2BJ.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12032012%26date%3D07052012%26date%3D12072012%26date%3D25042012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and in vivo pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 305-369. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00006-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00006-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00006-3%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252Bvitro%252BADME%252Band%252Bin%252Bvivo%252Bpharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D305%26epage%3D369%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carina  Lotz-Jenne</span>, <span class="hlFld-ContribAuthor ">Urs  Lüthi</span>, <span class="hlFld-ContribAuthor ">Sabine  Ackerknecht</span>, <span class="hlFld-ContribAuthor ">François  Lehembre</span>, <span class="hlFld-ContribAuthor ">Tobias  Fink</span>, <span class="hlFld-ContribAuthor ">Manuel  Stritt</span>, <span class="hlFld-ContribAuthor ">Matthias  Wirth</span>, <span class="hlFld-ContribAuthor ">Simona  Pavan</span>, <span class="hlFld-ContribAuthor ">Ruben  Bill</span>, <span class="hlFld-ContribAuthor ">Urs  Regenass</span>, <span class="hlFld-ContribAuthor ">Gerhard  Christofori</span>, <span class="hlFld-ContribAuthor ">Nathalie  Meyer-Schaller</span>. </span><span class="cited-content_cbyCitation_article-title">A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (18)
                                     , 25983-26002. <a href="https://doi.org/10.18632/oncotarget.8418" title="DOI URL">https://doi.org/10.18632/oncotarget.8418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.8418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.8418%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DA%252Bhigh-content%252BEMT%252Bscreen%252Bidentifies%252Bmultiple%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%252Bwith%252Bactivity%252Bon%252BTGF%2525CE%2525B2%252Breceptor%26aulast%3DLotz-Jenne%26aufirst%3DCarina%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D18%26spage%3D25983%26epage%3D26002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Defert</span>, <span class="hlFld-ContribAuthor ">Sandro  Boland</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase profiling in early stage drug discovery: sorting things out. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2015,</strong> <em>18 </em>, 52-61. <a href="https://doi.org/10.1016/j.ddtec.2015.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2015.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2015.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DKinase%252Bprofiling%252Bin%252Bearly%252Bstage%252Bdrug%252Bdiscovery%25253A%252Bsorting%252Bthings%252Bout%26aulast%3DDefert%26aufirst%3DOlivier%26date%3D2015%26volume%3D18%26spage%3D52%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and In vivo Pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 245-306. <a href="https://doi.org/10.1016/B978-0-12-411508-8.00006-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-411508-8.00006-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411508-8.00006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411508-8.00006-2%26sid%3Dliteratum%253Aachs%26atitle%3DIn%2525C2%2525A0vitro%252BADME%252Band%252BIn%2525C2%2525A0vivo%252BPharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2015%26spage%3D245%26epage%3D306%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2015%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard B.  Silverman</span>, <span class="hlFld-ContribAuthor ">Mark W.  Holladay</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Discovery and Lead Modification. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 19-122. <a href="https://doi.org/10.1016/B978-0-12-382030-3.00002-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-382030-3.00002-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-382030-3.00002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-382030-3.00002-7%26sid%3Dliteratum%253Aachs%26atitle%3DLead%252BDiscovery%252Band%252BLead%252BModification%26aulast%3DSilverman%26aufirst%3DRichard%2BB.%26date%3D2014%26spage%3D19%26epage%3D122%26pub%3DElsevier%26atitle%3DThe%252BOrganic%252BChemistry%252Bof%252BDrug%252BDesign%252Band%252BDrug%252BAction%26date%3D2014%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Pireddu</span>, <span class="hlFld-ContribAuthor ">Kara D.  Forinash</span>, <span class="hlFld-ContribAuthor ">Nan N.  Sun</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Shen-Shu  Sung</span>, <span class="hlFld-ContribAuthor ">Brian  Alexander</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Wayne C.  Guida</span>, <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>, <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lawrence</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (6)
                                     , 699. <a href="https://doi.org/10.1039/c2md00320a" title="DOI URL">https://doi.org/10.1039/c2md00320a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md00320a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md00320a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DPyridylthiazole-based%252Bureas%252Bas%252Binhibitors%252Bof%252BRho%252Bassociated%252Bprotein%252Bkinases%252B%252528ROCK1%252Band%252B2%252529%26aulast%3DPireddu%26aufirst%3DRoberta%26date%3D2012%26volume%3D3%26issue%3D6%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank  Wu</span>, <span class="hlFld-ContribAuthor ">Frank H.  Büttner</span>, <span class="hlFld-ContribAuthor ">Rhonda  Chen</span>, <span class="hlFld-ContribAuthor ">Eugene  Hickey</span>, <span class="hlFld-ContribAuthor ">Scott  Jakes</span>, <span class="hlFld-ContribAuthor ">Paul  Kaplita</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  Kashem</span>, <span class="hlFld-ContribAuthor ">Steven  Kerr</span>, <span class="hlFld-ContribAuthor ">Stanley  Kugler</span>, <span class="hlFld-ContribAuthor ">Zofia  Paw</span>, <span class="hlFld-ContribAuthor ">Anthony  Prokopowicz</span>, <span class="hlFld-ContribAuthor ">Cheng-Kon  Shih</span>, <span class="hlFld-ContribAuthor ">Roger  Snow</span>, <span class="hlFld-ContribAuthor ">Erick  Young</span>, <span class="hlFld-ContribAuthor ">Charles L.  Cywin</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 3235-3239. <a href="https://doi.org/10.1016/j.bmcl.2010.04.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.04.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.04.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituted%252B2H-isoquinolin-1-one%252Bas%252Bpotent%252BRho-Kinase%252Binhibitors.%252BPart%252B1%25253A%252BHit-to-lead%252Baccount%26aulast%3DWu%26aufirst%3DFrank%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D3235%26epage%3D3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature benchmark Rho kinase inhibitors with X-ray structures. ROCK1 data reported in refs <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and <a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">26a</a>. ROCK2 data reported in refs <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and <a onclick="showRef(event, 'cit34a'); return false;" href="javascript:void(0);" class="ref cit34a">34a</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Results for resynthesized compound <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Examples of bisbenzamide and ureiobenzamide actives from the screen. Compounds <b>7</b> and <b>9</b> are racemic.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A partial ribbon diagram shows the binding mode for bisbenzamide <b>16</b>. Key residues (backbone and/or side chain) are shown in space-filing mode and colored by element (blue = nitrogen, red = oxygen, yellow = sulfur). Compound <b>16</b> uses the aromatic <i>p</i>-methoxy oxygen for hinge binding to Met172 (3.0 Å), while the tetrahydroisoquinoline forms an interaction with the side chain acid of Asp385 (2.6 Å). Side chain fragments for a number of hydrophobic residues in the hinge-binding region (Met169, Ile98, Phe384, and Tyr171) are also depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, or <i>N</i>-methylmorpholine, DMF; (ii) SCX, dichloromethane; (iii) ammonia in methanol; (iv) Amberlyst A26 (OH<sup>−</sup> form), methanol/DMF; (v) formic acid, methanol; (vi) <i>Si</i>-DMA, DMF; (vii) SCX; (viii) LiOH, THF, water.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, DMF; (ii) trifluoroacetic acid, dichloromethane; (iii) formic acid, formaldehyde.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 4-Isocyanato-1,2-dimethoxy-benzene, DMF; (ii) Amberlyst A26 (OH<sup>−</sup> form), methanol, DMF, or methanol/DMF; (iii) formic acid, methanol; (iv) <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, <i>N</i>-methylmorpholine or <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (v) 3-(2-amino-ethyl)-piperidine-1-carboxylic acid <i>tert-</i>butyl ester (vi) SCX, dichloromethane; (vii) ammonia, methanol; (viii) isophthalic acid monomethyl ester; (ix) 3-aminobenzoic acid methyl ester; (x) SCX; (xi) <i>Si</i>-DMA; (xii) HCl, dioxane; (xiii) 3,4-dimethoxy-benzenesulfonyl chloride, <i>Si</i>-DMA, DMF; (xiv) 3-(aminomethyl)-1-<i>N</i>-boc-aniline; (xv) 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester; (xvi) (3-nitrophenyl)-acetic acid; (xvii) ammonium formate, Pd/C, methanol.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, diisopropylethylamine, DMF.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/medium/jm-2009-014263_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-2/jm9014263/production/images/large/jm-2009-014263_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9014263&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride, benzotriazole-1-ol, <i>N</i>,<i>N</i>-diisopropylethylamine or <i>N</i>-methylmorpholine, DMF; (ii) HCl, dioxane; (iii) <i>Si</i>-DMA, DMF; (iv) <i>p</i>-cyanophenylisocyanate, SCX, DMF; (v) SCX; (vi) trifluoroacetic acid, dichloromethane; (vii) 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester; DMF; (viii) SCX, dichloromethane; (ix) ammonia, methanol; (x) carbonyldiimidazole, DMF; (xi) SCX, methanol/acetonitrile; (xii) H<sub>2</sub>SO<sub>4</sub>, trifluoroacetic acid.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sams-Dodd, F.</span><span> </span><span class="NLM_article-title">Target-based drug discovery: is something wrong?</span> <span class="citation_source-journal">Drug Discovery Today: Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2FS1359-6446%2804%2903316-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15718163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=139-147&author=F.+Sams-Dodd&title=Target-based+drug+discovery%3A+is+something+wrong%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Target-based drug discovery: is something wrong?</span></div><div class="casAuthors">Sams-Dodd, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  For the past decade the pharmaceutical industry has experienced a steady decline in productivity and a striking observation is that the decline coincided with the introduction of target-based drug discovery.  The target-based approach can very effectively develop novel treatments for a validated target, but the process of target validation is complex and assocd. with a high degree of uncertainty.  The purpose of this paper is to analyze these aspects in detail to det. if weaknesses in this part of the drug discovery path might explain why this paradigm has not resulted in increased productivity over the traditional in vivo approach, considering its superiority in screening capacity and its ability to define rational drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCMCxkUpqTZbVg90H21EOLACvtfcHk0ljJpUdqoEuV-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbk%253D&md5=30240d6154c02518e5fabe9fb6ebd9c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903316-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903316-1%26sid%3Dliteratum%253Aachs%26aulast%3DSams-Dodd%26aufirst%3DF.%26atitle%3DTarget-based%2520drug%2520discovery%253A%2520is%2520something%2520wrong%253F%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Targets%26date%3D2005%26volume%3D10%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkinson, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinker, A. C.</span><span> </span><span class="NLM_article-title">Components of successful lead generation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.2174%2F1568026053828411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15892684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=421-439&author=A.+M.+Davisauthor=D.+J.+Keelingauthor=J.+Steeleauthor=N.+P.+Tomkinsonauthor=A.+C.+Tinker&title=Components+of+successful+lead+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Components of successful lead generation</span></div><div class="casAuthors">Davis, Andrew M.; Keeling, David J.; Steele, John; Tomkinson, Nicholas P.; Tinker, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-439</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review aims to give an overview of current good practice in the prosecution of Lead Generation.  It will assess experiences across the field as judged from the contents of the limited no. of peer-review disclosures to date.  It will also rely heavily on the experiences of the authors from many campaigns within this organization.  Its focus will be on the assembly of an appropriate compd. collection for application in High Throughput Screening (HTS), the prosecution of HTS, the profiling of HTS output and, lastly the Hit-to-Lead optimization of selected HTS output.  Excluded from the scope are detailed aspects of library design [1], parallel synthesis [2], virtual library applications [3], virtual screening [4] and fragment screening [5] approaches, all of which have been the subject of recent reviews.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5UYz5NF4m7Vg90H21EOLACvtfcHk0lhRLdSph4sspQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D&md5=ef29c85464f4ecbc63787210fda1b778</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568026053828411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828411%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DKeeling%26aufirst%3DD.%2BJ.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTomkinson%26aufirst%3DN.%2BP.%26aulast%3DTinker%26aufirst%3DA.%2BC.%26atitle%3DComponents%2520of%2520successful%2520lead%2520generation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D421%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alanine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. W.</span><span> </span><span class="NLM_article-title">Lead generation—enhancing the success of drug discovery by investing in the hit to lead process</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=12570752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlCmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=51-66&author=A.+Alanineauthor=M.+Nettekovenauthor=E.+Robertsauthor=A.+W.+Thomas&title=Lead+generation%E2%80%94enhancing+the+success+of+drug+discovery+by+investing+in+the+hit+to+lead+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead generation - enhancing the success of drug discovery by investing in the hit to lead process</span></div><div class="casAuthors">Alanine, Alexander; Nettekoven, Matthias; Roberts, Edward; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Improving on the poor success rates in the drug discovery industry requires that knowledge-based decisions are made to advance or stop a lead candidate as early as possible in the discovery process.  Failure to make such timely decisions on the rigorous selection of lead candidates has costly time and resource implications in downstream drug development.  To meet this challenge dedicated "hit to lead" groups have recently been established in many major pharmaceutical companies, and a key to the success of such groups is establishing a clear consistent process and rigorous metrics for lead quality.  The importance of such a "Lead Generation" group within the drug discovery process will be highlighted with the aim of placing a greater level of emphasis in discovering and refining novel lead series with enhanced drug-like properties.  This activity is facilitated by the application of productivity enhancing, integrated technologies coupled with the early evaluation of drug-like properties in the lead refinement process to ensure that a balanced activity - properties profile can be attained before committing to a full lead optimization program.  This article will survey the processes and tools employed in the hit to lead process in such a "Lead Generation" group in order to achieve these objectives, emphasizing the possible gains in productivity through close, early interactions between chem. and other expert groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcmXqBYvtvsrVg90H21EOLACvtfcHk0lhRLdSph4sspQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlCmtb4%253D&md5=0a6a05dba28e1fd884e251dd9517641a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DLead%2520generation%25E2%2580%2594enhancing%2520the%2520success%2520of%2520drug%2520discovery%2520by%2520investing%2520in%2520the%2520hit%2520to%2520lead%2520process%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2003%26volume%3D6%26spage%3D51%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bleicher, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyler, R.</span><span> </span><span class="NLM_article-title">Lead generation: sowing the seeds for future success</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=588-600&author=K.+H.+Bleicherauthor=M.+Nettekovenauthor=J.-U.+Petersauthor=R.+Wyler&title=Lead+generation%3A+sowing+the+seeds+for+future+success"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBleicher%26aufirst%3DK.%2BH.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWyler%26aufirst%3DR.%26atitle%3DLead%2520generation%253A%2520sowing%2520the%2520seeds%2520for%2520future%2520success%26jtitle%3DChimia%26date%3D2004%26volume%3D58%26spage%3D588%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Michne, W. F.</span><span> </span><span class="NLM_article-title">Hit-to-lead chemistry: A key element in new lead generation</span> <span class="citation_source-journal">Pharm. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADyaK28XmsFOqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=19-21&author=W.+F.+Michne&title=Hit-to-lead+chemistry%3A+A+key+element+in+new+lead+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-lead chemistry: A key element in new lead generation</span></div><div class="casAuthors">Michne, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical News</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">19-21</span>CODEN:
                <span class="NLM_cas:coden">PHNEEP</span>;
        ISSN:<span class="NLM_cas:issn">1071-894X</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">A review with refs.  Structure, purity validation, pharmacophore evaluation etc., in combinatorial chem. of pharmaceuticals are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBfdGfJ5xQRbVg90H21EOLACvtfcHk0lhRLdSph4sspQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFOqtLs%253D&md5=c9e06c47ee3f878bc082b275c9e740b3</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMichne%26aufirst%3DW.%2BF.%26atitle%3DHit-to-lead%2520chemistry%253A%2520A%2520key%2520element%2520in%2520new%2520lead%2520generation%26jtitle%3DPharm.%2520News%26date%3D1996%26volume%3D3%26spage%3D19%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Boureux, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignal, E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, P.</span><span> </span><span class="NLM_article-title">Evolution of the Rho family of ras-like GTPases in eukaryotes</span> <span class="citation_source-journal">Mol. Biol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=203-16&issue=1&author=A+Boureuxauthor=E+Vignalauthor=S+Faureauthor=P.+Fort&title=Evolution+of+the+Rho+family+of+ras-like+GTPases+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoureux%26aufirst%3DA%26aulast%3DVignal%26aufirst%3DE%26aulast%3DFaure%26aufirst%3DS%26aulast%3DFort%26aufirst%3DP.%26atitle%3DEvolution%2520of%2520the%2520Rho%2520family%2520of%2520ras-like%2520GTPases%2520in%2520eukaryotes%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2007%26volume%3D24%26issue%3D1%26spage%3D203%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span> </span><span class="NLM_article-title">Rho-kinase inhibition in the therapy of cardiovascular disease</span> <span class="citation_source-journal">Cardiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1097%2F01.crd.0000138079.91392.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16230885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A280%3ADC%252BD2MngslOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=285-292&author=A.+Laiauthor=W.+H.+Frishman&title=Rho-kinase+inhibition+in+the+therapy+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-kinase inhibition in the therapy of cardiovascular disease</span></div><div class="casAuthors">Lai Andrew; Frishman William H</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology in review</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">285-92</span>
        ISSN:<span class="NLM_cas:issn">1061-5377</span>.
    </div><div class="casAbstract">Rho is a GTPase known to be a major mediator in the formation of stress fibers and focal adhesions, cell morphology, and smooth muscle contraction.  Its role in smooth muscle contraction has led to exploration into the connection between Rho-mediated kinase activity and cardiovascular disease.  The role of Rho-kinase in calcium sensitization for vascular smooth muscle contraction has recently been characterized.  Inappropriate coronary artery vasoconstriction resulting from increased Rho-kinase in the vascular system is likely involved in the pathogenesis of exercise-induced myocardial ischemia, spontaneous coronary artery spasm, and hypertension.  In clinical trials, Rho-kinase inhibitors such as fasudil and Y-27632 have demonstrated antiischemic, antivasospastic, and antihypertensive effects.  These compounds have also exhibited the ability to blunt progression of cardiomyocyte hypertrophy and cardiac remodeling in heart failure.  As such, Rho-kinase inhibition represents a potential novel therapeutic approach in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbAYRfozPqNb5oR8RchjrrfW6udTcc2eYVlMdWetjxzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MngslOlsg%253D%253D&md5=f1d201c92db49a0f7356b7094085a29d</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1097%2F01.crd.0000138079.91392.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.crd.0000138079.91392.37%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26atitle%3DRho-kinase%2520inhibition%2520in%2520the%2520therapy%2520of%2520cardiovascular%2520disease%26jtitle%3DCardiol.%2520Rev.%26date%3D2005%26volume%3D13%26spage%3D285%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1517%2F14728222.9.4.715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16083339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFels74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=715-736&author=E.+Huauthor=D.+Lee&title=Rho+kinase+as+potential+therapeutic+target+for+cardiovascular+diseases%3A+opportunities+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges</span></div><div class="casAuthors">Hu, Erding; Lee, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">715-736</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via interaction with the small GTP-binding protein RhoA.  Growing evidence suggests that RhoA and ROCK participate in a variety of important physiol. functions in vasculature including smooth muscle contraction, cell proliferation, cell adhesion and migration, and many aspects of inflammatory responses.  As these processes mediate the onset and progression of cardiovascular disease, modulation of the Rho/ROCK signalling pathway is a potential strategy for targeting an array of cardiovascular indications.  Two widely employed ROCK inhibitors, fasudil and Y-27632, have provided preliminary but compelling evidence supporting the potential cardiovascular benefits of ROCK inhibition in preclin. animal disease models and in the clinic.  This review summarizes the mol. biol. of ROCK and its biol. functions in smooth muscle, endothelium and other vascular tissues.  In addn., there will be a focus on recent progress demonstrating the benefits of ROCK inhibition in several animal models of cardiovascular diseases.  Finally, recent progress in the identification of novel ROCK inhibitors and challenges assocd. with their development for clin. use will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotn9K3fSIGYbVg90H21EOLACvtfcHk0lh3xBNfwfeaxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFels74%253D&md5=fba30810e84a880da792e93647b033e8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.715%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DRho%2520kinase%2520as%2520potential%2520therapeutic%2520target%2520for%2520cardiovascular%2520diseases%253A%2520opportunities%2520and%2520challenges%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D715%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Takai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span> </span><span class="NLM_article-title">Small GTP-binding proteins</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=153-208&author=Y.+Takaiauthor=T.+Sasakiauthor=T.+Matozaki&title=Small+GTP-binding+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMatozaki%26aufirst%3DT.%26atitle%3DSmall%2520GTP-binding%2520proteins%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D153%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span> </span><span class="NLM_article-title">Rho-family GTPases in cadherin-mediated cell−cell adhesion</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2F35103068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=11733768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptF2rtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=887-897&author=M.+Fukataauthor=K.+Kaibuchi&title=Rho-family+GTPases+in+cadherin-mediated+cell%E2%88%92cell+adhesion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-family GTPases in cadherin-mediated cell-cell adhesion</span></div><div class="casAuthors">Fukata, Masaki; Kaibuchi, Kozo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">887-897</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell-cell adhesions are rearranged dynamically during tissue development and tumor metastasis.  Recently, Rho-family GTPases, including RhoA, Rac1 and Cdc42, have emerged as key regulators of cadherin-mediated cell-cell adhesion.  Following the identification and characterization of regulators and effectors of Rho GTPases, signal transduction pathways from cadherin to Rho GTPases and, in turn, from Rho GTPases to cadherin, are beginning to be clarified,.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp42-yzwOsrBbVg90H21EOLACvtfcHk0lh3xBNfwfeaxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptF2rtL4%253D&md5=93e679dc81b98c1468bd9ed3f0a4ac74</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2F35103068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35103068%26sid%3Dliteratum%253Aachs%26aulast%3DFukata%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26atitle%3DRho-family%2520GTPases%2520in%2520cadherin-mediated%2520cell%25E2%2588%2592cell%2520adhesion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D887%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ridley, A. J.</span><span> </span><span class="NLM_article-title">Rho family proteins: coordinating cell responses</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2FS0962-8924%2801%2902153-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=11719051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=471-477&author=A.+J.+Ridley&title=Rho+family+proteins%3A+coordinating+cell+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Rho family proteins: coordinating cell responses</span></div><div class="casAuthors">Ridley, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">471-477</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Rho GTPases hit the headlines several times in 1990-1992: the proteins regulating their GTP-GDP cycle were identified and they were found to be key signal transducers, mediating growth factor-induced changes to the actin cytoskeleton and activating the phagocyte NADPH oxidase.  Since then, they have been implicated in numerous cellular processes, from cell migration to cell survival, transcriptional regulation and vesicle trafficking.  An explanation for why they affect so many aspects of cell behavior might lie in their ability to interact with a no. of downstream targets, so that they can coordinately activate several mol. processes required for a particular cellular response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBIvFHK1j2B7Vg90H21EOLACvtfcHk0lh3xBNfwfeaxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFKls78%253D&md5=ce7f8f86d8b881783432b4bfe54e30e2</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2801%2902153-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252801%252902153-5%26sid%3Dliteratum%253Aachs%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DRho%2520family%2520proteins%253A%2520coordinating%2520cell%2520responses%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D471%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, M.</span><span> </span><span class="NLM_article-title">Development of Rho-kinase inhibitors for cardiovascular medicine</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=296-302&author=H.+Shimokawaauthor=M.+Rashid&title=Development+of+Rho-kinase+inhibitors+for+cardiovascular+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DRashid%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520Rho-kinase%2520inhibitors%2520for%2520cardiovascular%2520medicine%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D296%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Loirand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guérin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacaud, P.</span><span> </span><span class="NLM_article-title">Rho Kinases in cardiovascular physiology and pathophysiology</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=322-334&author=G.+Loirandauthor=P.+Gu%C3%A9rinauthor=P.+Pacaud&title=Rho+Kinases+in+cardiovascular+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoirand%26aufirst%3DG.%26aulast%3DGu%25C3%25A9rin%26aufirst%3DP.%26aulast%3DPacaud%26aufirst%3DP.%26atitle%3DRho%2520Kinases%2520in%2520cardiovascular%2520physiology%2520and%2520pathophysiology%26jtitle%3DCirc.%2520Res.%26date%3D2006%26volume%3D98%26spage%3D322%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Trauger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span> </span><span class="NLM_article-title">Kinetic mechanism for human Rho-Kinase II (ROCK-II)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">8948</span><span class="NLM_x">–</span> <span class="NLM_lpage">8953</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0258243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=8948-8953&author=J.+W.+Traugerauthor=F.-F.+Linauthor=M.+S.+Turnerauthor=J.+Stephensauthor=P.+V.+LoGrasso&title=Kinetic+mechanism+for+human+Rho-Kinase+II+%28ROCK-II%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi0258243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0258243%26sid%3Dliteratum%253Aachs%26aulast%3DTrauger%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DF.-F.%26aulast%3DTurner%26aufirst%3DM.%2BS.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26atitle%3DKinetic%2520mechanism%2520for%2520human%2520Rho-Kinase%2520II%2520%2528ROCK-II%2529%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D8948%26epage%3D8953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Leung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L.</span><span> </span><span class="NLM_article-title">The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=8816443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5313-5327&author=T.+Leungauthor=X.-Q.+Chenauthor=E.+Manserauthor=L.+Lim&title=The+p160+RhoA-binding+kinase+ROK%CE%B1+is+a+member+of+a+kinase+family+and+is+involved+in+the+reorganization+of+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton</span></div><div class="casAuthors">Leung, Thomas; Chen, Xiang-Qun; Manser, Edward; Lim, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5313-5327</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The GTPase RhoA has been implicated in various cellular activity, including the formation of stress fiber,s motility, and cytokinesis.  We recently reported on a p150 serine/threonine kinase (termed ROKα) binding RhoA only in its active GTP-bound state and on its cDNA; introduction of RhoA into HeLa cells resulted in translocation of the cytoplasmic kinase to plasma membranes, consistent with ROKα being a target for RhoA (T. Leung, E. Manser, L. Tan, and L. Lim, J. Biol. Chem. 256:29051-29054, 1995).  Reanal. of the cDNA revealed that ROKα contains an addnl. N-terminal region.  We also isolated another cDNA which encoded a protein (ROKβ) with 90% identity of ROKα in the kinase domain.  Both ROKα and ROKβ, which has a mol. mass of 160 kDa, contained a highly conserved cysteine/histidine-rich domain located within a putative pleckstrin homol. domain.  The kinases bound Rho, RhoB, and RhoC but not Rac1 and Cdc42.  The Rho-binding domain comprises about 30 amino acids.  Mutations within this domain caused partial or complete loss of Rho binding.  The morphol. effects of ROKα were investigated by microinjecting HeLa cells with DNA constructs encoding various forms of ROKα.  Full-length ROKα promoted formation of stress fibers and focal adhesion complexes, consistent with its being an effector of RhoA.  ROKα truncated at the C terminus promoted this formation and also extensive condensation of actin microfilaments and nuclear disruption.  The proteins exhibited protein kinase activity which was required for stress fiber formation; the kinase-dead ROKαK112A and N-terminally truncated mutants showed no such promotion.  The latter mutant instead induced disassembly of stress fibers and focal adhesion complexes, accompanied by cell spreading.  These effects were mediated by the C-terminal region contg. Rho-binding, cysteine/histidine-rich, and pleckstrin homol. domains.  Thus, the multidomained ROKα appears to be involved in reorganization of the cytoskeleton, with the N and C termini acting as pos. and neg. regulators, resp., of the kinase domain whose activity is crucial for formation of stress fibers and focal adhesion complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaok4XDTUh7Vg90H21EOLACvtfcHk0li8kOXNeoiTZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamt7g%253D&md5=ff30cf0f5819581e9d74001197154a25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.-Q.%26aulast%3DManser%26aufirst%3DE.%26aulast%3DLim%26aufirst%3DL.%26atitle%3DThe%2520p160%2520RhoA-binding%2520kinase%2520ROK%25CE%25B1%2520is%2520a%2520member%2520of%2520a%2520kinase%2520family%2520and%2520is%2520involved%2520in%2520the%2520reorganization%2520of%2520the%2520cytoskeleton%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5313%26epage%3D5327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Yoneda, A.; Multhaupt, H. A. B.; Couchman, J. R.</span><span> </span><span class="NLM_article-title">The Rho kinases I and II regulate different aspects of myosin II activity</span>.  <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span>− <span class="NLM_lpage">453</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2005&pages=443-453&author=A.+Yoneda&author=H.+A.+B.+Multhaupt&author=J.+R.+Couchman&title=The+Rho+kinases+I+and+II+regulate+different+aspects+of+myosin+II+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoneda%26aufirst%3DA.%26atitle%3DThe%2520Rho%2520kinases%2520I%2520and%2520II%2520regulate%2520different%2520aspects%2520of%2520myosin%2520II%2520activity%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D170%26spage%3D443%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Riento, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalonga, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guasch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, A. J.</span><span> </span><span class="NLM_article-title">RhoE function is regulated by ROCK I-mediated phosphorylation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1170-1180&author=K.+Rientoauthor=N.+Tottyauthor=P.+Villalongaauthor=R.+Gargauthor=R.+Guaschauthor=A.+J.+Ridley&title=RhoE+function+is+regulated+by+ROCK+I-mediated+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiento%26aufirst%3DK.%26aulast%3DTotty%26aufirst%3DN.%26aulast%3DVillalonga%26aufirst%3DP.%26aulast%3DGarg%26aufirst%3DR.%26aulast%3DGuasch%26aufirst%3DR.%26aulast%3DRidley%26aufirst%3DA.%2BJ.%26atitle%3DRhoE%2520function%2520is%2520regulated%2520by%2520ROCK%2520I-mediated%2520phosphorylation%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D1170%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rubenstein, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, G. L.</span><span> </span><span class="NLM_article-title">Selective glucocorticoid control of Rho kinase isoforms regulate cell−cell interactions</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2007&pages=603-607&author=N.+M.+Rubensteinauthor=J.+A.+Callahanauthor=D.+H.+Loauthor=G.+L.+Firestone&title=Selective+glucocorticoid+control+of+Rho+kinase+isoforms+regulate+cell%E2%88%92cell+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstein%26aufirst%3DN.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BA.%26aulast%3DLo%26aufirst%3DD.%2BH.%26aulast%3DFirestone%26aufirst%3DG.%2BL.%26atitle%3DSelective%2520glucocorticoid%2520control%2520of%2520Rho%2520kinase%2520isoforms%2520regulate%2520cell%25E2%2588%2592cell%2520interactions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D354%26spage%3D603%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wettschureck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, S.</span><span> </span><span class="NLM_article-title">Rho/Rho-kinase mediated signaling in physiology and pathophysiology</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1007%2Fs00109-002-0370-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=12395147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVClt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=629-638&author=N.+Wettschureckauthor=S.+Offermanns&title=Rho%2FRho-kinase+mediated+signaling+in+physiology+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho/Rho-kinase mediated signaling in physiology and pathophysiology</span></div><div class="casAuthors">Wettschureck, Nina; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The small GTPase Rho is implicated in many cellular functions such as cell adhesion, cell motility and migration, growth control, cell contraction, and cytokinesis.  One of its main effectors, Rho-kinase, appears to play a key role in the regulation of force and velocity of actomyosin crossbridging in smooth muscle and nonmuscle cells by inhibiting myosin phosphatase-mediated dephosphorylation of the regulatory chain of myosin II.  Abnormal activation of the Rho/Rho-kinase pathway has been shown to play a role in diseases such as hypertension and bronchial asthma.  This review summarizes the current knowledge on the physiol. and pathophysiol. function of the Rho/Rho-kinase mediated pathway in various tissues with a focus on its possible role as a target for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUHS23PFmT7Vg90H21EOLACvtfcHk0li8kOXNeoiTZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVClt7s%253D&md5=ea2b9a7f758e34d6d61392e8bf6e00de</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1007%2Fs00109-002-0370-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-002-0370-2%26sid%3Dliteratum%253Aachs%26aulast%3DWettschureck%26aufirst%3DN.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DRho%252FRho-kinase%2520mediated%2520signaling%2520in%2520physiology%2520and%2520pathophysiology%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2002%26volume%3D80%26spage%3D629%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span> </span><span class="NLM_article-title">Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">20246</span><span class="NLM_x">–</span> <span class="NLM_lpage">20249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=20246-20249&author=M.+Amanoauthor=M.+Itoauthor=K.+Kimuraauthor=Y.+Fukataauthor=K.+Chiharaauthor=T.+Nakanoauthor=Y.+Matsuuraauthor=K.+Kaibuchi&title=Phosphorylation+and+activation+of+myosin+by+Rho-associated+kinase+%28Rho-kinase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DFukata%26aufirst%3DY.%26aulast%3DChihara%26aufirst%3DK.%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DY.%26aulast%3DKaibuchi%26aufirst%3DK.%26atitle%3DPhosphorylation%2520and%2520activation%2520of%2520myosin%2520by%2520Rho-associated%2520kinase%2520%2528Rho-kinase%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D20246%26epage%3D20249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kureishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, T.</span><span> </span><span class="NLM_article-title">Rho-associated kinase of chicken gizzard smooth muscle</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">3744</span><span class="NLM_x">–</span> <span class="NLM_lpage">3752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=3744-3752&author=J.+Fengauthor=M.+Itoauthor=Y.+Kureishiauthor=K.+Ichikawaauthor=M.+Amanoauthor=N.+Isakaauthor=K.+Okawaauthor=A.+Iwamatsuauthor=K.+Kaibuchiauthor=D.+J.+Hartshorneauthor=T.+Nakano&title=Rho-associated+kinase+of+chicken+gizzard+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DKureishi%26aufirst%3DY.%26aulast%3DIchikawa%26aufirst%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DIsaka%26aufirst%3DN.%26aulast%3DOkawa%26aufirst%3DK.%26aulast%3DIwamatsu%26aufirst%3DA.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHartshorne%26aufirst%3DD.%2BJ.%26aulast%3DNakano%26aufirst%3DT.%26atitle%3DRho-associated%2520kinase%2520of%2520chicken%2520gizzard%2520smooth%2520muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D3744%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlyo, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlyo, A. P.</span><span> </span><span class="NLM_article-title">The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPgammaS-, and phorbol ester-induced Ca<sup>2+</sup>-sensitization of smooth muscle</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=1998&pages=183-187&author=X.+Fuauthor=M.+C.+Gongauthor=T.+Jiaauthor=A.+V.+Somlyoauthor=A.+P.+Somlyo&title=The+effects+of+the+Rho-kinase+inhibitor+Y-27632+on+arachidonic+acid-%2C+GTPgammaS-%2C+and+phorbol+ester-induced+Ca2%2B-sensitization+of+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DM.%2BC.%26aulast%3DJia%26aufirst%3DT.%26aulast%3DSomlyo%26aufirst%3DA.%2BV.%26aulast%3DSomlyo%26aufirst%3DA.%2BP.%26atitle%3DThe%2520effects%2520of%2520the%2520Rho-kinase%2520inhibitor%2520Y-27632%2520on%2520arachidonic%2520acid-%252C%2520GTPgammaS-%252C%2520and%2520phorbol%2520ester-induced%2520Ca2%252B-sensitization%2520of%2520smooth%2520muscle%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D440%26spage%3D183%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Budzyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marley, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Targeting Rho and Rho-kinase in the treatment of cardiovascular disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=97-104&author=K.+Budzynauthor=P.+D.+Marleyauthor=C.+G.+Sobey&title=Targeting+Rho+and+Rho-kinase+in+the+treatment+of+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudzyn%26aufirst%3DK.%26aulast%3DMarley%26aufirst%3DP.%2BD.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DTargeting%2520Rho%2520and%2520Rho-kinase%2520in%2520the%2520treatment%2520of%2520cardiovascular%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D97%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mueller, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teusch, N.</span><span> </span><span class="NLM_article-title">Rho kinase, a promising drug target for neurological disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2Fnrd1719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15864268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=387-398&author=B.+K.+Muellerauthor=H.+Mackauthor=N.+Teusch&title=Rho+kinase%2C+a+promising+drug+target+for+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase, a promising drug target for neurological disorders</span></div><div class="casAuthors">Mueller, Bernhard K.; Mack, Helmut; Teusch, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rho kinases (ROCKs), the first Rho effectors to be described, are serine/threonine kinases that are important in fundamental processes of cell migration, cell proliferation and cell survival.  Abnormal activation of the Rho/ROCK pathway has been obsd. in various disorders of the central nervous system.  Injury to the adult vertebrate brain and spinal cord activates ROCKs, thereby inhibiting neurite growth and sprouting.  Inhibition of ROCKs results in accelerated regeneration and enhanced functional recovery after spinal-cord injury in mammals, and inhibition of the Rho/ROCK pathway has also proved to be efficacious in animal models of stroke, inflammatory and demyelinating diseases, Alzheimer's disease and neuropathic pain.  ROCK inhibitors therefore have potential for preventing neurodegeneration and stimulating neuroregeneration in various neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3XJk9e8s-qLVg90H21EOLACvtfcHk0lhqogT_YJkGpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktLw%253D&md5=605b180f2f817091aadfc143df6d0205</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1719%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DB.%2BK.%26aulast%3DMack%26aufirst%3DH.%26aulast%3DTeusch%26aufirst%3DN.%26atitle%3DRho%2520kinase%252C%2520a%2520promising%2520drug%2520target%2520for%2520neurological%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrissobolis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Recent evidence for an involvement of Rho-kinase in cerebral vascular disease</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2174</span><span class="NLM_x">–</span> <span class="NLM_lpage">2180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=2174-2180&author=S.+Chrissobolisauthor=C.+G.+Sobey&title=Recent+evidence+for+an+involvement+of+Rho-kinase+in+cerebral+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrissobolis%26aufirst%3DS.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DRecent%2520evidence%2520for%2520an%2520involvement%2520of%2520Rho-kinase%2520in%2520cerebral%2520vascular%2520disease%26jtitle%3DStroke%26date%3D2006%26volume%3D37%26spage%3D2174%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ohnaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, R.</span><span> </span><span class="NLM_article-title">Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=337-342&author=K.+Ohnakaauthor=S.+Shimodaauthor=H.+Nawataauthor=H.+Shimokawaauthor=K.+Kaibuchiauthor=Y.+Iwamotoauthor=R.+Takayanagi&title=Pitavastatin+enhanced+BMP-2+and+osteocalcin+expression+by+inhibition+of+Rho-associated+kinase+in+human+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhnaka%26aufirst%3DK.%26aulast%3DShimoda%26aufirst%3DS.%26aulast%3DNawata%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DTakayanagi%26aufirst%3DR.%26atitle%3DPitavastatin%2520enhanced%2520BMP-2%2520and%2520osteocalcin%2520expression%2520by%2520inhibition%2520of%2520Rho-associated%2520kinase%2520in%2520human%2520osteoblasts%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, H.</span><span> </span><span class="NLM_article-title">Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1158%2F1535-7163.MCT-06-0689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17513600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1517-1525&author=L.+Yinauthor=K.+Morishigeauthor=T.+Takahashiauthor=K.+Hashimotoauthor=S.+Ogataauthor=S.+Tsutsumiauthor=K.+Takataauthor=T.+Ohtaauthor=J.+Kawagoeauthor=K.+Takahashiauthor=H.+Kurachi&title=Fasudil+inhibits+vascular+endothelial+growth+factor-induced+angiogenesis+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo</span></div><div class="casAuthors">Yin, Limei; Morishige, Ken-ichirou; Takahashi, Toshifumi; Hashimoto, Kae; Ogata, Seiji; Tsutsumi, Seiji; Takata, Keiko; Ohta, Tsuyoshi; Kawagoe, Jun; Takahashi, Kazuhiro; Kurachi, Hirohisa</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1517-1525</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF)-induced endothelial cell migration is an important components of tumor angiogenesis.  Rho and Rho-assocd. kinase (ROCK) are key regulators of focal adhesion, stress fiber formation, and thus cell motility.  Inhibitors of this pathway have been shown to inhibit endothelial cell motility and angiogenesis.  In this study, we investigated the antiangiogenic effect of fasudil, one of the ROCK inhibitors.  Fasudil inhibited VEGF-induced endothelial cell migration, viability, and tube formation in vitro in human umbilical vein endothelial cells.  VEGF-induced endothelial cell migration was reduced by fasudil assocd. with loss of stress fiber formation, focal adhesion assembly, and with the suppression of tyrosine phosphorylation of focal adhesion proteins.  Furthermore, fasudil inhibited VEGF-induced phosphorylation of myosin light chain, which is one of the main substrates of ROCK.  Therefore, the effect of fasudil was suggested to be ROCK dependent.  Fasudil not only inhibited VEGF-induced cell proliferation but also reversed the protective effect of VEGF on apoptosis, which resulted in the decrease of cell viability.  Moreover, fasudil inhibited VEGF-induced angiogenesis in a directed in vivo angiogenesis assay.  These data are the first demonstration that fasudil has antiangiogenic properties.  Therefore, fasudil might be useful for the treatment of angiogenesis-related diseases, esp. cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHdvoZLbqPLVg90H21EOLACvtfcHk0lhobwFUx5bUPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFaltL8%253D&md5=167575e2b22b39aaee3e0da760b8b514</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0689%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DL.%26aulast%3DMorishige%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTakata%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DKawagoe%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKurachi%26aufirst%3DH.%26atitle%3DFasudil%2520inhibits%2520vascular%2520endothelial%2520growth%2520factor-induced%2520angiogenesis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1517%26epage%3D1525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rattan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, I.</span><span> </span><span class="NLM_article-title">Rho/ROCK pathway as a target of tumor therapy</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1002%2Fjnr.20707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16385577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1altb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=243-255&author=R.+Rattanauthor=S.+Giriauthor=A.+K.+Singhauthor=I.+Singh&title=Rho%2FROCK+pathway+as+a+target+of+tumor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Rho/ROCK pathway as a target of tumor therapy</span></div><div class="casAuthors">Rattan, R.; Giri, S.; Singh, A. K.; Singh, I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-255</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This study emphasizes the importance of Rho/ROCK pathway in lovastatin-induced apoptosis as replenishment with exogenous isoprenoid, geranylgeranylpyrophosphate (GGPP), resulted in inhibition of apoptosis in cultured tumor cells.  Treatment of C6 glioma cells with Toxin B and exoenzyme C3 resulted in cell death suggesting the role of geranylgeranylated protein(s) in the survival of glioma cells.  Relative apoptotic death obsd. in cells transfected with dominant neg. constructs of RhoA, Rac, and cdc42 imply Rho A as playing the major role in cell survival.  Furthermore, the inhibition of Rho A kinase (ROCK), a direct downstream effector of Rho A, by Y-27632 or dominant neg. of ROCK, induced apoptosis in glioma cells.  These findings indicate that RhoA/ROCK pathway is involved neg. in the regulation of glioma cell death pathway.  Moreover, in vivo studies of lovastatin treatment in animals implanted with C6 glioma cell tumors also resulted in smaller tumor size and induced apoptosis in the tumor tissue.  The implantation of stably transfected C6 glioma cells with expression vector of C3 exoenzyme, dominant neg. of RhoA and ROCK, resulted in significant smaller tumor mass, further establishing the importance of geranylgeranylated proteins, specifically RhoA and its downstream effecter ROCK, in cell survival and tumor genesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6duHq3j294bVg90H21EOLACvtfcHk0lhobwFUx5bUPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1altb8%253D&md5=6db753cef0aae61efa584826e65309b0</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20707%26sid%3Dliteratum%253Aachs%26aulast%3DRattan%26aufirst%3DR.%26aulast%3DGiri%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DI.%26atitle%3DRho%252FROCK%2520pathway%2520as%2520a%2520target%2520of%2520tumor%2520therapy%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2006%26volume%3D83%26spage%3D243%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokata, K.</span><span> </span><span class="NLM_article-title">Mast cell tryptase causes homologous desensitization of β-adrenoceptors by Ca<sup>2+</sup> sensitization in tracheal smooth muscle</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=18028457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs12gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=135-144&author=M.+Kobayashiauthor=H.+Kumeauthor=T.+Ogumaauthor=Y.+Makinoauthor=Y.+Itoauthor=K.+Shimokata&title=Mast+cell+tryptase+causes+homologous+desensitization+of+%CE%B2-adrenoceptors+by+Ca2%2B+sensitization+in+tracheal+smooth+muscle"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell tryptase causes homologous desensitization of β-adrenoceptors by Ca2+ sensitization in tracheal smooth muscle</span></div><div class="casAuthors">Kobayashi, M.; Kume, H.; Oguma, T.; Makino, Y.; Ito, Y.; Shimokata, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Allergy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Recent studies have revealed that in asthma, mast cells infiltrate to the smooth muscle layer and release tryptase, an enzymic activator of protease-activated receptor 2 (PAR2).  This phenomenon, mast cell myositis, is proposed as a new feature of asthma.  However, little is known about the involvement of mast cell myositis in the pathophysiiol. of asthma.  This study was designed to det. whether mast cell degranulation has any functional impact on β-adrenoceptors via PAR2 in airway smooth muscle.  Moreover, we focused on Ca2+ signalling as a mechanism underlying alteration of smooth muscle tone and responsiveness.  Isometric tension and F340/F380, an indicator of the concn. of intracellular Ca2+ ([Ca2+]i), were simultaneously measured using fura-2-loaded tissues isolated from guinea-pig tracheal smooth muscle.  Tryptase (1-100 nM) caused tension with elevated F340/F380, and after exposure to tryptase for 15 min the inhibitory effect of isoprenaline (ISO) against methacholine was attenuated without elevating F340/F380 in a concn.-dependent manner.  Tryptase (< 1 nM) had a modest effect on tension, but prolonged treatment (≤ 120 min) with 0.1 nM tryptase also reduced the effects of ISO in a time-dependent manner.  When tissues were incubated with tryptase in the presence of Y-27632, a Rho-kinase inhibitor, reduced responsiveness to ISO by tryptase was reversed without affecting F340/F380.  In contrast, pre-treatment with SKF96365, a non-selective inhibitor of Ca2+ channels, did not antagonize the effect of tryptase.  Moreover, pre-treatment with SLIGKV-NH2, a non-enzymic activator of PAR2, resulted in a loss of β-adrenergic efficacy, similar to tryptase.  The effect of cAMP-related agents bypassing β-adrenoceptors was not attenuated after exposure to tryptase.  In mast cell myositis, tryptase released from mast cells acts on airway smooth muscle, leading to homologous β-adrenergic desensitization mediated by [Ca2+]i-independent mechanisms via PAR2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRi8myjepzLrVg90H21EOLACvtfcHk0lhobwFUx5bUPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs12gurY%253D&md5=d7273c991e8db28e4c3e0318ae11d2aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DKume%26aufirst%3DH.%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DMakino%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DShimokata%26aufirst%3DK.%26atitle%3DMast%2520cell%2520tryptase%2520causes%2520homologous%2520desensitization%2520of%2520%25CE%25B2-adrenoceptors%2520by%2520Ca2%252B%2520sensitization%2520in%2520tracheal%2520smooth%2520muscle%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2008%26volume%3D38%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Rao, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D. L.</span><span> </span><span class="NLM_article-title">Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=167-177&author=V.+P.+Raoauthor=D.+L.+Epstein&title=Rho+GTPase%2FRho+kinase+inhibition+as+a+novel+target+for+the+treatment+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DV.%2BP.%26aulast%3DEpstein%26aufirst%3DD.%2BL.%26atitle%3DRho%2520GTPase%252FRho%2520kinase%2520inhibition%2520as%2520a%2520novel%2520target%2520for%2520the%2520treatment%2520of%2520glaucoma%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_contrib-group">Tokushige, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanihara, H.</span><span> </span><span class="NLM_article-title">Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys</span> <span class="citation_source-journal">Invest. Ophthalmol. Visualization Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3216</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1167%2Fiovs.05-1617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17591891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A280%3ADC%252BD2sznsF2rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3216-2322&author=H.+Tokushigeauthor=M.+Inataniauthor=S.+Nemotoauthor=H.+Sakakiauthor=K.+Katayamaauthor=M.+Uehataauthor=H.+Tanihara&title=Effects+of+topical+administration+of+Y-39983%2C+a+selective+Rho-associated+protein+kinase+inhibitor%2C+on+ocular+tissues+in+rabbits+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys</span></div><div class="casAuthors">Tokushige Hideki; Inatani Masaru; Nemoto Shingo; Sakaki Hideyuki; Katayama Koushirou; Uehata Masayoshi; Tanihara Hidenobu</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3216-22</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  To elucidate the intraocular pressure (IOP)-lowering effects and associated characteristics of Y-39983, a selective Rho-associated coiled coil-forming protein kinase (ROCK) inhibitor derived from Y-27632, in animal eyes.  METHODS:  Y-39983 was compared with Y-27632 for selectivity of ROCK inhibition by biochemical assay.  The IOP was monitored by pneumatonometer in albino rabbits and cynomolgus monkeys that were given topically administered Y-39983.  The total outflow facility and uveoscleral outflow were measured by two-level constant-pressure perfusion and perfusion technique using fluorescein isothiocyanate-dextran, respectively, at 2 hours after topical administration of Y-39983 in albino rabbits.  The ocular toxicologic effects of topical administration of Y-39983 were observed in albino rabbits and cynomolgus monkeys.  RESULTS:  A biochemical assay showed that Y-39983 inhibited ROCK more potently than Y-27632.  In rabbits, topical administration of Y-39983 significantly increased conventional outflow by 65.5%, followed by significant, dose-dependent reduction in IOP.  Maximum IOP reduction was 13.2 +/- 0.6 mm Hg (mean +/- SE) at 0.1% Y-39983 in rabbits.  In monkeys, at 3 hours after topical administration of 0.05% Y-39983, maximum reduction of IOP was 2.5 +/- 0.8 mm Hg.  No serious side effects were observed in ocular tissues except sporadic punctate subconjunctival hemorrhage during long-term topical administration of Y-39983 four times a day (at 2-hour intervals) in rabbits or monkeys.  However, punctate subconjunctival hemorrhage was not observed with administration twice daily (at a 6-hour interval) or three times a day (at 5-hour intervals).  CONCLUSIONS:  Y-39983 causes increased outflow facility followed by IOP reduction.  Y-39983 ophthalmic solution may be a candidate drug for lowering of IOP, since it increases conventional outflow and produces relatively few side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhRiX7jL_YgZw7prLlxLOzfW6udTcc2eYoOVEqWp3Mirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sznsF2rsQ%253D%253D&md5=1fb9210486fe9cfc0f17360552415638</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1167%2Fiovs.05-1617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.05-1617%26sid%3Dliteratum%253Aachs%26aulast%3DTokushige%26aufirst%3DH.%26aulast%3DInatani%26aufirst%3DM.%26aulast%3DNemoto%26aufirst%3DS.%26aulast%3DSakaki%26aufirst%3DH.%26aulast%3DKatayama%26aufirst%3DK.%26aulast%3DUehata%26aufirst%3DM.%26aulast%3DTanihara%26aufirst%3DH.%26atitle%3DEffects%2520of%2520topical%2520administration%2520of%2520Y-39983%252C%2520a%2520selective%2520Rho-associated%2520protein%2520kinase%2520inhibitor%252C%2520on%2520ocular%2520tissues%2520in%2520rabbits%2520and%2520monkeys%26jtitle%3DInvest.%2520Ophthalmol.%2520Visualization%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D3216%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shimokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, A.</span><span> </span><span class="NLM_article-title">Rho-kinase is an important therapeutic target in cardiovascular medicine</span> <span class="citation_source-journal">Arterioscler. Thromb. Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1161%2F01.ATV.0000176193.83629.c8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16002741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1ers74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1767-1775&author=H.+Shimokawaauthor=A.+Takeshita&title=Rho-kinase+is+an+important+therapeutic+target+in+cardiovascular+medicine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine</span></div><div class="casAuthors">Shimokawa, Hiroaki; Takeshita, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1767-1775</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Rho-kinase was identified as one of the effectors of the small GTP-binding protein Rho.  Accumulating evidence has demonstrated that Rho/Rho-kinase pathway plays an important role in various cellular functions, not only in vascular smooth muscle cell (VSMC) contraction but also in actin cytoskeleton organization, cell adhesion and motility, cytokinesis, and gene expressions, all of which may be involved in the pathogenesis of cardiovascular disease.  At mol. level, Rho-kinase upregulates various mols. that accelerate inflammation/oxidative stress, thrombus formation, and fibrosis, whereas it downregulates endothelial nitric oxide synthase.  The expression of Rho-kinase itself is mediated by protein kinase C/NF-κB pathway with an inhibitory and stimulatory modulation by estrogen and nicotine, resp.  At cellular level, Rho-kinase mediates VSMC hypercontraction, stimulates VSMC proliferation and migration, and enhances inflammatory cell motility.  In animal studies, Rho-kinase was shown to be substantially involved in the pathogenesis of vasospasm, arteriosclerosis, ischemia/reperfusion injury, hypertension, pulmonary hypertension, stroke and heart failure, and to enhance central sympathetic nerve activity.  Finally, in clin. studies, fasudil, a Rho-kinase inhibitor, is effective for the treatment of a wide range of cardiovascular disease, including cerebral and coronary vasospasm, angina, hypertension, pulmonary hypertension, and heart failure, with a reasonable safety.  Thus, Rho-kinase is an important therapeutic target in cardiovascular medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj0SltEY8BZbVg90H21EOLACvtfcHk0lgejDYTeFw05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1ers74%253D&md5=e87eff04bc1d815a49af81d62ae2c186</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000176193.83629.c8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000176193.83629.c8%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DA.%26atitle%3DRho-kinase%2520is%2520an%2520important%2520therapeutic%2520target%2520in%2520cardiovascular%2520medicine%26jtitle%3DArterioscler.%2520Thromb.%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1767%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Budzyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobey, C. G.</span><span> </span><span class="NLM_article-title">Vascular rho kinases and their potential therapeutic applications</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=590-596&author=K.+Budzynauthor=C.+G.+Sobey&title=Vascular+rho+kinases+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudzyn%26aufirst%3DK.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26atitle%3DVascular%2520rho%2520kinases%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Viswambharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ming, X.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergères, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span> </span><span class="NLM_article-title">Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">918</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=918-925&author=H.+Viswambharanauthor=X.-F.+Mingauthor=S.+Zhuauthor=A.+Hubschauthor=P.+Lerchauthor=G.+Verg%C3%A8resauthor=S.+Rusconiauthor=Z.+Yang&title=Reconstituted+high-density+lipoprotein+inhibits+thrombin-induced+endothelial+tissue+factor+expression+through+inhibition+of+RhoA+and+stimulation+of+phosphatidylinositol+3-kinase+but+not+Akt%2Fendothelial+nitric+oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViswambharan%26aufirst%3DH.%26aulast%3DMing%26aufirst%3DX.-F.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DHubsch%26aufirst%3DA.%26aulast%3DLerch%26aufirst%3DP.%26aulast%3DVerg%25C3%25A8res%26aufirst%3DG.%26aulast%3DRusconi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DZ.%26atitle%3DReconstituted%2520high-density%2520lipoprotein%2520inhibits%2520thrombin-induced%2520endothelial%2520tissue%2520factor%2520expression%2520through%2520inhibition%2520of%2520RhoA%2520and%2520stimulation%2520of%2520phosphatidylinositol%25203-kinase%2520but%2520not%2520Akt%252Fendothelial%2520nitric%2520oxide%2520synthase%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D94%26spage%3D918%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, D. A.</span><span> </span><span class="NLM_article-title">Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=617-635&author=T.+A.+McKinseyauthor=D.+A.+Kass&title=Small-molecule+therapies+for+cardiac+hypertrophy%3A+moving+beneath+the+cell+surface"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DSmall-molecule%2520therapies%2520for%2520cardiac%2520hypertrophy%253A%2520moving%2520beneath%2520the%2520cell%2520surface%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D617%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jain, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridker, P. M.</span><span> </span><span class="NLM_article-title">Anti-inflammatory effects of statins: clinical evidence and basic mechanisms</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1038%2Fnrd1901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16341063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=977-987&author=M.+K.+Jainauthor=P.+M.+Ridker&title=Anti-inflammatory+effects+of+statins%3A+clinical+evidence+and+basic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms</span></div><div class="casAuthors">Jain, Mukesh K.; Ridker, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">977-987</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic inflammation is a key feature of vascular disease states such as atherosclerosis.  Multiple clin. studies have shown that a class of medications termed statins lower cardiovascular morbidity and mortality.  Originally developed to lower serum cholesterol, increasing evidence suggests that these medications have potent anti-inflammatory effects that contribute to their beneficial effects in patients.  Here, we discuss the clin. and exptl. evidence underlying the anti-inflammatory effects of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvbfgcemlOMbVg90H21EOLACvtfcHk0lgejDYTeFw05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjP&md5=164e13cfaee16c787e0b029471c356a2</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1901%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DM.%2BK.%26aulast%3DRidker%26aufirst%3DP.%2BM.%26atitle%3DAnti-inflammatory%2520effects%2520of%2520statins%253A%2520clinical%2520evidence%2520and%2520basic%2520mechanisms%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D977%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span> </span><span class="NLM_article-title">Rho-kinase inhibitors for cardiovascular disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=87-102&author=R.+A.+Stavenger&title=Rho-kinase+inhibitors+for+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26atitle%3DRho-kinase%2520inhibitors%2520for%2520cardiovascular%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D87%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iijima, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of Rho kinase inhibitors (I)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2115-2137&author=A.+Takamiauthor=M.+Iwakuboauthor=Y.+Okadaauthor=T.+Kawataauthor=H.+Odaiauthor=N.+Takahashiauthor=K.+Shindoauthor=K.+Kimuraauthor=Y.+Tagamiauthor=M.+Miyakeauthor=K.+Fukushimaauthor=M.+Inagakiauthor=M.+Amanoauthor=K.+Kaibuchiauthor=H.+Iijima&title=Design+and+synthesis+of+Rho+kinase+inhibitors+%28I%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakami%26aufirst%3DA.%26aulast%3DIwakubo%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DOdai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DTagami%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DIijima%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520Rho%2520kinase%2520inhibitors%2520%2528I%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2115%26epage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6-9&author=K.+B.+Goodmanauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=D.+E.+Gaitanopoulosauthor=R.+L.+Ivyauthor=C.+A.+Sehonauthor=R.+A.+Stavengerauthor=G.+Z.+Wangauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=S.+F.+Semusauthor=C.+Evansauthor=H.+E.+Friesauthor=L.+J.+Jolivetteauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=R.+Bentleyauthor=C.+P.+Doeauthor=E.+Huauthor=D.+Lee&title=Development+of+dihydropyridone+indazole+amides+as+selective+Rho-kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors</span></div><div class="casAuthors">Goodman, Krista B.; Cui, Haifeng; Dowdell, Sarah E.; Gaitanopoulos, Dimitri E.; Ivy, Robert L.; Sehon, Clark A.; Stavenger, Robert A.; Wang, Gren Z.; Viet, Andrew Q.; Xu, Weiwei; Ye, Guosen; Semus, Simon F.; Evans, Christopher; Fries, Harvey E.; Jolivette, Larry J.; Kirkpatrick, Robert B.; Dul, Edward; Khandekar, Sanjay S.; Yi, Tracey; Jung, David K.; Wright, Lois L.; Smith, Gary K.; Behm, David J.; Bentley, Ross; Doe, Christopher P.; Hu, Erding; Lee, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rho kinase (ROCK1) mediates vascular smooth muscle contraction and is a potential target for the treatment of hypertension and related disorders.  Indazole amide 3 was identified as a potent and selective ROCK1 inhibitor but possessed poor oral bioavailability.  Optimization of this lead resulted in the discovery of a series of dihydropyridones, exemplified by 13, with improved pharmacokinetic parameters relative to the initial lead.  Indazole substitution played a crit. role in decreasing clearance and improving oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOGlkSgS6prVg90H21EOLACvtfcHk0lhfro8ch-FF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbnF&md5=4a2b2f5636a4631f95e521ec98068e0e</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm0609014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609014%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DG.%2BZ.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DFries%26aufirst%3DH.%2BE.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520dihydropyridone%2520indazole%2520amides%2520as%2520selective%2520Rho-kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stavenger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitanopoulos, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060873p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2-5&author=R.+A.+Stavengerauthor=H.+Cuiauthor=S.+E.+Dowdellauthor=R.+G.+Franzauthor=D.+E.+Gaitanopoulosauthor=K.+B.+Goodmanauthor=M.+A.+Hilfikerauthor=R.+L.+Ivyauthor=J.+D.+Leberauthor=J.+P.+Marinoauthor=H.-J.+Ohauthor=A.+Q.+Vietauthor=W.+Xuauthor=G.+Yeauthor=D.+Zhangauthor=Y.+Zhaoauthor=L.+J.+Jolivetteauthor=M.+S.+Headauthor=S.+F.+Semusauthor=P.+A.+Elkinsauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=D.+K.+Jungauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=C.+P.+Doeauthor=R.+Bentleyauthor=Z.+X.+Chenauthor=E.+Huauthor=D.+Lee&title=Discovery+of+aminofurazan-azabenzimidazoles+as+inhibitors+of+Rho-kinase+with+high+kinase+selectivity+and+antihypertensive+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=10.1021%2Fjm060873p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060873p%26sid%3Dliteratum%253Aachs%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DFranz%26aufirst%3DR.%2BG.%26aulast%3DGaitanopoulos%26aufirst%3DD.%2BE.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DHilfiker%26aufirst%3DM.%2BA.%26aulast%3DIvy%26aufirst%3DR.%2BL.%26aulast%3DLeber%26aufirst%3DJ.%2BD.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DD.%2BK.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DZ.%2BX.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520aminofurazan-azabenzimidazoles%2520as%2520inhibitors%2520of%2520Rho-kinase%2520with%2520high%2520kinase%2520selectivity%2520and%2520antihypertensive%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Sehon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viet, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span> </span><span class="NLM_article-title">Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6631</span><span class="NLM_x">–</span> <span class="NLM_lpage">6634</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6631-6634&author=C.+A.+Sehonauthor=G.+Z.+Wangauthor=A.+Q.+Vietauthor=K.+B.+Goodmanauthor=S.+E.+Dowdellauthor=P.+A.+Elkinsauthor=S.+F.+Semusauthor=C.+Evansauthor=L.+J.+Jolivetteauthor=R.+B.+Kirkpatrickauthor=E.+Dulauthor=S.+S.+Khandekarauthor=T.+Yiauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=D.+J.+Behmauthor=R.+Bentleyauthor=C.+P.+Doeauthor=E.+Huauthor=D.+Lee&title=Potent%2C+selective+and+orally+bioavailable+dihydropyrimidine+inhibitors+of+Rho+kinase+%28ROCK1%29+as+potential+therapeutic+agents+for+cardiovascular+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=10.1021%2Fjm8005096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005096%26sid%3Dliteratum%253Aachs%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DG.%2BZ.%26aulast%3DViet%26aufirst%3DA.%2BQ.%26aulast%3DGoodman%26aufirst%3DK.%2BB.%26aulast%3DDowdell%26aufirst%3DS.%2BE.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520bioavailable%2520dihydropyrimidine%2520inhibitors%2520of%2520Rho%2520kinase%2520%2528ROCK1%2529%2520as%2520potential%2520therapeutic%2520agents%2520for%2520cardiovascular%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6631%26epage%3D6634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schürer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P.</span><span> </span><span class="NLM_article-title">Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800986w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24f&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6642-6645&author=Y.+Fengauthor=Y.+Yinauthor=A.+Weiserauthor=E.+Griffinauthor=M.+D.+Cameronauthor=L.+Linauthor=C.+Ruizauthor=S.+C.+Sch%C3%BCrerauthor=T.+Inoueauthor=P.+V.+Raoauthor=T.+Schr%C3%B6terauthor=P.+LoGrasso&title=Discovery+of+substituted+4-%28pyrazol-4-yl%29-phenylbenzodioxane-2-carboxamides+as+potent+and+highly+selective+Rho+kinase+%28ROCK-II%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24fR"><div class="casContent"><span class="casTitleNuber">24f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Substituted 4-(Pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors</span></div><div class="casAuthors">Feng, Yangbo; Yin, Yan; Weiser, Amiee; Griffin, Evelyn; Cameron, Michael D.; Lin, Li; Ruiz, Claudia; Schurer, Stephan C.; Inoue, Toshihiro; Rao, P. Vasanth; Schroter, Thomas; LoGrasso, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6642-6645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a new class of potent and selective ROCK-II inhibitors is presented.  Compd. SR-3677 (I) had an IC50 of ∼3 nM in enzyme and cell based assays and had an off-target hit rate of 1.4% against 353 kinases, and inhibited only 3 out of 70 nonkinase enzymes and receptors.  Pharmacol. studies showed that I was efficacious in both, increasing ex vivo aq. humor outflow in porcine eyes and inhibiting myosin light chain phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolgwD1AJB2GbVg90H21EOLACvtfcHk0lgBCJM6PTxpfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtLvJ&md5=1c550d187ef3a061cf249cdd001b7d04</span></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=10.1021%2Fjm800986w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800986w%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DWeiser%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DSch%25C3%25BCrer%26aufirst%3DS.%2BC.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BV.%26aulast%3DSchr%25C3%25B6ter%26aufirst%3DT.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520substituted%25204-%2528pyrazol-4-yl%2529-phenylbenzodioxane-2-carboxamides%2520as%2520potent%2520and%2520highly%2520selective%2520Rho%2520kinase%2520%2528ROCK-II%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6642%26epage%3D6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liao, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noma, K.</span><span> </span><span class="NLM_article-title">J. Rho kinase (ROCK) inhibitors</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=17-24&author=J.+K.+Liaoauthor=M.+Setoauthor=K.+Noma&title=J.+Rho+kinase+%28ROCK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26aulast%3DSeto%26aufirst%3DM.%26aulast%3DNoma%26aufirst%3DK.%26atitle%3DJ.%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitors%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, J.</span><span> </span><span class="NLM_article-title">The structure of dimeric ROCK I reveals the mechanism for ligand selectivity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=260-268&author=M.+Jacobsauthor=K.+Hayakawaauthor=L.+Swensonauthor=S.+Bellonauthor=M.+Flemingauthor=P.+Taslimiauthor=J.+Doran&title=The+structure+of+dimeric+ROCK+I+reveals+the+mechanism+for+ligand+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DDoran%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520dimeric%2520ROCK%2520I%2520reveals%2520the%2520mechanism%2520for%2520ligand%2520selectivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D260%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span> </span><span class="NLM_article-title">Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1093%2Fjb%2Fmvj172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16891330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2006&pages=305-311&author=H.+Yamaguchiauthor=Y.+Miwaauthor=M.+Kasaauthor=K.+Kitanoauthor=M.+Amanoauthor=K.+Kaibuchiauthor=T.+Hakoshima&title=Structural+basis+for+induced-fit+binding+of+Rho-kinase+to+the+inhibitor+Y-27632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632</span></div><div class="casAuthors">Yamaguchi, Hiroto; Miwa, Yukiko; Kasa, Miyuki; Kitano, Ken; Amano, Mutsuki; Kaibuchi, Kozo; Hakoshima, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-311</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Rho-kinase is a main player in the regulation of cytoskeletal events and a promising drug target in the treatment of both vascular and neurol. disorders.  Here we report the crystal structure of the Rho-kinase catalytic domain in complex with the specific inhibitor Y-27632.  Comparison with the structure of PKA bound to this inhibitor revealed a potential induced-fit binding mode that can be accommodated by the phosphate binding loop (P-loop).  This binding mode resembles that obsd. in the Rho-kinase-fasudil complex.  A structural database search indicated that a pocket underneath the phosphate-binding loop is present that favors binding to a small arom. ring.  Introduction of such a ring group might spawn a new modification scheme of pre-existing protein kinase inhibitors for improved binding capability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrechzHfFmzYbVg90H21EOLACvtfcHk0lgBCJM6PTxpfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7%252FF&md5=edbb89b5fe6cb429e915b84f3488a08f</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj172%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DY.%26aulast%3DKasa%26aufirst%3DM.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520for%2520induced-fit%2520binding%2520of%2520Rho-kinase%2520to%2520the%2520inhibitor%2520Y-27632%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D140%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span> </span><span class="NLM_article-title">Molecular mechanism for the regulation of Rho-kinase by dimerization and its inhibition by fasudil</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=589-600&author=H.+Yamaguchiauthor=M.+Kasaauthor=+K.author=M.+Amanoauthor=K.+Kaibuchiauthor=T.+Hakoshima&title=Molecular+mechanism+for+the+regulation+of+Rho-kinase+by+dimerization+and+its+inhibition+by+fasudil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DKasa%26aufirst%3DM.%26aulast%3DK.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DMolecular%2520mechanism%2520for%2520the%2520regulation%2520of%2520Rho-kinase%2520by%2520dimerization%2520and%2520its%2520inhibition%2520by%2520fasudil%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D589%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brickwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeTuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksiazek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledziona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Evolution of the thienopyridine class of inhibitors of IκB kinase-β: Part I—hit-to-lead strategies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2898</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0510979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2898-2908&author=T.+M.+Morwickauthor=A.+Berryauthor=J.+Brickwoodauthor=M.+Cardozoauthor=K.+Catronauthor=M.+DeTuriauthor=J.+Emeighauthor=C.+Homonauthor=M.+Hrapchakauthor=S.+Jacoberauthor=S.+Jakesauthor=P.+Kaplitaauthor=T.+Kellyauthor=J.+Ksiazekauthor=M.+Liuzziauthor=R.+Magoldaauthor=C.+Maoauthor=D.+Marshallauthor=D.+McNeilauthor=A.+III+Prokopowiczauthor=C.+Sarkoauthor=E.+Scoutenauthor=C.+Sledzionaauthor=S.+Sunauthor=J.+Watrousauthor=J.-P.+Wuauthor=C.+L.+Cywin&title=Evolution+of+the+thienopyridine+class+of+inhibitors+of+I%CE%BAB+kinase-%CE%B2%3A+Part+I%E2%80%94hit-to-lead+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0510979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0510979%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBrickwood%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DCatron%26aufirst%3DK.%26aulast%3DDeTuri%26aufirst%3DM.%26aulast%3DEmeigh%26aufirst%3DJ.%26aulast%3DHomon%26aufirst%3DC.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKaplita%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DKsiazek%26aufirst%3DJ.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMcNeil%26aufirst%3DD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BIII%26aulast%3DSarko%26aufirst%3DC.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DSledziona%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWatrous%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DEvolution%2520of%2520the%2520thienopyridine%2520class%2520of%2520inhibitors%2520of%2520I%25CE%25BAB%2520kinase-%25CE%25B2%253A%2520Part%2520I%25E2%2580%2594hit-to-lead%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2898%26epage%3D2908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Breitenlechner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gassel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossemeyer, D.</span><span> </span><span class="NLM_article-title">Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P: Structural Basis of Selectivity</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1595-1607&author=C.+Breitenlechnerauthor=M.+Gasselauthor=H.+Hidakaauthor=V.+Kinzelauthor=R.+Huberauthor=R.+A.+Enghauthor=D.+Bossemeyer&title=Protein+Kinase+A+in+Complex+with+Rho-Kinase+Inhibitors+Y-27632%2C+Fasudil%2C+and+H-1152P%3A+Structural+Basis+of+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenlechner%26aufirst%3DC.%26aulast%3DGassel%26aufirst%3DM.%26aulast%3DHidaka%26aufirst%3DH.%26aulast%3DKinzel%26aufirst%3DV.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DBossemeyer%26aufirst%3DD.%26atitle%3DProtein%2520Kinase%2520A%2520in%2520Complex%2520with%2520Rho-Kinase%2520Inhibitors%2520Y-27632%252C%2520Fasudil%252C%2520and%2520H-1152P%253A%2520Structural%2520Basis%2520of%2520Selectivity%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southall, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span> </span><span class="NLM_article-title">Characterization of chemical libraries for luciferase inhibitory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2372</span><span class="NLM_x">–</span> <span class="NLM_lpage">2386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701302v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2372-2386&author=D.+S.+Auldauthor=N.+T.+Southallauthor=A.+Jadhavauthor=R.+L.+Johnsonauthor=D.+J.+Dillerauthor=A.+Simeonovauthor=C.+P.+Austinauthor=J.+Inglese&title=Characterization+of+chemical+libraries+for+luciferase+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm701302v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701302v%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSouthall%26aufirst%3DN.%2BT.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520chemical%2520libraries%2520for%2520luciferase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2372%26epage%3D2386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><div class="note"><p class="first last">See also:</p></div><span class="NLM_contrib-group">Auld, D. S.; Zhang, Y.-Q.; Southall, N. T.; Rai, G.; Landsman, M.; MacLure, J.; Langevin, D.; Thomas, C. J.; Austin, C. P.; Inglese, J.</span><span> </span><span class="NLM_article-title">A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1450</span>− <span class="NLM_lpage">1458</span> for a comparison of assay reagents.</span><div class="citationLinks">[<a href="/doi/10.1021/jm8014525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1450-1458&author=D.+S.+Auld&author=Y.-Q.+Zhang&author=N.+T.+Southall&author=G.+Rai&author=M.+Landsman&author=J.+MacLure&author=D.+Langevin&author=C.+J.+Thomas&author=C.+P.+Austin&author=J.+Inglese&title=A+basis+for+reduced+chemical+library+inhibition+of+firefly+luciferase+obtained+from+directed+evolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fjm8014525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014525%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DA%2520basis%2520for%2520reduced%2520chemical%2520library%2520inhibition%2520of%2520firefly%2520luciferase%2520obtained%2520from%2520directed%2520evolution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1450%26epage%3D1458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morwick, T. M.</span><span> </span><span class="NLM_article-title">High-throughput ester hydrolysis with catch-and-release isolation of carboxylic acids</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc060064r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=649-651&author=T.+M.+Morwick&title=High-throughput+ester+hydrolysis+with+catch-and-release+isolation+of+carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput ester hydrolysis with catch-and-release isolation of carboxylic acids</span></div><div class="casAuthors">Morwick, Tina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-651</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of Amberlyst A26 for high-throughput esters hydrolysis with catch-ana-release isolation of the product carboxylic acids was studied.  It was found that electronic effects on reactivity were significant.  For electron-rich system, the modest conversions could be overcome using microwave irradn.  In addn., a strong acid eluent was required in some cases to achieve good recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxAQS7Xb7aNLVg90H21EOLACvtfcHk0ljZttaQOByF1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsrk%253D&md5=60807be7fdabda6e2437e9131ef1b650</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fcc060064r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc060064r%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26atitle%3DHigh-throughput%2520ester%2520hydrolysis%2520with%2520catch-and-release%2520isolation%2520of%2520carboxylic%2520acids%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2006%26volume%3D8%26spage%3D649%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergbreiter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romo, D.</span><span> </span><span class="NLM_article-title">Simultaneous deprotection and purification of BOC-amines based on ionic resin capture</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3471</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo972001o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3471&author=Y.-S.+Liuauthor=C.+Zhaoauthor=D.+E.+Bergbreiterauthor=D.+Romo&title=Simultaneous+deprotection+and+purification+of+BOC-amines+based+on+ionic+resin+capture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjo972001o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo972001o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-S.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DBergbreiter%26aufirst%3DD.%2BE.%26aulast%3DRomo%26aufirst%3DD.%26atitle%3DSimultaneous%2520deprotection%2520and%2520purification%2520of%2520BOC-amines%2520based%2520on%2520ionic%2520resin%2520capture%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">The Leukart Reaction</span> <span class="citation_source-journal">Org. React.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1941&pages=301-330&author=M.+L.+Moore&title=The+Leukart+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DThe%2520Leukart%2520Reaction%26jtitle%3DOrg.%2520React.%26date%3D1941%26volume%3D5%26spage%3D301%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manners, C. N.</span><span> </span><span class="NLM_article-title">Development of a generalized, quantitative physiochemical model of CYP3A4 inhibition for use in early drug discovery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=652-655&author=R.+J.+Rileyauthor=A.+J.+Parkerauthor=S.+Triggauthor=C.+N.+Manners&title=Development+of+a+generalized%2C+quantitative+physiochemical+model+of+CYP3A4+inhibition+for+use+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BJ.%26aulast%3DTrigg%26aufirst%3DS.%26aulast%3DManners%26aufirst%3DC.%2BN.%26atitle%3DDevelopment%2520of%2520a%2520generalized%252C%2520quantitative%2520physiochemical%2520model%2520of%2520CYP3A4%2520inhibition%2520for%2520use%2520in%2520early%2520drug%2520discovery%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D652%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Doe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafferty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolivette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, J. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willette, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span> </span><span class="NLM_article-title">Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1124%2Fjpet.106.110635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=17018693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=89-98&author=C.+Doeauthor=R.+Bentleyauthor=D.+J.+Behmauthor=R.+Laffertyauthor=R.+Stavengerauthor=D.+Jungauthor=M.+Bamfordauthor=T.+Panchalauthor=E.+Grygielkoauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=Z.+Chenauthor=C.+Webbauthor=S.+Khandekarauthor=T.+Yiauthor=R.+Kirkpatrickauthor=E.+Dulauthor=L.+Jolivetteauthor=J.+P.+Marinoauthor=R.+Willetteauthor=D.+Leeauthor=E.+Hu&title=Novel+Rho+kinase+inhibitors+with+anti-inflammatory+and+vasodilatory+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities</span></div><div class="casAuthors">Doe, Chris; Bentley, Ross; Behm, David J.; Lafferty, Robert; Stavenger, Robert; Jung, David; Bamford, Mark; Panchal, Terry; Grygielko, Eugene; Wright, Lois L.; Smith, Gary K.; Chen, Zunxuan; Webb, Christine; Khandekar, Sanjay; Yi, Tracey; Kirkpatrick, Robert; Dul, Edward; Jolivette, Larry; Marino, Joseph P., Jr.; Willette, Robert; Lee, Dennis; Hu, Erding</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Increased Rho kinase (ROCK) activity contributes to smooth muscle contraction and regulates blood pressure homeostasis.  We hypothesized that potent and selective ROCK inhibitors with novel structural motifs would help elucidate the functional role of ROCK and further explore the therapeutic potential of ROCK inhibition for hypertension.  In this article, we characterized two aminofurazan-based inhibitors, GSK269962A [N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]-oxy}benzamide] and SB-7720770-B [4-(7-{[(3S)-3-amino-1-pyrrolidinyl]carbonyl}-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine], as members of a novel class of compds. that potently inhibit ROCK enzymic activity.  GSK269962A and SB-772077-B have IC50 values of 1.6 and 5.6 nM toward recombinant human ROCK1, resp.  GSK269962A also exhibited more than 30-fold selectivity against a panel of serine/threonine kinases.  In lipopolysaccharide-stimulated monocytes, these inhibitors blocked the generation of inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-α.  Furthermore, both SB-772077-B and GSK269962A induced vasorelaxation in preconstricted rat aorta with an IC50 of 39 and 35 nM, resp.  Oral administration of either GSK269962A or SB-772077-B produced a profound dose-dependent redn. of systemic blood pressure in spontaneously hypertensive rats.  At doses of 1, 3, and 30 mg/kg, both compds. induced a redn. in blood pressure of approx. 10, 20, and 50 mm Hg.  In addn., administration of SB-772077-B also dramatically lowered blood pressure in DOCA salt-induced hypertensive rats.  SB-772077-B and GSK269962A represent a novel class of ROCK inhibitors that have profound effects in the vasculature and may enable us to further evaluate the potential beneficial effects of ROCK inhibition in animal models of cardiovascular as well as other chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOuPjuVLTrwrVg90H21EOLACvtfcHk0lifCD2xNK5ilg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFeqsw%253D%253D&md5=ab8ba12bca20241815721e2cc9273774</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110635%26sid%3Dliteratum%253Aachs%26aulast%3DDoe%26aufirst%3DC.%26aulast%3DBentley%26aufirst%3DR.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DLafferty%26aufirst%3DR.%26aulast%3DStavenger%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DD.%26aulast%3DBamford%26aufirst%3DM.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DGrygielko%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWebb%26aufirst%3DC.%26aulast%3DKhandekar%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DKirkpatrick%26aufirst%3DR.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DJolivette%26aufirst%3DL.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DWillette%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DE.%26atitle%3DNovel%2520Rho%2520kinase%2520inhibitors%2520with%2520anti-inflammatory%2520and%2520vasodilatory%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Turner, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trauger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. L.</span><span> </span><span class="NLM_article-title">Characterization and purification of truncated human Rho-kinase II expressed in <i>Sf</i>-21 cells</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2002&pages=13-20&author=M.+S.+Turnerauthor=F.-F.+Linauthor=J.+W.+Traugerauthor=J.+Stephensauthor=P.+L.+LoGrasso&title=Characterization+and+purification+of+truncated+human+Rho-kinase+II+expressed+in+Sf-21+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DF.-F.%26aulast%3DTrauger%26aufirst%3DJ.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%2BL.%26atitle%3DCharacterization%2520and%2520purification%2520of%2520truncated%2520human%2520Rho-kinase%2520II%2520expressed%2520in%2520Sf-21%2520cells%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2002%26volume%3D405%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khandekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span> </span><span class="NLM_article-title">Expression, purification, and characterization of an enzymatically active truncated human Rho-kinase I (ROCK I) domain expressed in <i>Sf</i>-9 insect cells</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.2174%2F092986606775974357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=16712513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Kru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=369-376&author=S.+S.+Khandekarauthor=T.+Yiauthor=E.+Dulauthor=L.+L.+Wrightauthor=S.+Chenauthor=G.+F.+Scottauthor=G.+K.+Smithauthor=D.+Leeauthor=E.+Huauthor=R.+B.+Kirkpatrick&title=Expression%2C+purification%2C+and+characterization+of+an+enzymatically+active+truncated+human+Rho-kinase+I+%28ROCK+I%29+domain+expressed+in+Sf-9+insect+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of an enzymatically active truncated human Rho-Kinase I (ROCK I) domain expressed in Sf-9 insect cells</span></div><div class="casAuthors">Khandekar, Sanjay S.; Yi, Tracey; Dul, Ed; Wright, Lois L.; Chen, Susan; Scott, Gilbert F.; Smith, Gary K.; Lee, Dennis; Hu, Erding; Kirkpatrick, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">369-376</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Rho Kinase I (ROCK I) is a serine/threonine kinase that is involved in diverse cellular signaling.  To further understand the physiol. role of ROCK I and to identify and develop potent and selective inhibitors of ROCK I, we have overexpressed and purified a constitutively active dimeric human ROCK I (3-543) kinase domain using the Sf9-baculovirus expression system.  In addn., using a limited proteolysis technique, we have identified a minimal functional subdomain of ROCK I that can be used in crystn. studies.  The availability of multimilligram amts. of purified and well characterized functional human ROCK I kinase domains will be useful in screening and structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHzawF_k5M77Vg90H21EOLACvtfcHk0lgAl67q6rjn2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Kru7Y%253D&md5=303f080a3e5bd3394aca7f2182f8ce88</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.2174%2F092986606775974357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986606775974357%26sid%3Dliteratum%253Aachs%26aulast%3DKhandekar%26aufirst%3DS.%2BS.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DG.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26atitle%3DExpression%252C%2520purification%252C%2520and%2520characterization%2520of%2520an%2520enzymatically%2520active%2520truncated%2520human%2520Rho-kinase%2520I%2520%2528ROCK%2520I%2529%2520domain%2520expressed%2520in%2520Sf-9%2520insect%2520cells%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2006%26volume%3D13%26spage%3D369%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Fjm9014263&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Fjm9014263&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Fjm9014263&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lgAl67q6rjn2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q8W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q8W','PDB','1Q8W'); return false;">PDB: 1Q8W</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/jm9014263">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03841"></div></div></div></div></div><hr /></hr><p class="last">ATP competition studies, data comparison for luciferase inhibitors using IMAP and luciferase assay formats, IMAP dose−response assay method, additional kinase selectivity data, and target independent profiling methods. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9014263/suppl_file/jm9014263_si_001.pdf">jm9014263_si_001.pdf (102.09 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9014263&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm9014263%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-2" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9014263" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799964e7ab03c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
